Washington University in St. Louis

Washington University Open Scholarship
Arts & Sciences Electronic Theses and
Dissertations

Arts & Sciences

Spring 5-15-2020

FGF20 in Olfactory System and Cochlea Development
Lu Morgan Yang
Washington University in St. Louis

Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds
Part of the Developmental Biology Commons, Genetics Commons, and the Neuroscience and
Neurobiology Commons

Recommended Citation
Yang, Lu Morgan, "FGF20 in Olfactory System and Cochlea Development" (2020). Arts & Sciences
Electronic Theses and Dissertations. 2257.
https://openscholarship.wustl.edu/art_sci_etds/2257

This Dissertation is brought to you for free and open access by the Arts & Sciences at Washington University Open
Scholarship. It has been accepted for inclusion in Arts & Sciences Electronic Theses and Dissertations by an
authorized administrator of Washington University Open Scholarship. For more information, please contact
digital@wumail.wustl.edu.

WASHINGTON UNIVERSITY IN ST. LOUIS
Division of Biology and Biomedical Sciences
Developmental, Regenerative and Stem Cell Biology

Dissertation Examination Committee:
David Ornitz, Chair
Joseph Dougherty
Timothy Holy
Kristen Kroll
Mark Warchol

FGF20 in Olfactory System and Cochlea Development
by
Lu Yang

A dissertation presented to
The Graduate School
of Washington University in
partial fulfillment of the
requirements for the degree
of Doctor of Philosophy

May 2020
St. Louis, Missouri

© 2020, Lu Yang

Table of Contents
List of Figures ................................................................................................................................ vi
List of Tables ............................................................................................................................... viii
Acknowledgments.......................................................................................................................... ix
Abstract .......................................................................................................................................... xi
Chapter 1: A Fibroblast Growth Factor 20-Expressing, Wnt-Responsive Progenitor Populates the
Olfactory Epithelium and Regulates Turbinate Growth ................................................................. 1
1.1 Summary ................................................................................................................................ 1
1.2 Introduction ........................................................................................................................... 1
1.3 Results ................................................................................................................................... 4
1.3.1

Fgf20 is expressed in a subset of Sox2+ cells in the developing OE..................................... 5

1.3.2

Fgf20 lineage includes all major OE cell types and responds to cues for expansion ............ 7

1.3.3

Fgf20-KO mice have reduced turbinate size and altered morphology ................................ 10

1.3.4

Fgf20 is required for mesenchymal proliferation early in turbinate development .............. 11

1.3.5

Ectopic activation of FGF ligand expression in the OE drives mesenchymal growth ........ 13

1.3.6

Wnt activity in the developing OE coincides with Fgf20 expression ................................. 14

1.3.7

βCat conditional deletion results in a severe deficit in turbinate development................... 15

1.3.8
Specific disruption of βCat signaling also results in a severe deficit in turbinate
development ........................................................................................................................................ 17
1.3.9
βCat conditional deletion causes decreased mesenchymal proliferation in developing
turbinates ............................................................................................................................................. 18
1.3.10 βCat conditional deletion leads to premature differentiation and progenitor depletion in the
OE ....................................................................................................................................................... 19
1.3.11 Specific disruption of βCat signaling leads to premature OE differentiation .......................... 20
1.3.12 βCat stabilization prevents differentiation of FEP cells ........................................................... 21
1.3.13 βCat stabilization results in mesenchyme expansion without condensation in turbinates ....... 23

1.4 Discussion ........................................................................................................................... 24
1.4.1

FEP cells are an embryonic OE progenitor population that expands the OE...................... 24

1.4.2

FEP cells have potential for dysplasia ................................................................................ 27

1.4.3

Wnt/βCat signaling maintains FEP stemness ...................................................................... 27

1.4.4
Disruptions to signaling, not cell adhesion, accounts for most of the βCat loss-of-function
phenotype ............................................................................................................................................ 29

ii

1.4.5
Wnt/βCat signaling in FEP cells regulates turbinate development via epithelialmesenchymal signaling ....................................................................................................................... 29

1.5 Methods ............................................................................................................................... 33
1.5.1

Mice .................................................................................................................................... 33

1.5.2

Doxycycline induction ........................................................................................................ 35

1.5.3

Sample preparation ............................................................................................................. 35

1.5.4

RNA in situ hybridization ................................................................................................... 36

1.5.5

Histology and immunofluorescence .................................................................................... 37

1.5.6

Antibodies ........................................................................................................................... 38

1.5.9

Measurements and cell quantification ................................................................................. 38

1.5.7

Cell proliferation assay ....................................................................................................... 43

1.5.8

Imaging ............................................................................................................................... 43

1.5.10

Statistics and plotting .......................................................................................................... 43

Chapter 2: Sculpting the Skull Through Neurosensory Epithelial-Mesenchymal Signaling: A
Literature Review.......................................................................................................................... 73
2.1 Summary .............................................................................................................................. 73
2.2 Introduction ......................................................................................................................... 73
2.3 Inner Ear ............................................................................................................................. 75
2.3.1

Structure and function ......................................................................................................... 75

2.3.2

Development ....................................................................................................................... 76

2.4 Main Olfactory System ........................................................................................................ 83
2.4.1

Structure and function ......................................................................................................... 83

2.4.2

Development ....................................................................................................................... 84

2.5 Conclusions and Future Directions .................................................................................... 89
Chapter 3: Fgf20 and Sox2 interact during cochlear sensory epithelium specification and
differentiation ................................................................................................................................ 96
3.1 Summary .............................................................................................................................. 96
3.2 Introduction ......................................................................................................................... 97
3.3 Results ............................................................................................................................... 100
3.3.1
The Fgf20-null cochlear phenotype is less severe than the Fgfr1-conditional null
phenotype .......................................................................................................................................... 100
3.3.2
Genetic rescue of the Fgf20-null phenotype suggests that FGF20 is required for hair cell
and supporting cell differentiation. ................................................................................................... 101

iii

3.3.3

FGFR1 has a role in prosensory specification in addition to differentiation .................... 104

3.3.4

Decrease in Sox2 expression results in similar phenotypes to Fgf20/Fgfr1 deletion ........ 105

3.3.5

Sox2 is upstream of, but epistatic to, Fgf20 ...................................................................... 107

3.3.6

Sox2 and Fgf20 interact epistatically during cochlea development .................................. 109

3.3.7
Sox2 and Fgf20 double mutants recapture the Fgfr1 conditional null and Sox2Ysb/phenotypes ........................................................................................................................................ 111

3.4 Discussion ......................................................................................................................... 112
3.4.1
Fgfr1 is involved in prosensory specification and differentiation, while Fgf20 is only
involved in differentiation................................................................................................................. 112
3.4.2

Fgf20 and Sox2 interact during cochlea development ...................................................... 114

3.4.3
The Fgf20-/-;Sox2Ysb/Ysb phenotype resembles that of both Fgfr1 conditional deletion and
Ysb/Sox2
........................................................................................................................................... 116
3.4.4
Outer compartment of the cochlear sensory epithelium is more sensitive to the loss of
Fgfr1, Fgf20, and Sox2 than the inner compartment. ....................................................................... 117
3.4.5

Conclusions ....................................................................................................................... 118

3.5 Methods ............................................................................................................................. 118
3.5.1

Mice .................................................................................................................................. 118

3.5.2

Doxycycline induction ...................................................................................................... 120

3.5.3

Sample preparation ........................................................................................................... 120

3.5.4

RNA in situ hybridization ................................................................................................. 121

3.5.5

Histology and immunofluorescence .................................................................................. 122

3.5.6

Antibodies ......................................................................................................................... 123

3.5.7

Cell proliferation assay ..................................................................................................... 123

3.5.8

Imaging ............................................................................................................................. 123

3.5.9

Measurements and cell quantification ............................................................................... 124

3.5.10

Statistics and plotting ........................................................................................................ 125

Chapter 4: Analysis of transcriptomic changes in cochlear prosensory progenitors in the absence
of FGF20 signaling ..................................................................................................................... 146
4.1 Introduction ....................................................................................................................... 146
4.2 Results ............................................................................................................................... 147
4.2.1

Fgf20Cre targets TRAP L10a-eGFP expression to the prosensory domain ....................... 147

4.2.2

Fgf20Cre TRAPseq enriched for prosensory domain mRNA ............................................ 148

4.2.3
TRAPseq revealed known and novel FGF target genes during cochlear sensory epithelium
differentiation .................................................................................................................................... 150

iv

4.3 Future Directions .............................................................................................................. 154
4.4 Methods ............................................................................................................................. 155
4.4.1

Mice .................................................................................................................................. 156

4.4.2

Translating ribosome affinity purification (TRAP) .......................................................... 156

4.4.3

qRT-PCR........................................................................................................................... 157

4.4.4

cDNA library preparation and sequencing ........................................................................ 158

4.4.5

Bioinformatic analysis ...................................................................................................... 158

4.4.6

RNA in situ hybridization ................................................................................................. 159

4.4.7

Immunofluorescence ......................................................................................................... 160

References ................................................................................................................................... 171

v

List of Figures
Figure 1.1

Fgf20 is expressed in a subset of Sox2+ cells in the developing OE.………..….45

Figure 1.2

Related to Figure 1.1…………………………………………………..…….…..47

Figure 1.3

“Neck” OE is more proliferative and less neurogenic than other
parts of the OE…………………………………………………………………...49

Figure 1.4

Fgf20 lineage includes all major OE cell types and responds to cues
for expansion..........................................................................................................51

Figure 1.5

Fgf20-KO mice have reduced turbinate size and altered morphology..…………53

Figure 1.6

Related to Figure 1.5………..…………………………………...……………….55

Figure 1.7

Related to Figure 1.5…………………………………………..…………………57

Figure 1.8

Wnt activity in the developing OE coincides with Fgf20 expression…...……….59

Figure 1.9

βCat conditional deletion results in a severe deficit in turbinate
development…………………………………………………………………..….61

Figure 1.10

Specific disruption of βCat signaling also results in a severe deficit
in turbinate development……………………………………………………...….63

Figure 1.11

βCat conditional deletion leads to premature differentiation and
progenitor depletion in the OE……………………………………………...……65

Figure 1.12

Specific disruption of βCat signaling leads to premature OE
differentiation…………………………………………………………………….67

Figure 1.13

βCat stabilization prevents differentiation of FEP cells……………………..…..69

Figure 1.14

βCat stabilization results in mesenchyme expansion without
condensation in turbinates………………………………………………………..71

Figure 2.1

Schematic of inner ear and periotic mesenchyme development…………………91

Figure 2.2

Schematic of main olfactory epithelium, posterior nasal capsule,
septum, and turbinate development……………………………………………...93

Figure 2.3

Turbinate protrusion shapes the OE to maintain OE progenitor
vi

cells………………………………………………………………………………94
Figure 2.4

Model of established epithelial-mesenchymal interactions during
inner ear and olfactory system development………………………………...…..95

Figure 3.1

The Fgf20-null cochlear phenotype is less severe than the Fgfr1conditional null phenotype………………….……………………………….….126

Figure 3.2

Related to Figure 3.1………………………………………………………..…..128

Figure 3.3

Genetic rescue of the Fgf20-null phenotype suggests that FGF20
is required for hair cell and supporting cell differentiation………….…………129

Figure 3.4

FGFR1 has a role in prosensory specification in addition to
differentiation…………………………………………………………………...131

Figure 3.5

Decrease in Sox2 expression results in similar phenotypes to
Fgf20/Fgfr1 deletion……………………………………………………………133

Figure 3.6

Related to Figure 3.5………………………………………………………..…..135

Figure 3.7

Sox2 is upstream of, but epistatic to, Fgf20…………………………………….137

Figure 3.8

Sox2 and Fgf20 interact epistatically during cochlea development………….…139

Figure 3.9

Sox2 and Fgf20 interact epistatically during cochlea development………….…140

Figure 3.10

Related to Figure 3.9…………………………………………………………....142

Figure 3.11

Sox2 and Fgf20 double mutants recapture the Fgfr1 conditional null
and Sox2Ysb/- phenotypes………………………………………………….…….144

Figure 4.1

Fgf20Cre targets TRAP L10a-eGFP expression to the prosensory
domain…………………………………………………………………………..161

Figure 4.2

Fgf20Cre TRAPseq enriched for prosensory domain mRNA…………………...162

Figure 4.3

Volcano plot showing Fgf20-KO versus control differentially
expressed genes identified by TRAPseq…………………………………..……164

Figure 4.4

TRAPseq revealed known and novel FGF target genes during
cochlear sensory epithelium differentiation………………………………….....165

vii

List of Tables
Table 4.1

Top 12 enriched gene ontology (GO) terms from a list of 2017
differentially expressed genes depleted by TRAP, compared to
preTRAP samples…………………………………………………………..…..166

Table 4.2

Top 12 enriched gene ontology (GO) terms from a list of 1833
differentially expressed genes enriched by TRAP, compared to
preTRAP samples……………………………………………………………....167

Table 4.3

Control versus Fgf20-KO TRAP differentially expressed genes
associated with FGF signaling………………………………………………….168

Table 4.4

Novel or interesting control versus Fgf20-KO TRAP differentially
expressed genes………………………………………………………………....169

Table 4.5

Top enriched gene ontology (GO) terms from a list of 385
differentially expressed genes in Fgf20-KO compared to control………….…..170

viii

Acknowledgments
I would like to thank, first and foremost, my mentor, David Ornitz. I have thoroughly enjoyed
working with and learning from Dave. His dedication to his work and to his students has really
allowed me to grow over the years as a scientist. He has always been someone I can turn to for
help and encouragement, as well as someone I am eager to share the latest results with. His
enthusiasm for science is inspiring. His patience is unyielding.
I would like to acknowledge past and present members of the Ornitz lab. Firstly, SungHo Huh, who taught me so much during my first two years in the lab and helped set the
foundation for the rest of my graduate school career. I would also like to acknowledge Andrew
Hagan, Yongjun Yin, Kel Vin Woo, Angela Castro, Craig Smith, and Ling Li, who were all very
gracious about lending their time to help me or to discuss science. I would further like to thank
our collaborators, Mark Warchol, Tejbeer Kaur, Matthew Barton, Joseph Dougherty, and Bo
Zhang for their invaluable advice and insight.
Finally, I would like to acknowledge the sources that have funded me and my research:
Washington University MSTP, The U.S. Navy, Action on Hearing Loss, March of Dimes,
NIDCD, and the Department of Developmental Biology.

Lu Yang
Washington University in St. Louis
May 2020

ix

Dedicated to my mother.

x

ABSTRACT OF THE DISSERTATION
FGF20 in Olfactory System and Cochlea Development
by
Lu Yang
Doctor of Philosophy in Biology and Biomedical Sciences
Developmental, Regenerative and Stem Cell Biology
Washington University in St. Louis, 2020
Professor David Ornitz, Chair
The olfactory epithelium (OE) is a neurosensory organ required for the sense of smell.
Turbinates, bony projections from the nasal cavity wall, increase the surface area within the nasal
cavity lined by the OE. We identified a population of OE progenitor cells that expand
horizontally during development to populate all lineages of the mature OE and increase OE
surface area. We show that these Fgf20-positive, epithelium-spanning progenitor (FEP) cells are
responsive to Wnt/β-Catenin signaling. Wnt signaling suppresses FEP cell differentiation into
OE basal progenitors and their progeny, and positively regulates Fgf20 expression. We further
show that FGF20 signals to the underlying mesenchyme to regulate the growth of turbinates. By
these mechanisms, growth of the OE in surface area is directly linked to the growth of the
underlying bone.
The cochlea is a neurosensory organ required for hearing. Development of the cochlear
sensory epithelium, which contains sensory hair cells (HCs) and supporting cells (SCs) that
detect sound, occurs in two main steps: progenitor specification and sensory cell differentiation.
FGF20-FGFR1 signaling is necessary for HC and SC development, and the loss of either Fgfr1
or Fgf20 leads to a loss of HCs and SCs in a similar pattern. We show that FGFR1 functions in
xi

both steps of cochlear sensory epithelium development, while FGF20 only functions during
differentiation, suggesting that another FGF ligand activates FGFR1 during progenitor
specification. Interestingly, we also uncovered an epistatic interaction between Fgf20 and Sox2.
We further use Translating Ribosome Affinity Purification to detect transcriptomic changes in
sensory progenitor cells in the absence of FGF20, and identify many genes downstream of
FGF20 potentially important for differentiation.

xii

Chapter 1
A Fibroblast Growth Factor 20-Expressing,
Wnt-Responsive Progenitor Populates the
Olfactory Epithelium and Regulates
Turbinate Growth
1.1 Summary
The olfactory epithelium (OE) is a neurosensory organ required for the sense of smell.
Turbinates, bony projections from the nasal cavity wall, increase the surface area within the nasal
cavity lined by the OE. Here, we use engineered Fibroblast Growth Factor 20 (Fgf20) knockin
alleles to identify a population of OE progenitor cells that fill all layers of the embryonic and
early postnatal OE, at specific locations. These cells expand horizontally during development to
populate all lineages of the mature OE. We show that these Fgf20-positive, epithelium-spanning
progenitor (FEP) cells are responsive to Wnt/β-Catenin signaling. Wnt signaling suppresses FEP
cell differentiation into OE basal progenitors and their progeny, and positively regulates Fgf20
expression. We further show that FGF20 signals to the underlying mesenchyme to regulate the
growth of turbinates. These studies thus identify a population of OE progenitor cells that
function to scale OE surface area with the underlying turbinates.

1.2 Introduction
The mammalian nose serves two main functions: respiration/air-conditioning and olfaction (Van
Valkenburgh et al., 2014a). Bony plates projecting from the nasal cavity wall, called turbinates,
1

greatly increase the surface area within the nasal cavity, which is lined by respiratory epithelia
and olfactory epithelia (OE). Turbinates in the posterior nasal cavity are mainly lined by OE,
which houses specialized receptor cells called olfactory receptor neurons (ORNs) that detect
chemical odorants and transmit electrical signals to the olfactory bulb and the brain (Albert
Farbman, 1992). In mammals, turbinate size and complexity varies dramatically among species.
It has been hypothesized that such interspecies differences in turbinate complexity, and therefore
surface area within the nasal cavity, correlates with interspecies differences in olfactory ability
(Negus, 1959; Van Valkenburgh et al., 2014a). Despite the importance of the OE and turbinates,
the developmental mechanisms that regulate their size and complexity are unknown.
The mature mouse OE is a pseudostratified epithelium consisting of three main cell types
with nuclei located in different layers of the epithelium: sustentacular cell (Sus, a supporting cell
population) nuclei in the apical layer, ORN nuclei in the middle layers, and basal cell (BC,
progenitors that give rise to Sus cells and ORNs) nuclei in the basal layer (Murdoch and
Roskams, 2007; Schwob et al., 2017a). Other OE cell types include Bowman’s duct cells and
microvillar cells (Weng et al., 2016). OE development and neurogenesis can be divided into two
main phases: embryonic day 10 (E10) to E13, and E13 to adult (Beites et al., 2005; Ikeda et al.,
2007; Smart, 1971). Neurogenesis begins at around E10 with the invagination of the olfactory
placode to form the nasal pit (Treloar et al., 2010). From this stage to E13, nuclei of Sox2expressing (Sox2+) progenitors are found throughout the thickness of the OE, particularly
apically. However, from E13 to adult, progenitor nuclei are found in the basal layer, and are
referred to as BCs (Cau et al., 1997a; Cuschieri and Bannister, 1975a, 1975b; Smart, 1971). This
shift in progenitor location is associated with the pseudostratification of the OE, as ORN and Sus
cell nuclei localize to their respective locations in the mature OE. BCs continue to divide and
2

differentiate into the overlying ORNs and Sus cells throughout life, a process termed
“established neurogenesis.” It has been suggested that during early development prior to E13, the
pool of OE progenitors mainly expand, while after E13, these progenitors fill the OE with ORNs
(Beites et al., 2005). In this article, we use the term “immature” to refer to OE in which
progenitor nuclei are located throughout the thickness of the OE, and the term “mature” to refer
to OE containing progenitor (BC) nuclei in the basal layer, ORN nuclei in the middle layers, and
Sus cell nuclei in the apical layer.
Established neurogenesis during development, adult homeostasis, and regeneration in the
OE is well understood. We refer to this process as vertical development, as it involves the
differentiation of BCs into cells that fill the upper layers of the OE. Horizontal development, or
OE surface area expansion, is less well understood. Despite the importance of OE surface area to
many mammals, the mechanism and a progenitor population regulating OE scaling has not been
found (Murdoch et al., 2010). Moreover, despite the evolutionary importance of nasal turbinates
and their large size relative to the rest of the skull, they are the least well studied craniofacial
structure (Van Valkenburgh et al., 2014a). The only mechanistic study investigating turbinate
morphogenesis in the mouse showed that mechanical forces from airflow affect the postnatal
development of the anterior (respiratory) turbinates (Coppola et al., 2014). The molecular and
genetic factors that regulate turbinate development are unknown.

A particularly interesting question is how OE expansion is scaled with turbinate growth.
Crosstalk between the OE and the underlying turbinates has been predicted but not identified
(Adameyko and Fried, 2016a). Notably, genetic manipulations resulting in early failure of OE
development seem to also lead to disrupted formation of turbinates and other nasal structures,
3

highlighting the importance of the OE to the growth of the nasal cavity (Duggan et al., 2008a;
Kawauchi et al., 2009a; Kersigo et al., 2011a; Laclef et al., 2003a). Here, we propose that
throughout embryonic and early postnatal development, there are regions of the OE that remain
immature and facilitate horizontal expansion of the OE, rather than vertical development. We
identify the cells that make up these regions as an OE progenitor population that regulates
turbinate growth via Fibroblast Growth Factor 20 (FGF20), a member of the FGF family of
signaling molecules (Ornitz and Itoh, 2015a). We further show that Wnt/β-Catenin (βCat, also
Ctnnb1) signaling is required for the maintenance of these Fgf20-positive, epithelium-spanning
progenitor (FEP) cells and their expression of Fgf20. These mechanisms regulate the overall size
of the olfactory system and ensure that the OE and underlying turbinates scale proportionally.

1.3 Results
In adult mice, the OE lines the nasal septum, the ethmo- (olfactory) turbinates, and the superior
and lateral nasal cavity walls of the olfactory recess (Barrios et al., 2014). A layer of
mesenchyme, called the lamina propria in the adult, separates the OE from the underlying
cartilaginous or bony structures (Figure 1.2H). Throughout development and in the adult, the six
olfactory turbinates have highly conserved branching, scrolling, and folding morphology
(Figures 1.2I and 1.2I’). In order of most anterodorsal to posteroventral, they are: endoturbinate I
(n1), ectoturbinate 1 (c1), endoturbinate II (n2), ectoturbinate 2 (c2), endoturbinate III (n3), and
endoturbinate IV (n4). Anteriorly, n2 separates into two branches, n2’ and n2”. In this study, we
focus mainly on c1. All images of turbinates presented are frontal sections through the posterior
nasal cavity. We refer to “neck” (site of attachment of turbinates to the nasal cavity wall) and
“tip” regions of the turbinate as shown in Figure 1.2H, inset. We refer to “neck” OE as the
4

negatively-curved OE directly overlying the “neck” region of the turbinate. In the adult, “neck”
regions have sometimes been referred to as the cul-de-sac of the turbinate (Greer et al., 2016).

1.3.1 Fgf20 is expressed in a subset of Sox2+ cells in the developing OE
Initial studies of the Fgf20βgal knockin allele showed Fgf20 expression in progenitor-like cells in
several developmental systems, including the inner ear (Huh et al., 2012a), kidney cap
mesenchyme (Barak et al., 2012), hair follicle (Huh et al., 2013), mammary buds (Elo et al.,
2017), taste buds (unpublished data), and OE (unpublished data). To further investigate the cell
type marked by Fgf20 expression in the developing OE, we used the Fgf20GFP-Cre allele (Huh et
al., 2015). Native GFP fluorescence from this allele is mostly undetectable; however, allele
expression can be readily detected using an anti-GFP antibody.
Fgf20GFP-Cre expression was found in the developing OE as early as E10.5, albeit very
weakly, in the lateral nasal pit (Figures 1.1A and 1.2A). Throughout its expression in the OE,
Fgf20 co-localized with a subset of Sox2+ cells, a marker expressed by progenitors that fill the
immature OE, and by BCs and Sus cells in the mature OE (Kawauchi et al., 2005a). At E12.5,
the shapes of turbinates n1, n2, and n3 can be observed, composed of mesenchyme surrounded
by OE and respiratory epithelia (Figure 1.2B, n3 not shown). At this stage, Fgf20 was still
mainly expressed in the lateral OE (Figure 1.1B). Importantly, Fgf20 was expressed in the OE
overlying the site of future c1 development (Figure 1.1B, asterisk).
Turbinates develop through endochondral ossification initiated via epithelial budding and
followed by proliferation of the underlying mesenchymal cells (Dieulafé, 1906; Martineau-Doizé
et al., 1992). At E14.5, turbinates c1, c2, and n4 began to appear as mesenchymal condensations
protruding from the nasal cavity wall (Figures 1.2C and 1.2C’, c2 and n4 not shown). At this
stage, most of the OE was mature, with an apical and a basal layer of Sox2+ cells separated by a
5

Sox2- middle layer of ORNs. In mature OE, Fgf20 was expressed in a subset of apical Sox2+
cells (Figure 1.1C, arrows). Fgf20 was also expressed in regions of negatively-curved OE. These
regions of the OE mostly retained an immature histology, where Fgf20+/Sox2+ cell nuclei were
found throughout all layers of the OE (Figure 1.1C, white arrowheads). The negative curvature
of the OE appeared to be formed by the protruding turbinates. Fgf20 expression was still found
in the OE overlying c1 at this stage (Figure 1.1C, asterisk).
By E17.5, in all six turbinates, cells of the mesenchymal condensations have
differentiated into chondrocytes (Figures 1.2D-1.2F, and 1.2E’). At this stage, intense Fgf20
expression remained localized to areas of negatively-curved OE, which surround the “neck” of
each of the six turbinates (Figures 1.1D-1.1F, arrowheads). Importantly, for turbinates n1, c1, c2,
n3, and n4, these areas remained immature, with Fgf20+/Sox2+ cell nuclei spanning the entire
thickness of the OE. For turbinate n2, the earliest turbinate to develop, “neck” OE has become
more mature by E17.5 and only retained Fgf20+/Sox2+ cell nuclei towards the apical layers of the
OE (Figure 1.1E, blue arrowheads). The medial “neck” OE of turbinate n1, formed by the nasal
septum and n1, has likewise become more mature by E17.5 (Figure 1.1E, blue arrowheads).
Turbinate chondrocytes undergo hypertrophy at early postnatal stages and by postnatal
day 7 (P7) most of the cartilage has been replaced by ossified bone (Figures 1.2G and 1.2G’). At
this stage, Fgf20 expression was still primarily found in negatively-curved “neck” OE, but at the
apical surface (Figure 1.1G, arrowheads). The concentrated expression seen at earlier stages has
mostly dissipated, as the “neck” OE of every turbinate became almost completely mature by P7.
After complete ossification, turbinates continue to grow, fold, and scroll until at least P30
(Figure 1.2I). At P30, Fgf20 expression was undetectable (data not shown).

6

Interestingly, at E17.5, just outside of Fgf20 expression hotspots in negatively-curved,
immature OE, low GFP fluorescence was detected in the Sox2+ basal and apical cells of the
mature OE (Figure 1.1E’, arrowheads). We suspect that this represents the capture of the
transient Fgf20GFP-Cre lineage, due to GFP-Cre perdurance, suggesting that Fgf20+ cells give rise
to adjacent Sox2+ BCs and Sus cells. These cells likely no longer actively transcribed Fgf20, but
still retained some undegraded GFP-Cre protein.
Overall in development, intense Fgf20 expression was found in immature regions of the
OE, in a pattern associated with the growing turbinates. Upon maturation of a region of OE,
Fgf20 expression was initially shifted towards the basal and particularly apical layers before
disappearing completely. Together, these observations led to the hypothesis that Fgf20+ cells are
a progenitor population in the developing OE. Based on results from experiments described
below, we term this population FEP (Fgf20-positive, epithelium-spanning progenitor) cells, as
their nuclei are found throughout all layers of the immature OE.

1.3.2 Fgf20 lineage includes all major OE cell types and responds to cues for
expansion
OE surface area expansion is not well understood. A recent study showed that proliferation and
neurogenesis shifts from dorsomedial zones of the OE to ventrolateral zones between E12.5 and
E15.5 (Eerdunfu et al., 2017). This suggests that expansion of the OE occurs in a dorsomedialto-ventrolateral direction. Interestingly, this wave of neurogenesis does not reach the OE at
“neck” regions of turbinates, where FEP cells are localized, until perinatal stages, when FEP
cells begin to disappear.
“Neck” OE housing FEP cells at E14.5 and E17.5 resemble immature OE at E12.5. Based
on this and the overall Fgf20 expression pattern, we hypothesized that Fgf20 may be a marker
for OE progenitors. To test this and to confirm findings by Eerdunfu et al. (2017), we first looked
7

at proliferation and neurogenesis rates in negatively-curved “neck” OE, where FEP cells are
located. At E17.5, these regions incorporated EdU at a higher rate than the OE at the turbinate
“tip” (Figures 1.3A and 1.3B). This difference could be partially explained by a relative lack of
post-mitotic ORNs in “neck” regions. Confirming this explanation, “neck” OE contained far
fewer olfactory marker protein (OMP) positive cells (Figures 1.3C and 1.3D, arrowheads), a
marker for mature ORNs (Hartman and Margolis, 1975). The only exception was the medial
“neck” OE of n1, the most mature “neck” OE at E17.5. The distribution of Fgf20+ cells and
OMP+ ORNs along the length of the c1 OE, when plotted along a straight line, showed low
OMP+ ORN density in areas of high Fgf20+ cell density (Figure 1.3E). No cells were found to
co-express Fgf20 and OMP.
In the adult, OE at “recesses of olfactory turbinates” have been shown to contain
Pde2a+ ORNs belonging to the “necklace” olfactory system, rather than OMP+ ORNs (Figure
1.3F; Juilfs et al., 1997). To rule out the possibility that “neck” OE contained these OMP- ORNs
during embryonic stages, we examined Pde2a expression at E17.5. Pde2a+ ORNs were not found
in “neck” OE or anywhere else at this stage (Figure 1.3G). Note: the term “necklace” refers to
the spatial organization of the glomeruli that receive projections from ORNs of the necklace
olfactory system. It is not to be confused with the term “neck,” which in this study refers to a
specific part of the turbinate. Altogether, these results suggest that immature, “neck” OE have
increased rates of proliferation and decreased rates of neurogenesis. This supports the idea that
these regions host embryonic progenitors involved in horizontal, as opposed to vertical,
development.
Next, we combined Fgf20GFP-Cre with Cre reporter alleles ROSAmTmG (Muzumdar et al.,
2007a) or ROSAtdTomato (Madisen et al., 2010) to trace the lineage of Fgf20GFP-Cre-expressing
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cells. The ROSAmTmG allele, in which Cre-expressing cells and their progeny express membranelocalized eGFP (mG), while all other cells express membrane-localized tdTomato (mT), showed
that the Fgf20GFP-Cre lineage includes most of the postnatal OE, and the entire ventrolateral OE
containing zones 2-4 (Figures 1.4A-1.4C; OE zones are described in Ressler et al., 1993; Vassar
et al., 1993). Only a few spots associated with the dorsomedial zone 1 were outside of the lineage
(Figures 1.4A-1.4C, arrowheads). This pattern was consistent across individuals. The other
olfactory structures with Fgf20GFP-Cre-lineage cells were the vomeronasal organ (VNO; Figure
1.3H) and septal organ (SO; Figure 1.3I).
Importantly, in Fgf20GFP-Cre-lineage OE, the entire thickness of the OE (the BC, ORN,
and Sus cell layers, as well as the brightly fluorescent cilia layer apical to the Sus cell layer)
expressed mG, and not mT (Figure 1.4B’). mG expression was restricted to the OE, except for
two accessory OE structures found in the lamina propria (mesenchymal layer): axon bundles
(Ax) projected by ORNs, and Bowman’s glands (BG), which associate with Bowman’s ducts
that traverse the OE. These structures can be readily identified based on their morphology.
We then examined the Fgf20GFP-Cre “real-time” expression, identified with an antibody to
GFP-Cre, compared to its lineage with the ROSAtdTomato reporter at various stages of OE
development. At E11.5, the lineage almost completely overlapped with real-time Fgf20
expression (Figure 1.4D). However, as the OE expands (E14.5 and E17.5), the lineage
increasingly exceeded the domain of real-time Fgf20 expression (Figures 1.4E and 1.4F).
Furthermore, quantification of surface area within and outside of the Fgf20GFP-Cre lineage showed
that growth of the Fgf20GFP-Cre-lineage OE far outpaced that of non-lineage OE (Figure 1.4G). In
fact, surface area of the non-lineage OE did not significantly change from E14.5 to P7: 0.38 ±
0.02 mm2 at E14.5, 0.46 ± 0.18 mm2 at E17.5, and 0.53 ± 0.25 mm2 at P7 (n = 3, mean ± SD, p =
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0.6, one-way ANOVA). The Fgf20GFP-Cre-lineage OE, on the other hand, grew significantly in
surface area during this period: 1.39 ± 0.21 mm2 at E14.5, 5.21 ± 0.06 mm2 at E17.5, and 16.5 ±
1.1 mm2 at P7 (p < 0.001, one-way ANOVA). Therefore, the Fgf20GFP-Cre lineage accounted for
nearly all the expanding OE from E14.5 to P7. Together with Fgf20GFP-Cre immunostaining
showing transient Fgf20 expression in BCs and Sus cells (Figure 1.1E’ arrowheads), Fgf20GFP-Cre
lineage tracing supports the hypothesis that FEP cells are multipotent progenitors of the OE
contributing to horizontal expansion.

1.3.3 Fgf20-KO mice have reduced turbinate size and altered morphology
Next, we investigated the function of FGF20 signaling in olfactory system development. Because
Fgf20 was expressed in a pattern associated with the developing turbinates (overlying sites of
future turbinate development at early stages and occupying “neck” regions at later stages), we
compared the morphology of turbinates in Fgf20-KO (Fgf20GFP-Cre/βgal) mice to those in
heterozygous littermate controls (Fgf20GFP-Cre/+). Gross overview of serial frontal sections of the
nasal cavity at P30 showed that most of the olfactory turbinates were smaller and/or differed in
shape in Fgf20-KO mice compared to control (Figures 1.5A-1.5D). These changes were
consistent across individuals. Measurement of the surface of each turbinate to estimate size
(Figure 1.5B’, outline) showed that of the six turbinates, c1, c2, and n4 were the most reduced in
size in Fgf20-KO mice, by 35%, 28%, and 34%, respectively (Figure 1.5E). Most strikingly, c1
showed reduced folding and was missing its dorsal branch (Figure 1.5B’). n1, n2, and n3, the
earliest turbinates to appear developmentally, were the least reduced in size, by 15%, 3.7%, and
7.0%, respectively (Figure 1.5E). In total, Fgf20-KO mice had a 17% average decrease in OE
surface area within the nasal cavity, due to smaller turbinates, while septal organ surface area
was not changed (Figure 1.5F). The septal organ is made up of olfactory epithelia, some of
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which is in the Fgf20GFP-Cre lineage (Figure 1.3I) and is only found overlying the nasal septum
and not turbinates. This makes it a good internal control for turbinate surface area. The nasal
cavity wall and septum did not appear to be affected by loss of FGF20 signaling.
We then examined Fgf20-KO mice at P0, when turbinates are still made up of
chondrocytes. Many of the turbinates in Fgf20-KO mice appeared smaller than those in control
(Figure 1.6A and 1.6B). Focusing on c1, there was a measurable decrease in the size of the
turbinate cartilage (p = 0.009) and in the OE surface area overlying the turbinate (p < 0.001;
Figures 1.6A’, 1.6C, and 1.6D). Therefore, the turbinate deformity seen in the adult can at least
be partially attributed to a defect prior to osteogenesis.

1.3.4 Fgf20 is required for mesenchymal proliferation early in turbinate
development
In the initial stages of endochondral bone development, mesenchymal cells condense to form a
mesenchymal condensation, and subsequently differentiate into chondrocytes (Long and Ornitz,
2013). To determine the cause of the decrease in c1 cartilage size at P0, we looked at these initial
stages in Fgf20-KO embryos. Development of turbinate c1 began at around E14.5, as
mesenchymal cells between the OE and the nasal cavity wall started to form a mesenchymal
condensation. The condensed mesenchymal cells were proliferative and had high Sox9
expression (Sox9hi; Figure 1.5G). Chondrocytes of the nasal cavity wall were also Sox9hi but
were distinguished from the condensed mesenchymal cells by their round nuclei and large soma.
Mesenchymal cells that remained diffuse (uncondensed) were found between the condensation
and the OE. These cells had weak or almost undetectable Sox9 expression (Sox9low).
In Fgf20-KO embryos at E14.5, the number of condensed cells and diffuse cells were not
significantly changed compared to control, although there was a trend towards fewer condensed
cells (Figures 1.5G, 1.5I, and 1.5J). Consistent with this, the ratio of condensed cells to diffuse
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cells was slightly decreased compared to control (p = 0.05; Figure 1.5K), suggesting a defect in
formation of the condensation. Analysis of EdU incorporation showed a decrease in proliferation
rate in condensed cells (p = 0.007; Figures 1.5G and 1.5L) and diffuse cells (p = 0.06; Figure
1.5M) in Fgf20-KO embryos, although the latter was not statistically significant. To identify the
cell type directly responding to FGF20, we examined Dusp6 expression by RNA in situ
hybridization. Dusp6 is a downstream target of FGF signaling (Ekerot et al., 2008; Kawakami et
al., 2003; Li et al., 2005, 2007; Ornitz and Itoh, 2015) and is a target of FGF20 signaling in the
cochlea (unpublished data). At E14.5, Dusp6 was expressed in the c1 mesenchyme directly
underneath the OE in control embryos (Figure 1.5H, arrows) and was markedly reduced in
Fgf20-KO embryos. This suggests that FGF20 is signaling to diffuse cells directly underneath
the OE to regulate proliferation and condensation. However, Dusp6 expression was not
completely absent in Fgf20-KO embryos (Figure 1.5H, arrow), suggesting that another FGF
ligand may be compensating for the loss of FGF20.
At E17.5, Sox9hi condensations were no longer observed in the turbinates. In Fgf20-KO
mice, the rate of proliferation was decreased in “neck” region mesenchymal cells compared to
control (Figures 1.7A, 1.7A’, and 1.7B), but not in “tip” region mesenchymal cells (Figure 1.7C).
There was no change in proliferation in turbinate chondrocytes at E17.5 (Figure 1.7D). Together,
these data suggest that Fgf20 regulates the proliferation of chondrocyte progenitors and
potentially the formation of the mesenchymal condensation.
We also investigated whether Fgf20-KO mice have a defect in OE development. At P30,
there was no measurable difference in OE thickness between control and Fgf20-KO mice (data
not shown). Interestingly, at E14.5, there was a slight but statistically significant increase in both
OE thickness (p = 0.04; Figures 1.6J and 1.6K) and the density of Sox2+ basal cells (p = 0.02;
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Figure 1.6L). The proliferation rate of Sox2+ BCs was unchanged (Figure 1.6M). This increase in
thickness and Sox2+ BC density may be an effect of the constriction in OE surface area due to a
smaller turbinate. By P0, Fgf20-KO pups had normal OE thickness (Figure 1.6F), likely having
adjusted to the constriction. Importantly, at P0, the OE of Fgf20-KO mice had a normal
complement of OMP+ ORNs, Sus cells, and Sox2+ BCs (Figures 1.6G-1.6I). In addition, neither
Fgf20 expression (Figure 1.6G) nor FEP cell proliferation (Figures 1.7A’ and 1.7E) was affected
in Fgf20-KO mice. Together, these data suggest that loss of FGF20 signaling does not affect OE
vertical development.

1.3.5 Ectopic activation of FGF ligand expression in the OE drives
mesenchymal growth
To determine whether overactivation of FGF signaling will increase proliferation in turbinate
mesenchyme, we combined Fgf20GFP-Cre with the ROSArtTA (Belteki et al., 2005) and TRE-Fgf9IRES-eGfp (White et al., 2006) alleles. We generated Fgf9-OA (Fgf20GFP-Cre/+; ROSArtTA; TREFgf9-IRES-eGfp) mice along with littermate controls (Fgf20GFP-Cre/+; ROSArtTA). The Fgf9-OA
mouse expresses the reverse tetracycline transactivator (rtTA) in the Fgf20GFP-Cre lineage, which
drives the expression of TRE-Fgf9-IRES-eGfp upon doxycycline (Dox) induction. FGF9 is
biochemically similar to FGF20 (Ornitz and Itoh, 2015a), and is able to rescue and compensate
for the loss of FGF20 signaling in the cochlea (Huh et al., 2012a, 2015a).
Pregnant dams were fed a Dox diet starting at E11.5 and embryos were collected at
E14.5. Fgf9-OA embryos showed a markedly thickened c1 mesenchymal layer (Figure 1.7F) and
expansion and increased intensity of Dusp6 expression (Figure 1.7G). Compared to control,
Fgf9-OA embryos had a slight but non-significant decrease in the number of condensed
mesenchymal cells (p = 0.1) and a two- to three-fold increase in the number of diffuse cells (p =
0.01; Figures 1.7F, 1.7H, and 1.7I). Correspondingly, the ratio of condensed to diffuse cells was
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significantly decreased (p = 0.002; Figure 1.7J). However, there was no significant change in
either condensed or diffuse cell proliferation (Figures 1.7F, 1.7K, and 1.7L).
The lack of a measurable increase in diffuse cell proliferation in Fgf9-OA embryos may
be due to increased mesenchyme thickness, causing cells further away from the OE to receive
less FGF signaling. Consistent with this, high levels of Dusp6 expression in Fgf9-OA embryos
was only found in the mesenchyme within 58 µm of the OE (average of four samples).
Therefore, we hypothesized that only diffuse cells close to the OE had an increase in
proliferation in Fgf9-OA embryos. In control embryos, the diffuse mesenchymal layer averaged
69 µm thick. Quantification of proliferation of diffuse cells within 69 µm of the OE (“OE
adjacent cells”) in Fgf9-OA embryos showed a significant increase compared to the total diffuse
cell population in controls (Figures 1.7F, brackets and 1.7L). These data suggest that the increase
in diffuse cell number in Fgf9-OA embryos likely had contributions from decreased
condensation as well as increased proliferation. Unfortunately, the Fgf9-OA pups die at birth,
precluding us from examining the postnatal phenotype.

1.3.6 Wnt activity in the developing OE coincides with Fgf20 expression
Given the interesting expression pattern of Fgf20 in the OE, the properties of Fgf20-expressing
cells, and the function of FGF20 signaling, we sought to understand the regulation of Fgf20
expression and FEP cell maintenance. We turned to the canonical Wnt/βCat signaling pathway,
which is a known direct transcriptional regulator of Fgf20 (Chamorro et al., 2005) and
commonly involved in progenitor and stem cell maintenance (Clevers and Nusse, 2012; Nusse
and Clevers, 2017).
We used the Tcf/Lef:H2b-Gfp mouse, a well-described Wnt/βCat signaling reporter
(Ferrer-Vaquer et al., 2010), to study Wnt/βCat activity in the developing OE. Interestingly, the
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Tcf/Lef:H2b-Gfp expression pattern was similar to that of Fgf20 throughout the developing OE.
H2B-GFP was detected in the lateral nasal pit at E10.5 (Figure 1.8A), consistent with previous
reports of Wnt/βCat activity at this stage (Brugmann et al., 2007; Zhu et al., 2016a). H2B-GFP
was detected in the OE overlying the site of c1 development at E12.5 and E14.5 (Figures 1.8B,
asterisk and 4C), and in negatively-curved “neck” OE at E17.5 (Figure 1.8D). At E17.5, H2BGFP expression was found in FEP cell nuclei, which span all layers of the “neck” OE (Figure
1.8D’, arrowheads). By P7, H2B-GFP expression was less concentrated, mainly found in the
apical layer at and surrounding “neck” OE (Figure 1.8E). Unlike Fgf20, Tcf/Lef:H2b-Gfp was
also highly expressed in the nasal pit rim at E10.5 (Figure 1.8A, arrowhead) and in the
respiratory epithelium (RE) at later stages (Figures 1.8B and 1.8C). In addition, H2B-GFP has a
long half-life, likely much longer than that of GFP-Cre (Waghmare et al., 2008), resulting in a
larger expression domain for Tcf/Lef:H2b-Gfp compared to Fgf20GFP-Cre. Consistent with this,
the size of the Tcf/Lef:H2b-Gfp expression domain lies in between that of Fgf20GFP-Cre real-time
expression and that of Fgf20GFP-Cre-lineage. Importantly, Tcf/Lef:H2b-Gfp expression was not
found in non-Fgf20GFP-Cre-lineage OE. Furthermore, products of the Tcf/Lef:H2b-Gfp and
Fgf20βgal reporters appeared to have similar half-lives. Expression patterns of these two reporters
more closely overlapped (Figures 1.8F and 1.8G).

1.3.7 βCat conditional deletion results in a severe deficit in turbinate
development
To determine the role of Wnt/βCat signaling in the OE, we combined Fgf20GFP-Cre with the
βCatfl(ex2-6) allele (Brault et al., 2001) to conditionally delete βCat. We generated βFF-CKO
(Fgf20GFP-Cre/+; βCatfl(ex2-6)/fl(ex2-6)) mice along with littermate controls (Fgf20GFP-Cre/+; βCatfl(ex2). Notably, since Fgf20 is a downstream target of Wnt/βCat signaling, Wnt/βCat signaling is

6)/+

predicted to activate prior to the onset of Fgf20GFP-Cre expression, leading to delayed disruption
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of Wnt/βCat signaling. βFF-CKO pups appeared grossly normal at birth but most died by P1,
with only a few surviving to adulthood. The surviving mice appeared smaller than littermate
controls.
At P0, Fgf20 expression was almost completely absent from the OE in βFF-CKO pups,
as expected (Figure 1.10A). Therefore, a defect in turbinate development was predicted, as
observed in Fgf20-KO mice. Examination of a few adult βFF-CKO mice that survived to P30
showed dramatically stunted turbinate growth of all six turbinates (Figure 1.10B). We focused
our quantitative analysis on P0 pups, since the surviving P30 cohort was a biased sample. In
addition, quantitation of turbinate size could be affected by the decreased overall size of βFFCKO adult mice.
At P0, very noticeably, βFF-CKO mice had a more severe defect in turbinate
development than Fgf20-KO mice (Figure 1.9A). This turbinate phenotype exhibited variability
across individuals. A few pups had almost no detectable structural defect compared to control,
while pups with the most severe phenotype had a complete lack of c1, c2, and n4 turbinates
(Figure 1.9A, shape 3). This variability is likely attributable to residual Wnt/βCat signaling from
delayed or inefficient βCat deletion, as well as to variability in Fgf20GFP-Cre expression.
Therefore, we believe mice with the most severe phenotypes represented the most complete βCat
deletion. Focusing on c1 (Figure 1.9A’), we classified the varying P0 βFF-CKO phenotypes into
3 categories based on turbinate shape: shape 1 resembles control, shape 2 has a reduction in size,
and shape 3 lacks c1. Shape 1 was relatively rare and not found in every experiment.
To quantify the size of c1, we measured cartilage volume and overlying surface area.
Cartilage volume was significantly decreased in βFF-CKO mice compared to control (p < 0.001;
Figure 1.9B), as was surface area (p < 0.001; Figure 1.9C). Mesenchyme thickness was
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noticeably decreased but only in the most severe (shape 3) βFF-CKO mice (Figure 1.9D). This
phenotype was not observed in Fgf20-KO mice (Figure 1.6E). OE thickness was decreased in
βFF-CKO mice, also a phenotype not observed in Fgf20-KO mice (see below).

1.3.8 Specific disruption of βCat signaling also results in a severe deficit in
turbinate development
βCat serves two major functions in epithelial cells: Wnt/βCat signaling and cell adhesion. To rule
out the contribution of disrupted cell adhesion to the βFF-CKO phenotype, we used the βCatDM
allele (Valenta et al., 2011) to generate a second βCat conditional deletion mouse: βDF-CKO
(Fgf20GFP-Cre/+; βCatDM/fl(ex2-6)), along with littermate controls (Fgf20GFP-Cre/+; βCat+/+, Fgf20GFP; βCatDM/+, and Fgf20GFP-Cre/+; βCatfl(ex2-6)/+). When not specified, “control” refers to

Cre/+

Fgf20GFP-Cre/+; βCatfl(ex2-6)/+. βDF-CKO pups appeared grossly normal at birth but almost all died
by P1.
Like βFF-CKO mice, Fgf20 expression was absent from βDF-CKO pups at P0 (Figure
1.10A). The βDF-CKO turbinate phenotype was similar to that of βFF-CKO mice. However, the
most severe βDF-CKO mice still had some observable c1, c2, and n4 development, unlike the
most severe βFF-CKO mice (Figures 1.10D and 1.10D’). Despite this, βDF-CKO mice (40%
reduction in cartilage volume, compared to control; Figure 1.10E) had a worse phenotype than
Fgf20-KO mice (21% reduction) at P0 (Figure 1.6C). Like βFF-CKO mice, βDF-CKO mice also
had decreased turbinate surface area and mesenchyme thickness, compared to littermate controls
(Figures 1.10D’, 1.10F, and 1.10G). Also, like βFF-CKO mice, examination of a few adult βDFCKO mice that survived to P30 showed dramatically stunted turbinate growth of all six
turbinates (Figure 1.10B).
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1.3.9 βCat conditional deletion causes decreased mesenchymal proliferation
in developing turbinates
To explain the decreased c1 turbinate size in βFF-CKO mice, we looked at proliferation in and
around the mesenchymal condensation. The earliest phenotype in βFF-CKO mice was observed
at E14.5. At this stage, there was a decrease in the number of Sox9hi condensed mesenchymal
cells in βFF-CKO mice compared to control (Figures 1.9E and 1.9F), but no difference in the
number of diffuse cells (Figure 1.9G), leading to a decreased ratio of condensed cells to diffuse
cells (Figure 1.9H). Like at P0, the phenotype at E14.5 was also variable, with the most severe
having almost no condensation. We did not categorize the E14.5 phenotype into shapes.
Proliferation in condensed cells was decreased in βFF-CKO mice (Figures 1.9E and 1.9I).
This proliferation defect was more severe than that of Fgf20-KO mice. There was also a decrease
in proliferation of diffuse cells at E14.5 (Figure 1.9J). The lack of a decrease in diffuse cell
number at E14.5, despite the decrease in proliferation, suggests a defect in the formation of the
condensation.
To directly assess effects on FGF signaling, Dusp6 expression was examined by in situ
hybridization. In the c1 mesenchymal layer in βFF-CKO mice at E14.5, Dusp6 expression was
absent (Figure 1.10C, arrows), unlike in Fgf20-KO mice at the same stage, where some Dusp6
expression remained. This suggests that other OE signals regulating mesenchymal Dusp6
expression could also be downregulated in βFF-CKO mice, in addition to FGF20. Also, Dusp6
expression appeared to be slightly, yet consistently decreased in Fgf20GFP-Cre/+; βCatflox/+ controls
compared to Fgf20GFP-Cre/+; βCat+/+ (compare Figures 1.10C and 1.5H). This may be attributable
to heterozygosity of βCat in the OE. Overall, the βFF-CKO phenotype was similar to that of
Fgf20-KO embryos, but more severe.
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1.3.10 βCat conditional deletion leads to premature differentiation and
progenitor depletion in the OE
Interestingly, βFF-CKO mice had significantly thinner OE compared to control at P0 (p < 0.001;
Figures 1.9A’, 1.11A, and 1.11B). In the most severe βFF-CKO mice at P0, OE at the tip of c1
was only 2-3 cell layers thick, whereas control OE was 7-9 cell layers thick in the same region.
Surprisingly, however, βFF-CKO OE contained a normal complement of Sus cells and OMP+
ORNs (Figures 1.11A, 1.11C, and 1.11D). Even the most severely thinned βFF-CKO OE had a
normal complement of these cells, which comprised nearly the entire OE. The presence of these
differentiated OE cell types suggest that vertical development is intact in βFF-CKO mice.
Notably, there was a lack of FEP cells in the more severe βFF-CKO mice at P0, as
evidenced by an absence of Sox2+ epithelium-spanning cells and maturation of negativelycurved “neck” OE, where Sox2+ cells were found only in the apical and basal layers (Figure
1.11A, arrowheads). In less severe βFF-CKO mice, some Sox2+ epithelium-spanning cells were
observed, resembling FEP cells in control mice (Figures 1.10A and 1.11A, arrows). However,
these cells did not express Fgf20 (Figure 1.10A, arrows). This shows that βCat is required for the
maintenance of both Fgf20 expression and FEP cells. There was also a decrease in the density of
Sox2+ BCs in βFF-CKO mice, with just a few cells remaining in the most severe cases (Figures
1.11A and 1.11D). Given that the severely thinned βFF-CKO OE contained a normal
complement of the most differentiated cell types, this decrease in progenitor number suggests
that FEP cells and Sox2+ BCs were not maintained in an undifferentiated state.

Next, we examined differentiation at an earlier stage. At E14.5, the OE was only slightly thinner
in βFF-CKO embryos (p = 0.05; Figures 1.11E and 1.11F). There was also a detectable decrease
in the number of Sox2+ BCs (p = 0.05; Figures 1.11E and 1.11G). Proliferation levels of Sox2+
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BCs did not appear to be dramatically changed (p = 0.2; Figures 1.11E and 1.11H). There was
also a noticeable decrease in the number of, or absence of, FEP cells in the c1 OE of βFF-CKO
embryos, based on a lack of epithelium-spanning Sox2+ cells (Figure 1.11E, asterisk indicates
“neck” region). At this stage, there was some residual Fgf20GFP-Cre expression in the n1 and n2
OE of βFF-CKO embryos (Figure 1.11I, arrowheads), likely attributable to GFP perdurance.
However, there was no Fgf20 expression in the c1 OE (Figure 1.11I, asterisk indicates “neck”
region).
Remarkably, there was an increase in the number of OMP+ ORNs in βFF-CKO mice at
E14.5 compared to control (Figures 1.11I and 1.11J), despite a slight decrease in OE thickness.
This supports the hypothesis that the P0 βFF-CKO phenotype was a result of premature
differentiation, leading to a depletion of progenitors. At an earlier stage of development (E13.5),
no obvious differences between βFF-CKO and control mice were observed (data not shown).
Examination of a few βFF-CKO mice that survived to P30 showed a lack of OE in some
areas, as indicated by absence of OMP expression. This was particularly noticeable in areas
overlying and surrounding “neck” regions of turbinates (Figure 1.10B, arrowhead). This suggests
a defect in OE expansion or maintenance in the surviving adult βFF-CKO mice.

1.3.11 Specific disruption of βCat signaling leads to premature OE
differentiation
βDF-CKO mice also exhibited decreased OE thickness at P0 (Figures 1.10D’, 1.12A, and
1.12B), with a normal complement of Sus cells and OMP+ ORNs (Figures 1.12A, 1.12C, and
1.12D). Similar to severe βFF-CKO mice, βDF-CKO mice also lacked FEP cells and showed
early maturation of negatively-curved “neck” OE (Figure 1.12A, arrowheads). Interestingly,
there was a small, but statistically significant increase in Sox2+ BC density in βDF-CKO mice (p
= 0.03; Figure 1.12D), opposite of the βFF-CKO phenotype.
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At E17.5 in βDF-CKO mice, the OE was only slightly thinner compared to control
(Figures 1.12E and 1.12F), with no change in Sox2+ BC density (Figure 1.12G). Sox2+ BCs were
less proliferative compared to control (p = 0.01; Figures 1.12E and 1.12H), suggesting that the
increase in Sox2+ BCs at P0 was not due to increased proliferation. Unlike at P0, at E17.5 some
FEP cells were still found in the c1 OE of βDF-CKO mice (Figure 1.12E, arrow), along with
Fgf20 expression (Figure 1.12I, arrows). The increase in Sox2+ BCs at P0 likely can be
explained by premature differentiation of FEP cells.
At E17.5, in control mice, regions of “neck” OE were filled with FEP cells, with a dearth
of OMP+ ORNs. However, in βDF-CKO mice, these regions were prematurely filled with OMP+
ORNs (Figure 1.12I, arrowheads). A distribution plot of OMP+ and Fgf20+ cells showed that in
control mice, OMP+ ORN density was lowest where Fgf20+ cell density was highest (“neck”
regions). In βDF-CKO mice, OMP+ ORNs were much more evenly distributed across the
turbinate.
Like βFF-CKO mice, examination of a few βDF-CKO mice that survived to P30 also
showed a lack of OE in areas surrounding “neck” regions of turbinates, as indicated by absence
of OMP expression (Figure 1.10B, arrowhead).

1.3.12 βCat stabilization prevents differentiation of FEP cells
To determine whether over-activation of Wnt/βCat signaling (gain-of-function) will produce the
opposite phenotype as inactivation (loss-of-function), we combined Fgf20GFP-Cre with the
βCatfl(ex3) allele (Harada et al., 1999) to activate a dominant stable version of βCat. βEX3-OA
(Fgf20GFP-Cre/+; βCatfl(ex3)/+) pups had pronounced growth retardation post-partum, compared to
littermate controls (Fgf20GFP-Cre/+; βCat+/+) and died within a few days of birth. Some had
notable abdominal distension and died at birth.
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At E17.5, βEX3-OA mice had increased Fgf20 expression in the OE compared to
controls. In control mice, native GFP fluorescence from the Fgf20GFP-Cre allele was barely
detectable without using an antibody to GFP (Figure 1.14A, arrowheads). However, in βEX3OA mice, native GFP fluorescence was broad and intense throughout the OE.
One of the most salient phenotypes in βEX3-OA mice at E17.5 was disrupted OE
development (Figure 1.13A). The c1 OE of βEX3-OA mice was very thin and contained almost
exclusively Fgf20+/Sox2+ FEP cells (Figures 1.13A’ and 1.13B) and very few OMP+ ORNs or
Sox2 single-positive (BC or Sus) cells (Figures 1.13B and 1.13C). This cell composition
resembles that of “neck” OE at E17.5 and the lateral OE at E12.5 in wildtype mice. Interestingly,
the FEP cells at E17.5 were mostly non-proliferative (Figure 1.14B), suggesting that the increase
in the number of FEP cells was due to lack of differentiation, and not an increase in proliferation.
Areas of the OE not targeted by Fgf20GFP-Cre (for example, overlying dorsomedial regions of n2)
showed comparatively normal appearing OE, with Sox2+ cells in apical and basal layers, and
OMP+ ORNs in between (Figures 1.14C and 1.14D).
In βEX3-OA mice, extra blebs of OE and mesenchyme were found throughout the nasal
cavity (Figure 1.13A, asterisk). There were also clumps of very densely packed and highly
Fgf20+ FEP cells (Figure 1.13B, arrowheads). These FEP cells appeared dysplastic, with
irregularly shaped nuclei and a high nuclear-to-cytoplasmic ratio (Figure 1.14A, inset). The
epithelial-mesenchymal boundary was difficult to identify in βEX3-OA mice. In fact, the OE
seemed to be invading into the mesenchyme, as highlighted by the presence of OMP+ cells
(Figure 1.13C, arrows) and duct structures (Figure 1.14A, arrows) in the mesenchyme.
Given the dense packing of cells, distorted cell morphology, and potentially disrupted
basement membrane, it was difficult to quantify OE cells at E17.5. Therefore, we examined
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E13.5, the earliest stage that a phenotype was detectable. At this stage, the OE was already
thinner in βEX3-OA mice (Figures 1.14E and 1.14F). There were also clumps of FEP cells
(Figure 1.14E, arrowheads) and a measurable increase in the density of FEP cells in the OE
(Figure 1.14G). At this stage, there was no change in FEP cell proliferation (Figures 1.14E and
1.14H), again suggesting that the increase in FEP cell number was due to inhibition of
differentiation, rather than increased proliferation.

1.3.13 βCat stabilization results in mesenchyme expansion without
condensation in turbinates
Examination of turbinate development showed a vast expansion of the mesenchymal layer in
βEX3-OA mice at E17.5, at the expense of the turbinate chondrocytes (Figure 1.13A’). At this
stage, the nasal cavity wall in βEX3-OA mice appeared relatively normal, containing Sox9hi
chondrocytes (Figure 1.13C). However, turbinate c1 was made up entirely of Sox9low
mesenchymal cells, suggesting a defect in formation of the mesenchymal condensation.
Chondrocytes of n2 and n3, the least affected turbinates in Fgf20-KO and βCat loss-of-function
mice, were also the least affected in βEX3-OA mice (Figure 1.14D). However, the shapes of
these turbinates were affected along with notable expansion of the mesenchymal layer (Figure
1.13A).
At E13.5, control embryos showed no sign of c1 protrusion from the lateral wall (Figure
1.13D), which does not occur until E14.5. However, in βEX3-OA mice, a large protrusion made
up of Sox9low mesenchyme could be seen in some embryos. These Sox9low cells formed the
shape of a turbinate, increasing the thickness of the mesenchyme (Figures 1.13D and 1.13E).
Similarly to E17.5, the mesenchymal cells in βEX3-OA embryos at E13.5 were more
proliferative than in control embryos (Figures 1.13D and 1.13F), accounting for the
mesenchymal expansion seen at E17.5. However, these mesenchymal cells remained Sox9low
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without showing any signs of condensation formation. Overall, the turbinate phenotype in βEX3OA mice was similar to that of Fgf9-OA embryos, but much more severe.

1.4 Discussion
The results presented here identify an Fgf20-expressing, Wnt-responsive OE progenitor
population, termed FEP cells. These cells horizontally expand the OE and scale its growth with
that of the underlying turbinates. We find that within these cells, Wnt/βCat signaling is required
to maintain an undifferentiated progenitor state and regulate the expression of Fgf20, while
FGF20 directly promotes turbinate growth.

1.4.1 FEP cells are an embryonic OE progenitor population that expands the
OE
A definitive embryonic progenitor population has not been identified in the OE, although a few
have been proposed. These include nestin+ radial glia-like progenitors (RGLPs) and Pax7+ cells.
RGLPs only give rise to ORNs, and their lineage is restricted to zone 1 of the OE (Murdoch and
Roskams, 2008). Pax7+ cells give rise to ORNs, Sus cells, BCs, and Bowman’s glands and ducts
(Murdoch et al., 2010). However, the Pax7Cre-lineage contribution to the OE is minimal,
accounting for only ~16% of the OE at E11.5, ~7% at P5, and ~1% in the adult. This pattern is
opposite to that of the Fgf20GFP-Cre lineage, which increases in percentage of total OE with age.
Murdoch et al. (2010) predicted that another progenitor population exists, which responds to
cues for OE expansion and gives rise to the rest of the OE. We propose that FEP cells could be
this complementary population. Other proposed embryonic OE progenitors include Meis1+ cells
and Foxg1+ cells, both of which may overlap with FEP cells at different stages. Meis1+ cells are
found in the lateral OE at E11.5, and are slow-dividing, self-renewing, and less neurogenic
relative to more medial progenitors (Tucker et al., 2010a). These properties are reminiscent of
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FEP cells. It is likely that Fgf20 and Meis1 expression overlap at E11.5. However, the expression
pattern of Meis1 post E11.5 has not been reported. Foxg1 expression is found early in the
olfactory placode, and its lineage therefore includes the entire OE (Duggan et al., 2008a; Hébert
and McConnell, 2000a). At E10.5, Foxg1 is expressed mainly in the medial and central nasal pit,
unlike Fgf20, which is expressed laterally (Duggan et al., 2008; Kawauchi et al., 2009). From
E12.5 to E17.5, Foxg1+ cells are found in the ventrolateral OE, in a pattern somewhat similar to
that of the Fgf20GFP-Cre lineage. However, Foxg1+ cells are located in the BC layer and coexpress BC markers, unlike FEP cells. This suggests that Foxg1+ BCs could be derived from
FEP cells.
We propose that FEP cells are an embryonic OE progenitor population. FEP cells were
identified in the early embryonic (E10.5 and E12.5) lateral OE, which is less developed than the
medial OE (Eerdunfu et al., 2017; Tucker et al., 2010a). Even after the OE begins to mature and
undergo established neurogenesis at E13 (Cau et al., 1997a; Cuschieri and Bannister, 1975a,
1975b; Smart, 1971), FEP cells continued to be localized laterally in immature and
undifferentiated OE, which resembled early-stage embryonic OE. This suggests that FEP cells
define parts of the developing OE focused on progenitor expansion (horizontal development),
rather than established neurogenesis (vertical development). Moreover, given that the OE
expands in a ventrolateral direction, at around E12.5 to E15.5, after initial development of the
dorsomedial region (Eerdunfu et al., 2017), FEP cells occupy the correct location to account for
this lateral expansion. Consistent with this, the Fgf20GFP-Cre lineage included the entire
ventrolateral OE (zones 2-4) but spared some of the dorsomedial OE (zone 1).
The total lineage of FEP cells included all the major cell types of the OE, including Sus
cells, ORNs, BCs, as well as Bowman’s glands and ducts. Transient Fgf20 lineage labeling,
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taking advantage of GFP-Cre perdurance, suggests that FEP cells give rise immediately to Sox2+
BCs. Sox2+ BCs, in turn, differentiate in a well-described, step-wise manner into ORNs in
established neurogenesis (reviewed in Calof et al., 2002; Maier et al., 2014). Transient Fgf20
lineage tracing also suggests that FEP cells can differentiate directly to Sus cells. In addition, it
has been recently shown that Ascl3+ cells found in the apical layer of the embryonic OE are
progenitors for both Bowman’s gland and duct cells, and microvillar cells (Weng et al., 2016).
We predict that FEP cells give rise to these Ascl3+ progenitors.
A caveat in analyzing Fgf20GFP-Cre lineage tracing data is that the lineage is cumulative.
To definitively show that FEP cells give rise to the expanding OE will require an inducible
system to target the FEP population at a specific time point. Nevertheless, results from the
cumulative lineage strongly suggest that FEP cells contribute to OE expansion. The Fgf20GFP-Cre
lineage accounted for nearly all of the OE expansion that occurred from E14.5 to P7, during
which the OE surface area increased by eleven-fold. This high rate of expansion coincided with
FGF20-regulated cartilaginous growth of turbinates beginning at E14.5 with the formation of a
mesenchymal condensation and ending around P7 with ossification of the turbinates. From P7 to
P30, the OE surface area continued to expand by roughly three-fold, as turbinates grow by what
has been hypothesized as secondary membranous bone extensions (Martineau-Doizé et al.,
1992). During these stages, Fgf20GFP-Cre-lineage OE and non-lineage OE grew proportionally,
which is expected, given the absence of FEP cells at these stages. This suggests a different
method of OE expansion accompanying a different method of turbinate growth. Furthermore,
while the Fgf20GFP-Cre lineage did not extend beyond the FEP domain at the start of OE
development (E11.5), it quickly and increasingly exceeded the FEP domain horizontally during
the stages of rapid OE expansion (E14.5 and E17.5). These lineage trace data, together with
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results showing increased proliferation and decreased neurogenesis in FEP regions of the OE,
strongly support a role for FEP cells in horizontal OE development.

1.4.2 FEP cells have potential for dysplasia
In βCat gain-of-function mice, FEP cells became dysplastic, densely packed clumps of
undifferentiated cells. A similar tumorigenic phenotype has been recently studied, in which
Sox2:CreERT2 was used to activate the βCatfl(ex3) allele (Engel et al., 2016), presumably targeting
FEP cells along with Sox2+ BCs and Sus cells. Notably, the strongest tumorigenic phenotype
occurred when tamoxifen was given at E14.5. The phenotype was markedly and progressively
less severe when tamoxifen was given at P7, P14, and P21 (no phenotype). This strongly
suggests that FEP cells, which are present early in development and disappear after P7, were the
cells responding to Wnt/βCat overactivation in their experiment. Therefore, our βEX3-OA
experiment most likely targets the more specific cell type. Engel et al. also discuss the similarity
and differences between this tumorigenic phenotype and human tumors, including olfactory
neuroblastoma and sinonasal haemangiopericytoma. The results from Engel et al. indicated a
turbinate phenotype, but it was not described.

1.4.3 Wnt/βCat signaling maintains FEP stemness
The “neck” OE where FEP cell were found may define a niche environment to maintain these
embryonic progenitors into perinatal stages. Wnt/βCat signaling is often an important component
of stem cell and progenitor niches (Clevers and Nusse, 2012; Nusse and Clevers, 2017). This
ubiquitous signaling pathway has been studied in the OE at the nasal pit stage in the context of
facial development (Brugmann et al., 2007; Mani et al., 2010; Reid et al., 2011; Zhu et al.,
2016a) and at the postnatal and adult stage in the context of OE stem cell maintenance (Chen et
al., 2014; Wang et al., 2011). However, it has not been studied at the stages in between, except
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for an ectopic activation study (see below; Engel et al., 2016). Here, we report Wnt/βCat activity
at various stages throughout the embryonic and early postnatal OE using the Tcf/Lef:H2b-Gfp
mouse (Ferrer-Vaquer et al., 2010) in addition to Fgf20GFP-Cre expression, an established
transcriptional target of Wnt signaling (Chamorro et al., 2005).
βCat loss- and gain-of-function experiments show that Wnt/βCat signaling is necessary
and sufficient for the maintenance of FEP cells. Loss-of-function led to loss of FEP cells due to
premature differentiation into Sox2+ BCs, and in turn, ORNs, while gain-of-function led to
sustained FEP cell maintenance without differentiation into other cell types. Notably, in βEX3OA mice at E17.5, almost the entire OE resembled early-stage immature OE. Loss-of-function
experiments also suggest that Wnt/βCat signaling is necessary for the maintenance of Sox2+
BCs, perhaps secondary to defects in the FEP cells that give rise to them.
Other signals may also be important for FEP niche maintenance. Mechanical forces from
negative curvature generation and signals from the turbinates or nasal cavity wall could be
important, since negatively-curved OE is formed by the developing turbinates. These signals
could be Wnt ligands or other factors upstream of Wnt/βCat signaling. This possibility suggests
an interesting feedback loop in which developing turbinates help shape the niche to maintain
expansive OE progenitors that, in turn, secrete signals to promote turbinate growth. It is further
conceivable that the loss of FEP cells in βCat loss-of-function mice is secondary to defects in
turbinate growth affecting OE negative curvature formation. However, we believe that Wnt/βCat
signaling most likely acts directly to maintain FEP cells, since Wnt/βCat activity has the same
pattern of expression as Fgf20. Furthermore, overactivation of Wnt/βCat signaling was sufficient
to maintain FEP cells outside of negatively-curved “neck” OE.
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1.4.4 Disruptions to signaling, not cell adhesion, accounts for most of the βCat
loss-of-function phenotype
βFF-CKO mice have disruptions in both the signaling and cell adhesion functions of βCat.
However, evidences suggest that defects in cell adhesion were not responsible for the βFF-CKO
phenotype. Importantly, βDF-CKO mice, in which only signaling was affected, had similar
phenotypes to the complete knockout. Furthermore, a recent study found no defects in the total
number of ORNs and Sus cells in the P0 OE in mice lacking functional αN-catenin, an important
component of cell adhesion that is highly expressed in ORNs (Katsunuma et al., 2016).
However, in these mice, there was abnormal adhesion between ORNs and Sus cells, resulting in
abnormal apical patterning of the OE.
The βCatDM allele is hypomorphic, and βDF-CKO mice had similar but less severe
phenotypes compared to βFF-CKO mice. One difference between the two knockouts is that
Sox2+ BC density was increased in βDF-CKO mice at P0 but decreased in βFF-CKO mice. We
hypothesize that this difference was due to a later onset of premature differentiation in βDF-CKO
mice. Supporting this idea, FEP cells could still be found at E17.5 in βDF-CKO mice, while they
were almost completely gone in the most severe βFF-CKO mice as early as E14.5. The increase
in Sox2+ BC density at P0, therefore, was likely the result of premature differentiation of the FEP
cells remaining at E17.5.

1.4.5 Wnt/βCat signaling in FEP cells regulates turbinate development via
epithelial-mesenchymal signaling
Mice lacking Fgf20 had decreased total OE surface area, but normal OE cellular composition and
organization. Based on these findings, we conclude that the OE is not directly affected by loss of
FGF20 signaling. Rather, FGF20 appears to be signaling directly to the underlying mesenchyme
to regulate turbinate growth. Consistent with this, in the absence of FGF20, expression of the
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FGF target gene Dusp6 is markedly decreased in diffuse mesenchymal cells directly beneath the
OE. Conversely, ectopic activation of FGF signaling led to increased Dusp6 expression in the
diffuse cells. However, we cannot completely rule out the possibility that FGF20 may be
signaling to both the mesenchyme and the OE, which is the case during cochlea development
(Huh et al., 2012a, 2015a).
The βCat loss- and gain-of-function experiments strongly suggest that Fgf20 is a
downstream target of Wnt/βCat signaling. Wnt/βCat activity and Fgf20 expression were detected
in a pattern associated with turbinate development prior to their complete calcification at around
P7. Consistent with this, loss of Wnt/βCat-FGF20 signaling affected the cartilaginous growth of
turbinates. Prior to and during the initiation of turbinate c1 development at E14.5, Wnt/βCat
activity and Fgf20 expression were detected in the OE overlying the site of c1 development. This
suggests that the OE has a role in the initiation of turbinate development, as hypothesized
previously (Adameyko and Fried, 2016a; Dieulafé, 1906). In both Fgf20-KO and βFF-CKO
mice, the ratio of c1 condensed mesenchymal cells to diffuse cells at E14.5 was decreased. Both
also showed decreased proliferation of diffuse cells as well as the normally highly proliferative
condensed cells. Dusp6 expression showed that diffuse cells are likely the direct targets of
FGF20 signaling. Together, these results suggest that Wnt/βCat-FGF20 signaling is required for
chondrocyte progenitor proliferation and potentially mesenchymal condensation. The reason for
reduced proliferation of condensed cells is not clear at this point. Fgf9-OA and βEX3-OA mice,
which had dramatically increased Fgf20 expression, had increased proliferation of diffuse
mesenchymal cells, but decreased or a lack of condensed cells. In βEX3-OA mice, this led to an
expansion of the mesenchymal layer at the expense of turbinate cartilage. Together, these results
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show that an appropriate level of Wnt/βCat-FGF20 signaling is required for normal chondrocyte
progenitor proliferation and formation of the mesenchymal condensation.
Strikingly, in both βFF-CKO and βDF-CKO mice, turbinate phenotypes were more
severe than that of Fgf20-KO mice. In the most severe βFF-CKO mice, there was no formation
of the mesenchymal condensation. This indicates that other Wnt/βCat-regulated epithelialmesenchymal signals may complement FGF20 and compensate for its loss during turbinate
development. We hypothesize that these signals are also expressed by FEP cells; however, we
cannot rule out the possibility that they are expressed by other parts of the OE within the FEPlineage. These signals could be other members of the FGF family, which often have
complementary and redundant functions with each other (Ornitz and Itoh, 2015a). Consistent
with this, some residual expression of the FGF target gene Dusp6 was found in the turbinate
mesenchyme in Fgf20-KO embryos, but not in βFF-CKO embryos.
FGFs shown to be expressed in or around the embryonic nasal pit and OE include Fgf3,
4, 7, 8, 9, 10, 15, and 17 (Bachler and Neubüser, 2001a; Kawauchi et al., 2004a, 2005a; Zhu et
al., 2016a). Among these, only Fgf8 has been shown in vivo to be necessary for olfactory
development, although whether it is directly or indirectly required is a topic of debate. Fgf8 is
expressed at the rim of the nasal pit, and its conditional deletion leads to death of cells required
for OE neurogenesis (Kawauchi et al., 2005a). This causes loss of almost all OE cells and other
olfactory structures in the nasal cavity very early in development. Interestingly, Fgf8 expression
in the nasal pit is partly regulated by Wnt/βCat signaling (Reid et al., 2011). However, it has
been shown that Fgf8 expression and lineage is restricted to the respiratory epithelium, and loss
of Fgf8 leads to olfactory defects secondary to defects in craniofacial development (Forni et al.,
2013a).
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Other candidate FGFs that potentially work together with FGF20 include FGF9, which is
a part of the same FGF subfamily as FGF20, and has been shown to work with FGF20 in kidney
(Barak et al., 2012) and cochlea (Huh et al., 2015a) development. FGF10, which is essential for
the initiation of limb bud formation (Min et al., 1998; Sekine et al., 1999), is also a candidate.
However, neither Fgf9; Fgf20 nor Fgf10; Fgf20 double-knockout mice exhibited a more severe
phenotype than Fgf20-KO (unpublished data). Future experiments targeting Fgfrs for deletion in
turbinate chondrocyte progenitors can help address FGF redundancy.
Bone morphogenetic proteins (BMPs) are another class of Wnt/βCat-regulated signaling
factors that have well described roles in chondrogenesis (Lin et al., 2016) and could promote
turbinate growth. Bmp2, 4, 6, and 7 expression have been detected in the embryonic OE,
particularly in ORNs (Peretto et al., 2002; Shou et al., 2000). These genes have not been studied
in the context of in vivo turbinate development, although there is in vitro evidence that they
function in feedback inhibition of ORN differentiation (Shou et al., 1999, 2000), similarly to
other members of the TGFβ superfamily (Gokoffski et al., 2011a; Kawauchi et al., 2004a, 2009a;
Wu et al., 2003). Unlike FGF20, other epithelial-mesenchymal signals may not necessarily be
directly regulated by Wnt/βCat signaling. In the absence of Wnt/βCat signaling, FEP cells are
not maintained, resulting in the loss of signals produced by FEP cells.
The decrease in OE surface area and turbinate size and complexity in Fgf20-KO mice
makes them a potentially useful model for understanding olfaction, particularly from an
evolutionary perspective. Turbinate complexity is highly variable among mammals, and this
variability has been hypothesized to be correlated with, and evolutionarily driven by, the
importance of olfaction (Negus, 1959). However, the idea that increased OE surface area results
in increased olfactory ability has not been directly tested (Van Valkenburgh et al., 2014a).
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Fgf20-KO mice are useful for testing this hypothesis. Olfactory receptors in the OE are zonally
distributed (Ressler et al., 1993; Vassar et al., 1993). Fgf20-KO mice may therefore have a
deficiency in specific zones of the OE, resulting in a decrease of a specific subset of olfactory
receptors. This could be studied by examining distribution patterns of various olfactory receptors
in the Fgf20-KO OE and testing for ability to detect a range of different odorants.
Overall, this study addresses several important gaps in knowledge in olfactory system
development, including the identity of an expansive pool of OE progenitors, mechanisms
regulating OE expansion, genetic regulation of turbinate development, role of Wnt/βCat
signaling in olfactory development, and mechanisms linking scaling of the OE and the
underlying turbinates. We do not know whether FEP cells exist in other mammalian species, but
our findings have implications for mammalian evolution. Evolutionarily-driven factors acting on
FEP cell number and function are a potential mechanism accounting for the diversity of OE
surface area and turbinate complexity seen across mammals. Furthermore, dysregulation of FEP
cells or their equivalent in humans may contribute to human diseases such as anosmia and
olfactory tumors. Finally, this study provides an interesting model for tissue-scaling and
progenitor niche maintenance with potential relevance to other developmental systems.

1.5 Methods
1.5.1 Mice
Mice were group housed with littermates, in breeding pairs, or in a breeding harem (2 females to
1 male), with food and water provided ad libitum. For timed-pregnancy experiments, embryonic
day 0.5 (E0.5) was assigned as noon of the day the vaginal plug was found. For postnatal
experiments, postnatal day 0 (P0) was determined as the day of birth. All studies performed were
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in accordance with the Institutional Animal Care and Use Committee at Washington University
in St. Louis.
Mice were of mixed sexes and maintained on a mixed C57BL/6J x 129X1/SvJ genetic
background. All mouse lines were previously reported:
•

Fgf20GFP-Cre: knockin allele containing a sequence encoding a GFP-Cre fusion protein
replacing exon 1 of Fgf20, resulting in a null mutation (Huh et al., 2015a).

•

Fgf20βgal: knockin allele containing a sequence encoding β-galactosidase (βgal) replacing
exon 1 of Fgf20, resulting in a null mutation (Huh et al., 2012a).

•

ROSAmTmG: knockin allele containing a sequence encoding a membrane-localized
tdTomato (mT) flanked by loxP sequences, followed by a sequence encoding a
membrane-localized eGFP (mG), targeted to the ubiquitously expressed ROSA26 locus.
In the absence of Cre-mediated recombination, mT is expressed; upon Cre-mediated
recombination, mG is alternatively expressed (Muzumdar et al., 2007a).

•

ROSAtdTomato: Ai9 knockin allele containing a loxP-Stop-loxP sequence followed by a
sequence encoding tdTomato, targeted to the ubiquitously expressed ROSA26 locus.
Upon Cre-mediated recombination, tdTomato is expressed (Madisen et al., 2010).

•

ROSArtTA: knockin allele containing a loxP-Stop-loxP sequence followed by a sequence
encoding rtTA-IRES-eGFP, targeted to the ubiquitously expressed ROSA26 locus. Upon
Cre-mediated recombination, reverse tetracycline transactivator (rtTA) and eGFP are
expressed (Belteki et al., 2005).

•

TRE-Fgf9-IRES-eGfp: transgene containing seven tetracycline-inducible regulatory
elements driving the expression of FGF9-IRES-eGFP (White et al., 2006).
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•

Tcf/Lef:H2b-Gfp: transgene containing a sequence encoding a histone 2B-eGFP (H2BGFP) fusion protein, expressed under the control of six copies of a TCF/LEF responsive
element (Ferrer-Vaquer et al., 2010). TCF/LEFs are transcription co-factors that bind βCatenin to activate Wnt/β-Catenin regulated genes (Clevers and Nusse, 2012; Nusse and
Clevers, 2017).

•

βCatfl(ex2-6): allele containing loxP sequences flanking exons 2 (containing ATG) through
6 of β-Catenin. Upon Cre-mediated recombination, produces a null mutation (Brault et
al., 2001).

•

βCatDM: allele containing a constitutive double mutation that partially blocks the
signaling capacity of β-Catenin, while preserving its function in adherens junctions
(Valenta et al., 2011).

•

βCatfl(ex3): allele containing loxP sequences flanking exon 3 (containing all regulatory
phosphorylation sites) of β-Catenin. Upon Cre-mediated recombination, produces a
dominant stabilized β-Catenin to activate Wnt/β-Catenin signaling (Harada et al., 1999).

1.5.2 Doxycycline induction
For the Fgf9-OA experiment, pregnant dams were fed Dox Diet, Grain-Based Doxycycline, 200
mg/kg (Bio-Serv, S3888) ad libitum starting at noon on E11.5 until sample harvest at E14.5.

1.5.3 Sample preparation
Heads from mice younger than five days old were fixed in 4% PFA in PBS overnight at 4°C with
gentle agitation. Samples were then washed x3 in PBS and cryoprotected in 15% sucrose in PBS
overnight and then in 30% sucrose in PBS overnight. Samples were embedded in Tissue-Tek
O.C.T. compound (VWR International, 4583) and frozen on dry ice. Serial frontal sections
through the nasal cavity were cut at 12 µm with a cryostat, dried at room temperature, and stored
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at -80°C until use. Mice that were five days old or older were perfused with PBS and 4% PFA in
PBS prior to post-fixation in 4% PFA in PBS overnight at 4°C with gentle agitation. After PBS
wash, parts of the head posterior to the maxilla and frontal bone were cut and removed, along
with the mandible, hard palate, and most of the remaining exposed soft tissue, except for the
olfactory bulb. Front incisors and molars, if any, were removed with rongeurs. The remaining
skulls with intact nasal cavity were then decalcified by incubation in 0.5 M EDTA, pH 8 at 4°C
with gentle agitation for two days, or three days for mice two weeks old or older, with daily
EDTA solution replacement. Cryoprotection, embedding, and sectioning were performed as
above, except prior to embedding, samples were submerged in O.C.T. and placed in a vacuum
chamber to remove air bubbles from inside the nasal cavity.

1.5.4 RNA in situ hybridization
Probe preparation: plasmid containing 413 bp of Dusp6 5’-UTR was a gift from Suzanne
Mansour (Li et al., 2007). To make antisense probe, the plasmid was linearized with restriction
enzyme Acc65I (New England Biolabs, R0599S) and transcribed with T7 RNA polymerase
(New England Biolabs, M0251S) according to manufacturer’s instructions, with DIG RNA
Labeling Mix (Sigma-Aldrich, 11277073910). After treatment with RNase-free DNase I (SigmaAldrich, 04716728001) for 15 min at 37°C, probes were hydrolyzed in hydrolysis buffer (40 mM
NaHCO3, 60 mM Na2CO3) at 65°C for 30 min.
Frozen section in situ hybridization: frozen slides were warmed for 20 min at room
temperature and then 5 min at 50°C on a slide warmer. Sections were fixed in 4% PFA in PBS
for 20 min at room temperature, washed x2 in PBS and treated with pre-warmed 10 µg/ml
Proteinase K (Sigma-Aldrich, 03115828001) in PBS for 7 min at 37°C. Sections were then fixed
in 4% PFA in PBS for 15 min at room temperature, washed x2 in PBS, acetylated in 0.25%
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acetic anhydrate in 0.1M Triethanolamine, pH 8.0, for 10 min, and washed again in PBS.
Sections were then placed in pre-warmed hybridization buffer (50% formamide, 5x SSC buffer,
5 mM EDTA, 50 µg/ml yeast tRNA) for 3 h at 60°C in humidified chamber for prehybridization.
Sections were then hybridized in 10 µg/ml probe/hybridization buffer overnight (12-16 h) at
60°C. The next day, sections were washed in 1x SSC for 10 min at 60°C, followed by 1.5x SSC
for 10 min at 60°C, 2x SSC for 20 min at 37°C x2, and 0.2x SSC for 30 min at 60°C x2. Sections
were then washed in KTBT (0.1 M Tris, pH 7.5, 0.15 M NaCl, 5 mM KCl, 0.1% Triton X-100)
at room temperature and blocked in KTBT + 20% sheep serum + 2% Blocking Reagent (SigmaAldrich, 11096176001) for 4 h. Blocking Reagent was dissolved in 100 mM Maleic acid, 150
mM NaCl, pH 7.5. Sections were then incubated in sheep anti-Digoxigenin-AP, Fab fragments
(1:1000, Sigma-Aldrich, 11093274910) in KTBT + 20% sheep serum + 2% Blocking Reagent
overnight at 4°C. Sections were then washed x3 in KTBT for 30 min at room temperature, and
then washed x2 in NTMT (0.1 M Tris, pH 9.5, 0.1 M NaCl, 50 mM MgCl2, 0.1% Tween 20) for
15 min. Sections were next incubated in NTMT + 1:200 NBT/BCIP Stock Solution (SigmaAldrich, 11681451001) in the dark at room temperature until color appeared. Sections were then
washed in PBS, post-fixed in 4% PFA in PBS for 15 min and washed x2 in PBS. Finally,
sections were dehydrated in 30% and then 70% methanol, 5 min each, followed by 100%
methanol for 15 min. Sections were then rehydrated in 70% and 30% methanol and then PBS, 5
min each, and mounted in 95% glycerol.

1.5.5 Histology and immunofluorescence
H&E staining was done by the Washington University Developmental Biology Histology Core.
Immunofluorescence: frozen slides were warmed for 30 min at room temperature and washed in
PBS before incubating in PBS + 0.5% Triton X-100 (PBST) for 1 h to permeabilize the tissue.
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Sections were then blocked using in PBST + 5% donkey serum for 1 h and then incubated in
PBST + 1% donkey serum with the primary antibody overnight at 4°C in a humidified chamber.
Sections were then washed x3 in PBS and incubated in PBS + 1% Triton X-100 with the
secondary antibody. After wash in PBS x3, slides were mounted in VectaShield antifade
mounting medium with DAPI (Vector Labs, H-1200).

1.5.6 Antibodies
Antibodies for immunofluorescence were used at the following concentrations:
•

Rabbit anti-GFP (1:500; Life Technologies, A-11122)

•

Chick anti-Beta galactosidase (1:500; Abcam, ab9361)

•

Goat anti-Sox2 (1:200; Santa Cruz, sc-17320)

•

Rabbit anti-Sox9 (1:500; Millipore, AB5535)

•

Goat anti-OMP (1:1000; Wako Chemicals, 544-10001)

•

Goat anti-Pde2a (1:100; Santa Cruz, sc-17227)

•

Alexa Fluor conjugated secondary antibodies (1:500; Thermo Fisher)

•

Sheep anti-Digoxigenin-AP, Fab fragments (1:1000, Sigma-Aldrich, 11093274910)

1.5.9 Measurements and cell quantification
Measurements and cell quantification (using the Cell Counter plugin by Kurt De Vos) were done
using ImageJ. For OE surface area measurements, length along the apical surface of the OE was
measured in serial frontal sections starting just anterior to endoturbinate I and ending at the end
of the nasal cavity. The measured length was then multiplied by the distance between sections to
calculate surface area. OE was differentiated from respiratory epithelia based on histology (OE is
pseudostratified); where ambiguous, epithelia <30 µm thick were not considered OE.

38

Fgf20GFP-Cre lineage quantification
OE surface area was measured as above, with the following specifics:
•

E11.5: measurements were done on eleven to 14 sections per sample, starting anteriorly
when the VNO was reached.

•

E14.5: nine sections per sample, starting mid VNO, when n1 and n2 were reached.

•

E17.5: eleven sections per sample, starting posterior to the VNO, when n2 was reached.

•

P7: 14 sections per sample, starting posterior to the VNO, when n2 was reached.

•

P30, nine to ten sections per sample, starting posterior to the VNO, when n2 was reached.

Linear Fgf20+ and OMP+ cell distribution plot
OE of turbinate c1 was linearized in ImageJ at the level of OMP+ ORNs. The location of each
Fgf20+ and OMP+ cell was marked along this line. Plots from multiple samples were scaled to
their average length and combined to represent an average/combined distribution across multiple
samples. Plots were made in Canvas X (ACD Systems)

Phenotype analyses at P30
•

Individual turbinate size: length was measured at the apical OE surface of each turbinate
from two comparable sections at the anteroposterior middle of each turbinate, and then
summed to estimate relative turbinate size. Outlines in Figure 1.5B’ indicate
measurements used to estimate turbinate size.

•

Total surface area: OE surface area was measured as above, using 26-29 frontal sections,
starting immediately posterior to the VNO for the OE, and 3-6 frontal sections spanning
the entire septal organ anteroposteriorly, for the septal organ.
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For the rest of this study (methods below), we focused on turbinate c1.

Phenotype analyses at E13.5 and E14.5
•

OE thickness: average of three measurements made on one frontal section halfway
through the turbinate. Measurements were at the turbinate tip/center and 50 µm on either
side. Each measurement was the shortest distance from the epithelial-mesenchymal
boundary to the apical surface of the OE.

•

Mesenchyme thickness: as with OE thickness, average of three measurements at the
turbinate tip/center and 50 µm on either side. Each measurement was the shortest
distance from the epithelial-mesenchymal boundary to the nasal cavity wall.

Cell counts were made on comparable frontal sections halfway through the turbinate.
•

Condensed mesenchymal cells were identified by high Sox9 staining, small soma, and
dense packing of cells. A few cells outside of the condensations at E14.5 (closer to the
epithelium) had high Sox9 expression, but were counted as diffuse mesenchymal cells.
Condensed and diffuse cell numbers were normalized to the number of Sox9+
chondrocytes in the adjacent nasal cavity wall to adjust for potential slight differences in
angle of sectioning.

•

Quantification of “OE adjacent cell” proliferation in the Fgf9-OA experiment: average c1
diffuse mesenchyme thickness in control embryos was measured to be 69 µm. In Fgf9OA embryos, the c1 OE was outlined at the basal side; this outline was then moved 69
µm away from the basal side of the OE. Cells between this line and the OE were
considered “OE adjacent cells.” The average normalized number of “OE adjacent cells”
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quantified was 1.2 ± 0.1 in Fgf9-OA embryos, the same as the normalized number of
diffuse cells in control (1.2 ± 0.2).
•

BC number was normalized to OE basal surface length. OMP+ cell number was
normalized to OE apical surface length. Fgf20+ cell counts were normalized to OE area
on a section.

Phenotype analyses at E17.5 and P0
•

Turbinate cartilage size: a curved line was drawn to the contour of the lateral nasal cavity
wall dorsal and ventral to c1; the cartilage projection medial to this line was considered
the turbinate. Cartilaginous area of c1 was measured in 5 to 7 serial frontal sections
spanning the entire turbinate anteroposteriorly. The measured area was then multiplied by
the distance between sections to calculate volume.

•

Turbinate OE surface area: length of the turbinate was measured along the epithelialmesenchymal boundary in 5 to 7 serial frontal sections and multiplied by the distance
between sections. Inflection points in the OE curvature at “neck” regions were used to
differentiate between turbinate OE (OE overlying the turbinate) and OE overlying the
nasal cavity wall. For reference, see dashed line in Figures 1.6H, 1.11C, and 1.12C. In
cases where the turbinate was completely absent (βFF-CKO, shape 3), what was
considered turbinate OE was estimated based on the height (dorsoventral length) of the
turbinate in less severe βFF-CKO littermates (see Figure 1.11C, dashed line). Note the
“neck” OE regions of c1 are further apart in βFF-CKO mice (turbinate “neck” cartilage is
thicker); this was taken into consideration in the estimate.
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•

Mesenchyme thickness: three measurements at the turbinate tip/center and 100 µm on
either side, on 3 sections 96 µm apart for a total of 9 measurements (which were then
averaged). Each measurement was the shortest distance from the epithelial-mesenchymal
boundary to the turbinate cartilage.

•

OE thickness: same as mesenchyme thickness. Each measurement was the shortest
distance from the epithelial-mesenchymal boundary to the apical surface of the OE.

•

Sox2+ and OMP+ cell count: on comparable sections at the anteroposterior middle of the
turbinate. BC number was normalized to OE basal surface length. Sus cell and ORN
numbers were normalized to OE apical surface length.

•

Mesenchyme EdU-incorporating cell count: “neck” region mesenchyme was defined as
mesenchyme adjacent to FEP cell area, both dorsal and ventral to c1, combined. “Tip”
region was a similarly sized area at the tip of c1.

•

Chondrocyte EdU-incorporating cell count: all chondrocytes of c1 (“neck” and “tip”) on
a frontal section halfway through the turbinate were counted.

In situ hybridization analyses
In situ hybridization for Dusp6 was evaluated, blinded to genotype, by alkaline phosphatase
color reaction intensity in the c1 mesenchyme. 2-3 serial sections per sample from Fgf20-KO (n
= 7 control, 7 Fgf20-KO), Fgf9-OA (n = 4 control, 4 Fgf9-OA), and βFF-CKO (n = 4 control, 6
βFF-CKO) E14.5 embryos were examined. For Fgf20-KO samples, the genotypes of 13 out of
14 total samples were scored correctly based on Dusp6 expression intensity (one control sample
was wrongly scored as Fgf20-KO). Figures 1.5H, 1.7G, and 1.10C show representative images
of each genotype.
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1.5.7 Cell proliferation assay
EdU (Thermo Fisher, E10187) was injected i.p. into pregnant dams at 100 µg per gram body
weight. Except where noted, embryos were harvested at 1 h after injection. For 4 h EdU
incorporation, 100 µg per gram body weight of EdU was injected at 4 h and 2 h before embryos
were harvested. EdU was detected using the Click-iT Plus EdU Alexa Fluor 594 or 647 picolyl
azide toolkit (Thermo Fisher, C10639, C10640) according to manufacturer’s instructions.

1.5.8 Imaging
Brightfield microscopy was done using a Hamamatsu NanoZoomer slide scanning system with a
20x objective or on a Zeiss AxioPlan 2 with a 10x or 20x objective. Images were processed with
the NanoZoomer Digital Pathology (NDP.view2) software or ImageJ (imagej.nih.gov).
Fluorescent microscopy was done using a Zeiss Axio Imager Z1 with Apotome 2, with zstack step-size determined based on objective lens type (10x or 20x), as recommended by the
ZEN software (around 1 µm). Fluorescent images shown are maximum projections. Low
magnification fluorescent images shown required stitching together, by hand, several images to
capture the entire structure of interest. Some fluorescence microscopy was also done using a
Zeiss Axio Imager Z2 with Apotome 2. In all cases, except where noted, Fgf20GFP-Cre expression
was detected with an anti-GFP antibody. In all cases, mGFP, mTomato, tdTomato, and H2BGFP expressions were detected by native fluorescence. Images were processed with ImageJ.

1.5.10

Statistics and plotting

All figures were made in Canvas X. Data analysis was performed using the Python programming
language (python.org) in Jupyter Notebook (jupyter.org) with the following libraries: Pandas
(pandas.pydata.org), NumPy (numpy.org) and SciPy (scipy.org). Plotting was done using the
Matplotlib library (matplotlib.org). Statistics (t-test and one-way ANOVA) were performed
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using the SciPy module Stats; Tukey’s HSD was performed using the Statsmodels package
(statsmodels.org).
Data from βFF-CKO mice were plotted in different colors to visualize differences in
phenotype severity (shapes 1, 2, and 3). However, data from all shapes were combined for
statistical analysis. Comparisons of two means in βFF-CKO experiments were performed using
two-tailed, unpaired Welch’s (unequal variance) t-test, since βFF-CKO mice exhibited variability
in phenotype while controls did not. All other comparisons of two means were performed using
two-tailed, unpaired Student’s t-test. For comparisons of more than two means, one-way
ANOVA was used; for significant results at α = 0.05, Tukey’s HSD was performed for post-hoc
pair-wise analysis.
All statistical details can be found in the figures and figure legends. In all cases, sample
size (n) represents the number of animals. Data are represented as mean ± standard deviation
(SD).
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Figure 1.1 Fgf20 is expressed in a subset of Sox2+ cells in the developing OE
(A-G) Fgf20 expression detected via an anti-GFP antibody in Fgf20GFP-Cre/+ mice (green). The
OE is identified via an anti-Sox2 antibody (red). Sox2 is expressed throughout the OE at
E10.5 (A) and E12.5 (B), and mainly in the basal and apical layers at E14.5 (C), E17.5
(D-F), and P7 (G).
(A)

Faint Fgf20GFP-Cre expression in the nasal pit at E10.5. Arrowheads indicate extent of the
expression. Arrow indicates autofluorescence from red blood cells outside of the nasal
pit.
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(B)

Fgf20GFP-Cre expression in the OE at E12.5. * indicates site of future c1 development.
VNO, vomeronasal organ.

(C)

Fgf20GFP-Cre expression in the OE at E14.5. White arrowheads indicate immature
negatively-curved OE. Blue arrowheads indicate mature negatively-curved OE. Arrows
indicate apical Fgf20 expression in OE outside of regions of negative curvature. *
indicates expression in OE overlying c1.

(D-F) Fgf20GFP-Cre expression in anterior (D), mid (E), and posterior (F) sections at E17.5.
White arrowheads indicate immature negatively-curved OE. Blue arrowheads indicate
mature negatively-curved OE.
(E’)

Magnification of the c1 neck region, boxed in (E). Arrowheads indicate fainter Fgf20GFPCre
expression in Sox2+ basal and apical cells adjacent to negatively-curved OE (*). A,
apical layer; B, basal layer indicated in the merged image.

(G)

Fgf20GFP-Cre expression at P7. Arrowheads indicate apical Fgf20GFP-Cre expression at
negatively-curved OE. Inset, 2.5x magnification of boxed region.

(H)

Diagram of a mid-sagittal mouse nasal cavity showing locations of the three sections in
(D-F). A, anterior; M, mid; P, posterior.

RE, respiratory epithelium. S, nasal septum. D, dorsal; M, medial. Dashed line, epithelialmesenchymal boundary. DAPI, nuclei (blue). Scale bars, 100 µm (A-C, E’), 500 µm (D-G).

46

47

Figure 1.2 Related to Figure 1.1
(A-G) H&E staining in frontal sections through the nasal cavity.
(A)

Nasal pit (NP) at E10.5.

(B)

Turbinates n1 and n2 at E12.5. n3 appears at this stage and can be found in more
posterior sections (data not shown). * indicates site of future c1 development. VNO,
vomeronasal organ.

(C)

Turbinates n1, c1, and n2 at E14.5. n1 and n2 are connected at this section. c2, n3, and n4
appear at this stage and can be found in more posterior sections (data not shown).

(C’)

Magnification of the boxed region in (C). c1 appears as a mesenchymal condensation (M)
between the OE and the nasal cavity wall (N).

(D-F) All six turbinates in anterior (D), mid (E), and posterior (F) sections at E17.5.
(E’)

Magnification of the boxed region in (E). Condensed mesenchymal cells have
differentiated into chondrocytes. N, nasal cavity wall; T, turbinate cartilage; M,
mesenchyme.

(G)

All six turbinates at P7.

(G’)

Magnification of the boxed region in (G). Cartilage have been mostly replaced by
eosinophilic ossified bone. * indicates remaining hypertrophic chondrocytes. N, nasal
cavity wall; T, ossified turbinate; M, mesenchyme.

(H)

Diagram of a frontal section through the nasal cavity at perinatal stages, showing three
layers of tissue: OE, mesenchyme (mes), and cartilage. Inset: zoom showing “neck” and
“tip” regions of c1.

(I)

H&E staining in anterior (1), mid-anterior (2), mid-posterior (3), and posterior (4) frontal
sections through the mouse nasal cavity at P30. Individual turbinates (n1, c1, n2, c2, n3,
n4) are outlined. OB, olfactory bulb.

(I’)

Diagram of a mid-sagittal adult mouse nasal cavity showing locations of the four sections
in (I).

S, nasal septum. D, dorsal; M, medial. Scale bars, 100 µm (A-C, C’, E’, G’), 500 µm (D-G), 1
mm (H).
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Figure 1.3 “Neck” OE is more proliferative and less neurogenic than other parts of the OE
(A)

Fgf20GFP-Cre expression and EdU incorporation in Fgf20GFP-Cre/+ c1 OE at E17.5. OE
overlying the “neck” and “tip” regions of the developing turbinate are outlined.

(B)

Quantification of proliferating cells in c1 OE overlying “neck” and “tip” regions per 1000
µm2 of OE.

(C,D) Fgf20GFP-Cre and OMP expression in anterior (C) and posterior (D) sections at E17.5. RE,
respiratory epithelium. Arrowheads indicate negatively-curved “neck” OE.
(E)

Linear plot of OMP+ ORN and Fgf20+ cell distribution along c1 OE (dashed outline in
(C)) at E17.5. Length: 1.27 mm.

(F)

Pde2a expression in c1 dorsal “neck” or cul-de-sac region at P30.

(G)

Fgf20GFP-Cre and (lack of) Pde2a expression in c1 dorsal “neck” region at E17.5.

(H)

Fgf20GFP-Cre; ROSAmTmG lineage (mG) in the vomeronasal organ (VNO, outlined).

(I)

Fgf20GFP-Cre; ROSAmTmG lineage (mG) in the septal organ (SO, outlined).

Dashed line, epithelial-mesenchymal boundary. DAPI, nuclei. Scale bars, 500 µm (C, H), 100
µm (A, F, G). Error bars, mean ± SD.
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Figure 1.4 Fgf20 lineage includes all major OE cell types and responds to cues for expansion
(A-C) mG expression in the Fgf20GFP-Cre lineage and mT expression (arrowheads) in nonFgf20GFP-Cre lineage in anterior (A), mid (B), and posterior (C) frontal sections of
Fgf20GFP-Cre/+; ROSAmTmG mice at P15. S, nasal septum. Dotted line, zone 1 and zones 2-4
demarcation.
(B’)

Magnification of boxed region in (B). mG expression in the basal cell (BC), olfactory
receptor neuron (ORN), sustentacular cell (Sus), and cilia layers of the OE, as well as in
axon bundles (Ax) and Bowman’s glands (BG) found in the lamina propria.

(D-F) Real-time Fgf20 expression (GFP-Cre) and Fgf20GFP-Cre lineage (tdTomato) in Fgf20GFPCre/+
; ROSAtdTomato mice at E11.5 (D), E14.5 (E), and E17.5 (F). Dashed line, epithelialmesenchymal boundary.
(G)

Quantification of total Fgf20GFP-Cre lineage and non-Fgf20GFP-Cre lineage OE surface area
at E11.5, E14.5, E17.5, P7, and P30. Error bars, mean ± SD; n = 3 at each stage; each bar
represents one mouse

DAPI, nuclei. Scale bars, 500 µm (A-F), 100 µm (B’).
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Figure 1.5 Fgf20-KO mice have reduced turbinate size and altered morphology
(A-D) H&E staining in anterior (A), mid-anterior (B), mid-posterior (C), and posterior (D)
sections through the nasal cavity in control (Fgf20GFP-Cre/+) and Fgf20-KO (Fgf20GFPCre/βgal
) mice at P30. S, nasal septum.
(B’)

Magnification of boxed region in (B). Dashed outline used to estimate relative turbinate
size.

(E)

Quantification of turbinate size for each turbinate at P30. * indicates p < 0.05. p = 0.03
(n1), p < 0.001 (c1), p = 0.02 (n2), p = 0.02 (c2), p = 0.05 (n3), p < 0.001 (n4), n = 4,
Student’s t-test.

(F)

Quantification of OE surface area and septal organ (SO) surface area at P30. n = 4,
Student’s t-test

(G)

EdU incorporation in c1 condensed and diffuse mesenchymal cells at E14.5. Dashed
outline, c1 mesenchyme (M), including both condensed (Sox9hi) and diffuse cells. N,
nasal cavity wall.

(H)

In situ hybridization at E14.5 showing c1 mesenchymal Dusp6 expression in control
(arrows) and reduced expression in Fgf20-KO embryos (arrow). Data is representative of
7 control and 7 Fgf20-KO embryos. N, nasal cavity wall.

(I-M) Quantification of c1 normalized condensed cell number (I), normalized diffuse cell
number (J), ratio of condensed cells to diffuse cells (K), and percent of EdUincorporating condensed cells (L) and EdU-incorporating diffuse cells (M) at E14.5. n =
7, Student’s t-test.
DAPI, nuclei. Scale bars, 1 mm (A-D), 500 µm (B’), 100 µm (G, H). Error bars, mean ± SD.
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Figure 1.6 Related to Figure 1.5
(A,B) H&E staining in anterior (A) and posterior (B) sections through the nasal cavity in
control (Fgf20GFP-Cre/+) and Fgf20-KO (Fgf20GFP-Cre/βgal) mice at P0. S, nasal septum.
(A’)

Magnification of boxed region in (A). N, nasal cavity wall; T, turbinate cartilage; M,
mesenchyme.

(C-F) Quantification of c1 cartilage volume (C), OE surface area (D), mesenchyme thickness
(E), and OE thickness (F) at P0. n = 7 control, 8 Fgf20-KO, Student’s t-test.
(G)

Fgf20GFP-Cre and Sox2 expression in c1 at P0. BC, basal cells; Sus, sustentacular cells.

(H)

OMP expression in c1 at P0.

(I)

Quantification of c1 OMP+ ORNs, Sus cells, and Sox2+ BCs per 100 µm OE at P0. n = 4,
Student’s t-test.

(J)

EdU incorporation in c1 OE Sox2+ cells at E14.5. M, mesenchyme.

(K-M) Quantification of c1 OE thickness (K), Sox2+ BCs per 100 µm (L), and percent of EdUincorporating Sox2+ BCs (M) at E14.5. n = 7, Student’s t-test.
Dashed line, epithelial-mesenchymal boundary. DAPI, nuclei. Scale bars, 500 µm (A), 100 µm
(A’, G, H, J). Error bars, mean ± SD.
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Figure 1.7 Related to Figure 1.5
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(A-E) EdU incorporation in control (Fgf20GFP-Cre/+) and Fgf20-KO (Fgf20GFP-Cre/βgal) mice at
E17.5.
(A)

Fgf20GFP-Cre expression and 1 h EdU incorporation in c1 at E17.5. N, nasal cavity wall; T,
turbinate cartilage; M, mesenchyme.

(A’)

Magnification of boxed region in (A). M, mesenchyme. Dashed line, epithelialmesenchymal boundary. Solid line, cartilage-mesenchyme boundary.

(B-E) Quantification of 1 h (n = 6) and 4 h (n = 3 control, 4 Fgf20-KO) EdU incorporation in c1
“neck” region mesenchymal cells (B), “tip” region mesenchymal cells (C), “neck” and
“tip” chondrocytes (D), and FEP cells (E) at E17.5. Student’s t-test.
(F-L) EdU incorporation and Dusp6 in situ hybridization in control (Fgf20GFP-Cre/+; ROSArtTA)
and Fgf9-OA (Fgf20GFP-Cre/+; ROSArtTA; TRE-Fgf9-IRES-eGfp) mice at E14.5.
(F)

EdU incorporation in c1 condensed and diffuse mesenchymal cells at E14.5. Dashed
outline, c1 mesenchyme (M), including both condensed (Sox9hi) and diffuse cells. N,
nasal cavity wall. Brackets, “OE adjacent cells” within 69 µm below OE.

(G)

In situ hybridization at E14.5 showing c1 mesenchymal Dusp6 expression in control and
increased expression in Fgf9-OA embryos (arrows). Data is representative of 4 control
and 4 Fgf9-OA embryos. N, nasal cavity wall.

(H-L) Quantification of c1 normalized condensed cell number (H), normalized diffuse cell
number (I), ratio of condensed cells to diffuse cells (J), and percent of EdU-incorporating
condensed cells (K) and EdU-incorporating diffuse cells (L) at E14.5. n = 4 control and 6
Fgf9-OA, Student’s t-test.
DAPI, nuclei. Scale bars, 100 µm. Error bars, mean ± SD.
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Figure 1.8 Wnt activity in the developing OE coincides with Fgf20 expression
(A-E) Tcf/Lef:H2b-Gfp expression at E10.5 (A), E12.5 (B), E14.5 (C), E17.5 (D), and P7 (E).
Arrowhead indicates rim of the nasal pit (NP). Arrow indicates epithelium outside of the
nasal pit. * indicates site of future c1 development. RE, respiratory epithelium.
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(D’)

Magnification of boxed region in (D). Arrowheads indicate immature, negatively-curved
OE.

(F,G) Tcf/Lef:H2b-Gfp and Fgf20βgal expression in Tcf/Lef:H2b-Gfp; Fgf20βgal/+ mice at E17.5.
Dashed line, epithelial-mesenchymal boundary. DAPI, nuclei. Scale bar, 100 µm (A-C),
500 µm (D-G, D’).
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Figure 1.9 βCat conditional deletion results in a severe deficit in turbinate development
(A)

H&E staining in control (Fgf20GFP-Cre/+; βCatfl(ex2-6)/+) and βFF-CKO (Fgf20GFP-Cre/+;
βCatfl(ex2-6)/fl(ex2-6)) mice, with two phenotype examples (shapes 2 and 3) at P0. S, nasal
septum.

(A’)

Magnification of boxed region in (A). N, nasal cavity wall; T, turbinate cartilage; M,
mesenchyme. Inset, 2x magnification of the OE at the turbinate tip. Dashed line,
epithelial-mesenchymal boundary.

(B-D) Quantification of c1 cartilage volume (B), OE surface area (C), and mesenchyme
thickness (D) at P0. βFF-CKO phenotype categorized into three shapes (1, 2, and 3). n =
9 control, 14 βFF-CKO, Welch’s t-test.
(E)

EdU incorporation in c1 condensed and diffuse mesenchymal cells at E14.5, with two
βFF-CKO phenotype examples. Dashed outline, c1 mesenchyme (M), including both
condensed (Sox9hi) and diffuse cells. N, nasal cavity wall.

(F-J)

Quantification of c1 normalized condensed cell number (F), normalized diffuse cell
number (G), ratio of condensed cells to diffuse cells (H), and percent of EdUincorporating condensed cells (I) and EdU-incorporating diffuse cells (J) in control and
βFF-CKO at E14.5. n = 8 control, 10 βFF-CKO, Welch’s t-test.

DAPI, nuclei. Scale bars, 500 µm (A), 100 µm (A’, E). Error bars, mean ± SD.
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Figure 1.10 Specific disruption of βCat signaling also results in a severe deficit in turbinate
development
(A)

Fgf20GFP-Cre and Sox2 expression in control (Fgf20GFP-Cre/+; βCatfl(ex2-6)/+), βFF-CKO
(Fgf20GFP-Cre/+; βCatfl(ex2-6)/fl(ex2-6)), and βDF-CKO (Fgf20GFP-Cre/+; βCatDM/fl(ex2-6)) mice at
P0, with two βFF-CKO phenotype examples (shapes 2 and 3). S, nasal septum. Inset, 2x
magnification of the boxed region; arrows indicate presence of FEP cells (Fgf20 and
Sox2 double-positive in control; Sox2 single-positive in βFF-CKO, shape 2).

(B)

Left: H&E staining in control, βFF-CKO, and βDF-CKO mice at P30. S, nasal septum.
Right: 10x magnification of boxed regions showing OMP expression on an adjacent
frontal section from the same sample. Region a, magnification of c1 “tip” OE; region b,
magnification of c1 “neck” OE. Arrowhead indicates area with extremely thin or absent
OE, as indicated by lack of OMP expression. Ax, axon bundles. Dashed line, epithelialmesenchymal boundary.

(C)

In situ hybridization at E14.5 showing c1 mesenchymal Dusp6 expression in control and
loss of in βFF-CKO embryos (arrows). Data is representative of 4 control and 6 βFFCKO embryos. N, nasal cavity wall.

(D)

H&E staining in control (Fgf20GFP-Cre/+; βCatfl(ex2-6)/+) and βDF-CKO (Fgf20GFP-Cre/+;
βCatDM/fl(ex2-6)) mice at P0. S, nasal septum.

(D’)

Magnification of boxed region in (D). N, nasal cavity wall; T, turbinate cartilage; M,
mesenchyme. Inset, 2x magnification of the OE at the turbinate tip. Dashed line,
epithelial-mesenchymal boundary.

(E-G) Quantification of c1 cartilage volume (E, p < 0.001, one-way ANOVA), surface area (F,
p < 0.001, one-way ANOVA), and mesenchyme thickness (G, p = 0.04, one-way
ANOVA) of Fgf20GFP-Cre/+; βCat+/+ (n = 7), Fgf20GFP-Cre/+; βCatDM/+ (n = 5), Fgf20GFPCre/+
; βCatfl(ex2-6)/+ (n = 5), and Fgf20GFP-Cre/+; βCatDM/fl(ex2-6) (n = 7) mice at P0. *
indicates statistically significant at α = 0.05 by Tukey’s HSD.
DAPI, nuclei. Scale bars, 1 mm (B), 500 µm (A, D), 100 µm (C, D’). Error bars, mean ± SD.
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Figure 1.11 βCat conditional deletion leads to premature differentiation and progenitor depletion
in the OE
(A)

Sox2 expression in c1 of control (Fgf20GFP-Cre/+; βCatfl(ex2-6)/+) and βFF-CKO (Fgf20GFPCre/+
; βCatfl(ex2-6)/fl(ex2-6)) mice at P0, with two phenotype examples (shapes 2 and 3).
Arrows indicate presence of FEP cells in control and the less severe βFF-CKO
phenotype. Arrowheads indicate absence of FEP cells in the severe βFF-CKO phenotype.
BC, basal cells; Sus, sustentacular cells.

(B)

Quantification of c1 OE thickness at P0. βFF-CKO phenotype categorized into three
shapes (1, 2, and 3). n = 9 control, 14 βFF-CKO, Welch’s t-test.

(C)

OMP expression in c1 at P0.

(D)

Quantification of c1 OMP+ ORNs (n = 4 control, 5 βFF-CKO), Sus cells (n = 6 control, 8
βFF-CKO), and Sox2+ BCs (n = 6 control, 8 βFF-CKO) per 100 µm OE at P0. βFF-CKO
phenotype categorized into two shapes (2 and 3). Welch’s t-test.

(E)

EdU incorporation in c1 Sox2+ cells at E14.5. * indicates “neck” region. M,
mesenchyme.

(F-H) Quantification of c1 OE thickness (H), Sox2+ BCs per 100 µm OE (F), and percent of
EdU-incorporating Sox2+ BCs (G) at E14.5. n = 8 control, 10 βFF-CKO, Welch’s t-test.
(I)

Fgf20GFP-Cre and OMP expression in c1 at E14.5, with two βFF-CKO phenotype
examples. * indicates “neck” region. Arrowheads indicate Fgf20 expression in n1 and n2
OE. M, mesenchyme.

(J)

Quantification of c1 OMP+ ORNs per 100 µm OE at E14.5. n = 3 control, 6 βFF-CKO,
Welch’s t-test.

Dashed line, epithelial-mesenchymal boundary. Solid line, OE apical surface. DAPI, nuclei.
Scale bars, 100 µm. Error bars, mean ± SD.
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Figure 1.12 Specific disruption of βCat signaling leads to premature OE differentiation
(A)

Sox2 expression in c1 of control (Fgf20GFP-Cre/+; βCatfl(ex2-6)/+) and βDF-CKO (Fgf20GFPCre/+
; βCatDM/fl(ex2-6)) mice at P0. Arrows indicate presence of FEP cells in control mice.
Arrowheads indicate absence of FEP cells in βDF-CKO mice. BC, basal cells; Sus,
sustentacular cells.

(B)

Quantification of c1 OE thickness in Fgf20GFP-Cre/+; βCat+/+ (n = 7), Fgf20GFP-Cre/+;
βCatDM/+ (n = 5), Fgf20GFP-Cre/+; βCatfl(ex2-6)/+ (n = 5), and Fgf20GFP-Cre/+; βCatDM/fl(ex2-6) (n
= 7) mice at P0. p < 0.001, one-way ANOVA. * indicates statistically significant at α =
0.05 by Tukey’s HSD.

(C)

OMP expression in c1 at P0.

(D)

Quantification of c1 OMP+ ORNs (n = 4), Sus cells (n = 4 control, 5 βDF-CKO), and
Sox2+ BCs (n = 4 control, 5 βDF-CKO) per 100 µm OE at P0. Student’s t-test.

(E)

EdU incorporation in c1 OE Sox2+ cells at E17.5. Arrow indicates presence of FEP cells.
T, turbinate cartilage; M, mesenchyme.

(F-H) Quantification of c1 OE thickness (F), Sox2+ BCs per 100 µm OE (G), and percent of
EdU-incorporating Sox2+ BCs (H) at E17.5. n = 3, Student’s t-test.
(I)

Fgf20GFP-Cre and OMP expression in c1 at E17.5, with linear plot of OMP+ ORN and
Fgf20+ cell distribution along the c1 OE (dashed outline). Distribution plot length: 1.27
mm, control; 0.787 mm, βDF-CKO (average of n = 3). Arrows indicate Fgf20 expression.
Arrowheads indicate c1 “neck” region OE. N, “neck”; T “tip”.

Dashed line, epithelial-mesenchymal boundary. DAPI, nuclei. Scale bars, 100 µm. Error bars,
mean ± SD.
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Figure 1.13 βCat stabilization prevents differentiation of FEP cells
(A)

H&E staining in control (Fgf20GFP-Cre/+; βCat+/+) and βEX3-OA (Fgf20GFP-Cre/+;
βCatfl(ex3)/+) mice at E17.5. * indicate extra blebs of OE and mesenchyme. S, nasal
septum.

(A’)

Magnification of boxed region in (A). N, nasal cavity wall; T, turbinate cartilage; M,
mesenchyme.

(B)

Fgf20GFP-Cre and Sox2 expression in c1 at E17.5. Arrowheads indicate dense clumps of
FEP cells. Solid line, OE apical surface.

(C)

Sox9 and OMP expression in c1 at E17.5. Dashed line, epithelial-mesenchymal
boundary. Solid line, OE apical surface. * indicates Sox9low mesenchyme. Arrows
indicate OMP+ ORNs in the mesenchyme. Arrowheads indicate OMP+ ORNs in the n2
OE (see Figure 1.14D). N, nasal cavity wall; T, turbinate cartilage.

(D)

EdU incorporation and Sox9 expression in c1 at E13.5. Dashed line, epithelialmesenchymal boundary. Solid line, nasal cavity wall (N)-mesenchymal (M) boundary.
Green fluorescence in the βEX3-OA OE is from Fgf20GFP-Cre.

(E,F) Quantification of c1 mesenchyme thickness (E) and percent of EdU-incorporating
mesenchymal cells (F) at E13.5. n = 4, Student’s t-test.
DAPI, nuclei. Scale bars, 500 µm (A), 100 µm (A’, B-D). Error bars, mean ± SD.
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Figure 1.14 βCat stabilization results in mesenchyme expansion without condensation in
turbinates
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(A)

Fgf20GFP-Cre expression without anti-GFP antibody staining in c1 in control (Fgf20GFPCre/+
; βCat+/+) and βEX3-OA (Fgf20GFP-Cre/+; βCatfl(ex3)/+) mice at E17.5. N, nasal cavity
wall; T, turbinate cartilage; M, mesenchyme. Arrowheads indicate faint Fgf20GFP-Cre
expression in control. Arrows indicate duct structures in the mesenchyme. Inset, 3x
magnification of boxed region. Note: in all other figures except 1.14A, GFP-Cre
expression was detected with an anti-GFP antibody (including 1.14B, 1.14C, and 1.14E).

(B)

Fgf20GFP-Cre expression and EdU incorporation in c1 at E17.5. Dashed outline, epithelialmesenchymal boundary in control, FEP cell clumps in βEX3-OA. Solid line, cartilagemesenchyme boundary. N, nasal cavity wall; T, turbinate cartilage; M, mesenchyme.

(C)

Fgf20GFP-Cre and Sox2 expression in dorsomedial n2 at E17.5. BC, basal cells; Sus,
sustentacular cells.

(D)

Sox9 and OMP expression in dorsomedial n2 at E17.5. Note: high Sox9 expression was
also found in Bowman’s gland and duct cells, which can be seen in the mesenchymal
layer and OE, respectively (Packard et al., 2011).

(E)

Fgf20GFP-Cre expression and EdU incorporation in c1 at E13.5. M, mesenchyme.
Arrowheads indicate a dense clump of FEP cells.

(F-H) Quantification of c1 OE thickness (F), Fgf20+ cells per 100 µm2 of OE (G), and percent
of EdU-incorporating Fgf20+ cells (H) at E13.5. n = 4, Student’s t-test.
DAPI, nuclei. Dashed line, epithelial-mesenchymal boundary. Scale bars, 100 µm. Error bars,
mean ± SD.
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Chapter 2
Sculpting the Skull Through Neurosensory
Epithelial-Mesenchymal Signaling: A
Literature Review
2.1 Summary
The vertebrate skull is a complex structure housing the brain and specialized sensory organs,
including the eye, the inner ear, and the olfactory system. The close association between bones of
the skull and the sensory organs they encase has posed interesting developmental questions about
how the tissues scale with one another. Mechanisms that regulate morphogenesis of the skull are
hypothesized to originate in part from the encased neurosensory organs. Conversely, the
developing skull is hypothesized to regulate the growth of neurosensory organs, through
mechanical forces or molecular signaling. Here, we review studies of epithelial-mesenchymal
interactions during inner ear and olfactory system development that may coordinate the growth
of the two sensory organs with their surrounding bone. We highlight recent progress in the field
and provide evidence that mechanical forces arising from bone growth may affect olfactory
epithelium development.

2.2 Introduction
The vertebrate skull is an intricate and protective housing for the brain and specialized sensory
organs, including the eye, the inner ear, and the olfactory system. The size and shape of the
vertebrate head differs dramatically among species. Such morphological diversity has fueled
hypotheses about the adaptive importance of the size and shape of the skull and the structures it
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supports (see Fish, 2017). While bone protects neurosensory organs, it also limits their size and
shape. Therefore, selective pressures driving evolution of the size and shape of neurosensory
structures must also act on the skull. For example, the sizes of the orbit and the eye have both
increased substantially in the evolution of digited tetrapods from finned fish, providing an
evolutionary advantage for terrestrial (above water) vision (MacIver et al., 2017). In a more
striking example, the structural complexity of the posterior nasal turbinates, which is linked to
the surface area of the overlying olfactory epithelium, varies highly among mammals (Van
Valkenburgh et al., 2014b). This variation has been hypothesized to correlate with the adaptive
importance of olfaction during evolution. For instance, terrestrial carnivorous caniforms have
increased olfactory surface area relative to body size compared to omnivorous caniforms,
correlating with their need to detect far-away prey due to their more specialized diet (Green et
al., 2012). Furthermore, a recent study found that across mammals, the number of olfactory
receptor genes encoded in the genome correlates with the size of the cribriform plate, a bony
structure that olfactory axons cross to reach the brain (Bird et al., 2018).
The close association of parts of the skull and neuro- and neurosensory epithelia, such as
that between the cranium and the brain, poses interesting developmental questions. It has been
hypothesized that crosstalk between neurosensory structures and the surrounding bone during
development must exist to ensure that the tissues scale proportionally (reviewed in Adameyko
and Fried, 2016). Such signaling interactions are potential targets for adaptive forces during
evolution, accounting for the diversity of skull and neurosensory organ morphologies. Indeed,
existence of epithelial-mesenchymal interactions between the ectoderm and underlying facial
primordia during early craniofacial development has been known for a long time (see Francis-
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West et al., 1998). However, the identification of molecular signals mediating such interactions
during neurosensory development is lacking.
In this review, we discuss the current understanding of how neurosensory epithelia shape
the surrounding skull, and vice versa, by reviewing studies of epithelial-mesenchymal
interactions during development. Specifically, we focus on the development of the inner ear otic
epithelium and its surrounding otic capsule, and of the main olfactory epithelium and the
posterior nasal capsule and turbinates.

2.3 Inner Ear
This template uses a 12-point, Times New Roman font throughout and is recommended for your
dissertation or thesis. However, should you choose to use a different font, you should match the
font size as close as possible. Use double-spacing for body text. Use either left justification with
a ragged right edge or full justification.

2.3.1 Structure and function
The inner ear, divided into the dorsal vestibule and the ventral cochlea, contains six structures
required for balance and hearing: three semicircular canals, utricle, saccule, and cochlea (Figure
2.1D). These structures contain neurosensory epithelia filled with mechanosensory hair cells and
supporting cells, and are uniquely shaped. The three semicircular canals (horizontal, superior,
and posterior), which detect head movement in three-dimensional space, are oriented to three
different planes at right angles to one another. The size of the semicircular canals is believed to
be functionally important, as larger canals are associated with higher sensitivity to rotations
(Alsina and Whitfield, 2017; Ekdale, 2015). In mammals, the cochlea, which contains the sounddetecting organ of Corti, is a coiled duct. Although the functional significance of the coiling is
not entirely known (Ekdale, 2015), the length of the cochlea likely has a role in hearing.
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Movement of the basilar membrane in response to different frequencies of detected sound elicit
activation of hair cells at specific positions along the length of the cochlea (Mann and Kelley,
2011). This is referred to as the tonotopic organization of the cochlea. Another epithelial
structure of the inner ear is the endolymphatic duct and sac (Figure 2.1D), which contains
endolymph, a fluid essential for the functions of the inner ear. The entire adult inner ear is
encased in the bony otic capsule, which is a part of the temporal bone.

2.3.2 Development
Development of the inner ear begins at around embryonic day 8.5 (E8.5) with the thickening of
the otic placode, which invaginates and pinches off to form the otic vesicle (otocyst; reviewed in
Basch et al., 2015; Sai and Ladher, 2015). The otocyst then undergoes outgrowth and
morphogenesis to form the vestibule and the cochlea (see Figs. 1A-D). Throughout its
development, the otic capsule tightly associates with the inner ear, with the contours of the
capsule matching the intricate shape of the inner ear structures (Figs. 1A-D). Spatial restriction
placed on the inner ear due to the size of the otic capsule is thought to influence the development
of the inner ear, in particular the coiling of the cochlea (Li and McPhee, 1978, 1979). However,
this has not been shown definitively or mechanistically.
The otic capsule develops from the periotic mesenchyme (POM), a tissue of mixed neural
crest and cranial paraxial mesoderm origin that surrounds the inner ear (otic) epithelia (Ladher,
2017; Trainor and Tam, 1995). Specifically, the otic capsule develops from the outer POM layer
via endochondral ossification (McPhee and Van De Water, 1985; Sher, 1971). In the developing
mouse, the POM begins to condense at E10 (Frenz and Van De Water, 1991), differentiates into
chondrocytes shortly after, and ossifies postnatally. The inner POM layer forms other
mesenchyme-derived structures, such as the spiral ligament and the spiral limbus (refer to Figure
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2.1E), which are made up of differentiated otic fibrocytes (Cohen-Salmon et al., 2000; Sher,
1971; Trowe et al., 2010). The fluid-filled chambers of the cochlea, scala vestibuli and scala
tympani (refer to Figure 2.1E), are formed by cavitation of the inner POM layer (Phippard et al.,
1999).

Epithelial-to-mesenchymal signaling in the developing inner ear
Early studies in mouse embryos using cultures of dissociated POM, dissected free of otic
epithelium, showed that the presence of otic epithelial tissue affects chondrocyte differentiation
(see McPhee and Water, 1986; Van De Water and Ruben, 1974). These experiments found that
the otic epithelium promotes mesenchymal condensation in POM from E10.5 to E12, but inhibits
it at E14 (Frenz and Van De Water, 1991). They also showed that TGFβ1 (Frenz et al., 1992),
FGF2 (Frenz et al., 1994), SHH (Liu et al., 2002), retinoic acid (Frenz and Liu, 1997, 2000;
Frenz et al., 1996) and BMP4 (Chang et al., 2002; Liu et al., 2003) could be signals from the otic
epithelium regulating POM chondrogenesis. However, these in vitro experiments do not rule out
the possibility of other tissues serving as sources of these signals, including the POM itself.
Furthermore, no in vivo genetic data currently exists to back up the epithelial-to-mesenchymal
(E→M) function of any of these particular signals.
The first genetic evidence of E→M cross talk in the inner ear came from experiments
with Fgf9 null mice. FGF9, like FGF2, is a member of the Fibroblast Growth Factor (FGF)
family of signaling molecules (Ornitz and Itoh, 2015b). FGF9 is a member of the FGF9
subfamily of FGFs, which also includes FGF16 and FGF20. This subfamily is often expressed in
epithelia and has a preference for binding the mesenchyme-expressed IIIc splice forms of FGF
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receptors 1 and 2 (FGFR1 and FGFR2; Ornitz and Itoh, 2015; Zhang et al., 2006), making them
ideal candidates for mediating E→M signaling.
Fgf9 is expressed in the otic epithelium as early as E10.5 (Pirvola et al., 2004). In Fgf9null mice, the otic capsule, especially the vestibular portion, appeared hypoplastic at E14.5 and
was thin and incompletely formed at E18.5. In addition, while Fgf9-null mice had normal
vestibular and cochlear sensory epithelia, other epithelial structures, particularly the semicircular
canals, were malformed (see next section). These defects were attributed to decreased
proliferation of the POM at E12.5. Other signs of mesenchymal malformation included an
enlarged scala vestibuli, which may be due to mesenchymal remodeling (Pirvola et al., 2004). It
is currently not known if loss of FGF9 leads to all of these defects directly.
More recently, FGF9 and FGF20 from the developing cochlear epithelium were shown in
vivo to signal to FGFR1 and FGFR2 in the POM at E11.5-E12.5 (Huh et al., 2015b). Deletion of
both Fgf9 and Fgf20 (here referred to as Fgf9/20-null) led to a severely shortened cochlear duct
with decreased coiling attributable to decreased epithelial progenitor proliferation. This
phenotype was reproduced with mesenchyme-specific deletion of both Fgfr1 and Fgfr2 (here
referred to as Fgfr1/2mes:null), but not with epithelium-specific deletion of these Fgfrs.
Interestingly, this implies that FGF signaling in the mesenchyme activates a mesenchymal-toepithelial (M→E) signal that, in turn, regulates epithelial proliferation and cochlear duct growth
(see Figure 2.4A; Huh et al., 2015). The identity of this M→E signal(s) is currently unknown.
Canonical Wnt/βCatenin (βCat, also Ctnnb1) signaling has also been proposed, based on
in vivo genetic evidence, to be an E→M signal during inner ear development. Axin2, a negative
regulator and widely used marker of Wnt/βCat activity, is highly expressed in the POM
throughout development, including the inner, but not outer, POM layer surrounding the cochlea,
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(Bohnenpoll et al., 2014). Wnt ligands 4, 5a, 7a, and 7b, meanwhile, are expressed by the
cochlear duct at E12.5. Mesenchyme-specific deletion of βCat (here referred to as βCatmes:null)
led to a slight thickening of the otic capsule and loss of parts of the capsule medial to the
cochlea. There was a further defect in otic fibrocyte proliferation and differentiation, leading to a
loss of the spiral ligament and spiral limbus. The pericochlear cavities, scala vestibuli and scala
tympani, were missing as well (Bohnenpoll et al., 2014). These findings are suggestive of
epithelia-expressed Wnt ligands regulating fibrocyte and otic capsule development. A
complementary experiment in which Wnt ligands are specifically deleted from the epithelium
will help make this conclusion more definitive.
Mesenchymal deletions of Fgfr1 and Fgfr2 (Huh et al., 2015b) and βCat (Bohnenpoll et
al., 2014) had similar effects on the cochlea. In both studies, hair cell differentiation in the organ
of Corti was not disrupted, but the cochlear duct was much shorter. However, while the short
cochlea phenotype in Fgfr1/2mes:null mice was attributed to decreased proliferation at E11.5 and
E12.5, the similar phenotype in βCatmes:null mice was attributed to increased apoptosis in the
cochlear epithelium at E13.5 and E14.5. Despite these differences, the two studies both indicated
that there are M→E signals regulating otic epithelium development. As Bohnenpoll et al. (2014)
hypothesized, these signals could be a result of spatial restrictions on the growing cochlea due to
the thickened capsule wall in βCatmes:null inner ears.

Mesenchymal-to-epithelial signaling in the developing inner ear
Early studies of inner ear development involving grafting and explant cultures of
mesenchyme-free otocysts showed that the POM is necessary for proper inner ear development
(see Anniko and Schacht, 1984; Doetzlhofer et al., 2004; Miura et al., 2004; Montcouquiol and
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Kelley, 2003; Swanson et al., 1990). However, the extent to which the POM affects epithelial
differentiation and morphogenesis was unclear, as results from different studies were not always
consistent with one another. For example, Anniko and Schacht (1984) found that E12.5
mesenchyme-free otocyst explants failed to undergo much vestibular and cochlear
morphogenesis, while Miura et al. (2004) observed both semicircular canal formation and
cochlear spiraling. This difference could be explained by differences in culturing method; Miura
et al. (2004) used Matrigel for their experiments. Further confounding these grafting and explant
experiments, other nearby structures such as the notochord, hindbrain, and ganglion cells are
sources of developmental signals, in particular Sonic Hedgehog (SHH) and Wnt, for the
developing inner ear (Bok et al., 2007a, 2007b, 2013; Brown and Epstein, 2011; Miura et al.,
2004; Riccomagno et al., 2002, 2005; Tateya et al., 2013).
In terms of in vivo experiments, no M→E signal has been identified. However, studies
have suggested that during semicircular canal morphogenesis, mechanical forces from the
proliferation of mesenchymal cells are required to push epithelial walls together to form the
fusion plate (Figs. 1B, 4B). This process, potentially regulated by Netrin 1 and FGF9 from the
epithelia, is required for the initiation of duct formation (See Figure 2.4A, Netrin 1 not shown;
Pirvola et al., 2004; Salminen et al., 2000). Additionally, a few mesenchyme-expressed
transcription factors have been found to affect otic epithelial development. Two of these, Prx1
and Prx2, are expressed in the POM surrounding the developing semicircular canals and are
required for their outgrowth (ten Berge et al., 1998). Others include Tbx1, Pou3f4, Sox9, and
Zic2, as detailed below. Notably, while deletion of each of these genes led to defects in growth,
morphogenesis, or differentiation of the otic epithelia, as detailed below, the mechanism by
which they affect epithelial development has not been elucidated.
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Tbx1 is expressed in both the otic epithelium and the POM during development (Raft et
al., 2004; Vitelli et al., 2003). Tbx1 constitutive KO mice exhibited a smaller otocyst and failure
of sensory organ development (Jerome and Papaioannou, 2001; Vitelli et al., 2003), a phenotype
recapitulated by otic epithelium-specific deletion of Tbx1 (Arnold et al., 2006; Xu et al., 2007a).
Mesenchyme-specific deletion of Tbx1 resulted in a severely shortened cochlear duct with a lack
of organ of Corti hair cells, except at the very base (Braunstein et al., 2009; Xu et al., 2007b).
This cochlear phenotype was attributed to a decrease in progenitor proliferation in the epithelium
at E11.5 and E12.5, similar to what was observed in mice lacking mesenchymal FGFR1/2 (Huh
et al., 2015b), as well as to increased cell death. Furthermore, the otic capsule medial to the
cochlea was missing (Braunstein et al., 2009; Xu et al., 2007b), similar to what was observed in
mice lacking mesenchymal βCat (Bohnenpoll et al., 2014).
Pou3f4 (also Brn4) is expressed in the condensing POM during development, and some
knockout mice had a shortened cochlea with reduced coiling (Phippard et al., 1999).
Interestingly, the penetrance of this cochlear phenotype was enhanced when a copy of Tbx1 was
also lost (Pou3f4-/-; Tbx1+/-), which could be partially accounted for by increased apoptosis and
decreased proliferation in the cochlear duct at E12.5 (Braunstein et al., 2008, 2009). This
indicates a genetic interaction between Pou3f4 and Tbx1. In fact, mesenchymal Tbx1 has been
shown to regulate Pou3f4 expression (Arnold et al., 2006; Braunstein et al., 2009). The M→E
signals regulated by Pou3f4 and Tbx1 that, in turn, regulates cochlear growth have not been
identified, although retinoic acid is a candidate (Braunstein et al., 2009; Monks and Morrow,
2012).
The otic epithelium has been hypothesized to regulate Pou3f4 and Tbx1 expression in the
POM. The shortened cochlea phenotypes of Pou3f4 and Tbx1 mutants resemble that of
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Fgfr1/2mes:null and βCatmes:null mice. However, the expression of the two transcription factors were
not affected in Fgf9/20-null mice (Huh et al., 2015b). Interestingly, Pou3f4 expression in the
POM was lost in βCatmes:null mice at E18.5, which could partially account for the cochlear and
otic capsule phenotype observed in these mice. Contrarily, Pou3f4 expression was not changed
in βCatmes:null mice at E12.5, which is when the proliferation and apoptosis phenotypes were
observed in Pou3f4-null mice (Bohnenpoll et al., 2014). Experiments with Shh-null mice
suggested that non-otic tissues regulate Tbx1 and Pou3f4 expression. In Shh-null mice, the
expression of both Tbx1 and Pou3f4 was lost from the POM at E10.5, indicating that SHH
signaling is upstream of the two genes (Riccomagno et al., 2002). At this stage, Shh is expressed
in the notochord and hindbrain floor plate, but not in the otic epithelium. The entire inner ear was
severely hypoplastic in Shh-null mice, however, so the loss of Tbx1 and Pou3f4 expression may
have been secondary to otic epithelial defects (Riccomagno et al., 2002).
Sox9 is expressed in the ventral POM starting at E10.5, and is mostly restricted to the
outer POM layer at E12.5 (Trowe et al., 2010). After E15.5, Sox9 was found in the spiral
ligament. Mesenchyme-specific deletion of Sox9 resulted in decreased POM proliferation, a lack
of otic capsule from the cochlear region, underdeveloped/lack of the spiral ligament, scala
vestibuli, and scala tympani, and a shortened cochlea with normal differentiation (Trowe et al.,
2010). These phenotypes are very similar to those of βCatmes:null mice, except the spiral limbus
appeared to be intact in Sox9-null mice, but not in βCatmes:null mice. However, Sox9 expression
was unchanged in βCatmes:null mice at E12.5, and only decreased in the spiral ligament at E18.5,
potentially accounting for the loss of the spiral ligament in βCatmes:null mice (Bohnenpoll et al.,
2014). It is not known if Sox9 may be acting upstream of or in parallel with Wnt/βCat signaling
in other parts of the POM.
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All five members of the Zic family of transcription factors are expressed in the POM
starting as early as E9.5, but not in the otic epithelium (Chervenak et al., 2013). Zic2 is
additionally highly expressed in the mesenchyme surrounding the growing cochlear duct at
E12.5 and E13.5. Thus far, only Zic2-null mice have been found to have an inner ear
development phenotype, although redundancy between Zic family members has not been
thoroughly investigated. In Zic2-null mice, the inner ear was severely hypoplastic, with
shortened semicircular canals and cochlea, and loss of the endolymphatic duct and sac
(Chervenak et al., 2014). Currently, signaling pathways acting upstream and downstream of Zic2
during inner ear development have not been identified. Chervenak et al. (2014) hypothesized that
the epithelial phenotypes in Zic2 null mutants could be attributable to displacement of the
developing otocyst relative to the hindbrain, a source of signals that pattern the otocyst. This idea
highlights the potential complexity of mesenchymal regulation of epithelial development, which
may involve direct signaling via diffusible molecules, as well as mechanical forces and indirect
regulation.

2.4 Main Olfactory System
2.4.1 Structure and function
The olfactory epithelium (OE) is required for the sense of smell. The OE contains three main cell
types: olfactory receptor neurons (ORNs), the nuclei of which are located in the middle layers of
the OE and project ciliated membrane structures to the apical surface and axons to the olfactory
bulb; sustentacular cells, a supporting cell population with nuclei located apically; and basal
cells, a progenitor population that gives rise to both sustentacular cells and ORNs (reviewed in
Schwob et al., 2017). The OE lines the interior of the posterior nasal cavity, called the olfactory
recess, protected by the walls of the nasal capsule. Bony scrolls called turbinates project inward
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from the walls of the nasal capsule and provide increased surface area for the OE (Figure 2.2D).
Here, we use the term turbinate to refer exclusively to ethmoturbinates or “olfactory” turbinates,
which are mainly lined by OE in the mouse. Turbinate size and complexity vary greatly among
mammalian species. As mentioned in the introduction, OE surface area is hypothesized to be
important to olfactory ability (Van Valkenburgh et al., 2014b).

2.4.2 Development
Development of the olfactory system begins at around E9.5 with the thickening of the olfactory
placode, which invaginates to form the olfactory (nasal) pit (reviewed in Sokpor et al., 2018).
The epithelia lining the nasal pit develops into the OE, while the skeletogenic mesenchyme
surrounding the pit develops into the nasal capsule and the nasal septum, which divides the left
and right sides of the nasal cavity (see Figure 2.2). This mesenchyme is derived from the neural
crest (McBratney-Owen et al., 2008). Development of the olfactory turbinates has long been
described as budding of the OE followed by proliferation and development of the underlying
mesenchyme, adjacent to the developing nasal capsule, into turbinates (Dieulafé, 1906;
Martineau-Doizé et al., 1992). Like the otic capsule, the posterior nasal capsule, septum, and
turbinates (here referred to collectively as olfactory structures) develop by endochondral
ossification.
The close association and correlated growth of the OE and underlying olfactory structures
implies, even more enticingly than in the inner ear, the existence of intricate epithelialmesenchymal crosstalk (Adameyko and Fried, 2016; Kaucka et al., 2018). Consistent with this
idea, experiments in which the OE was blocked from forming or arrested at very early stages
also led to malformed nasal cavity and surrounding craniofacial structures. This was observed in
Fgf8-conditional null (Kawauchi et al., 2005b), Foxg1-null (Duggan et al., 2008b; Kawauchi et
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al., 2009b), Six1/4-double null (Kaucka et al., 2018; Laclef et al., 2003b), Dlx5/6-double null
(Gitton et al., 2011), and Dicer1-conditional null (Kersigo et al., 2011b) mice. Up until recently,
however, an epithelial-mesenchymal signal regulating OE and olfactory structure development
has remained elusive (Adameyko and Fried, 2016b; Van Valkenburgh et al., 2014b).
Interestingly, it has been pointed out that while early disruptions to OE development affects
nasal cavity development, later disruptions (i.e. to more differentiated progenitors) do not
(Kaucka et al., 2018). For instance, deletion of Ascl1, a transcription factor required for
neurogenesis, resulted in an OE devoid of immediate neuronal progenitors and olfactory neurons,
but did not affect nasal capsule or turbinate morphology (Cau et al., 1997b; Guillemot et al.,
1993; Kaucka et al., 2018). This suggests that an early, less differentiated OE progenitor cell is
the source of signals regulating the development of the olfactory structures.

Epithelial-to-mesenchymal signaling in the developing main olfactory system
Most studies of E→M interactions in the OE have focused on early development at the
nasal pit stage. During these stages, FGF8 from the rim of the nasal pit is important for nasal pit
invagination, and conditional inactivation of FGF8 in the OE resulted in failed development of
the OE and olfactory structures (Griffin et al., 2013; Kawauchi et al., 2005b; Maier et al., 2010).
In the chick, explant experiments showed that FGF signaling is similarly required for early
craniofacial morphogenesis (Abzhanov and Tabin, 2004; Szabo-Rogers et al., 2008), potentially
via direct signaling to the early nasal mesenchyme (Firnberg and Neubüser, 2002). However,
many factors could contribute to the disruption of olfactory structure development in Fgf8-null
mice besides the loss of direct FGF8 signaling. These include malformation of other craniofacial
structures affecting the development of olfactory structures, loss of the OE and any OE-derived
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signal required for the development of olfactory structures, and a combination of direct and such
indirect effects. The early-onset and severity of the Fgf8-null craniofacial phenotype has made it
difficult to tease out the exact mechanism leading to olfactory developmental defects. For
instance, the OE phenotype in these mice has been attributed to apoptosis of OE progenitors
(Kawauchi et al., 2005b), inhibition of neuronal fate in OE progenitors (Tucker et al., 2010b),
loss of inhibition of respiratory epithelium fate (Maier et al., 2010), and loss of mesenchymal
BMP4/Noggin signals required for OE development (Forni et al., 2013b). Moreover, whether
Fgf8 is even expressed in the OE or by olfactory progenitor cells has been called into question.
Forni et al. (2013) showed that Fgf8 expression and lineage is restricted to the respiratory
epithelium and epidermis. Therefore, OE signals that regulate olfactory structure development
remained elusive.
To date, only two OE-expressed signaling factors have been proposed to regulate
olfactory structure development through E→M signaling: SHH and FGF20 (see next paragraph).
Shh expression was detected in regions of the developing OE as early as E11.5 and has been
implicated in nasal capsule roof development (Kaucka et al., 2018). Despite the suggestive
evidence from this study, OE-specific deletion of Shh is required before a definitive conclusion
can be reached. Shh is also expressed by other tissues nearby olfactory structures, such as the
brain; brain-specific deletion of Shh resulted in malformation of the posterior nasal capsule and
the nasal septum (Kaucka et al., 2018).
Fgf20 is expressed in the embryonic and early postnatal OE, and its expression seems to
correlate with turbinate development (Yang et al., 2018). At early stages, Fgf20 is expressed in
the OE overlying sites of future turbinate formation; at later stages, Fgf20 is expressed in regions
of negatively-curved OE formed by the growing turbinates (see Fig 4B). Deletion of Fgf20 led
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specifically to malformed turbinates, due to defects in formation of mesenchymal condensations
at the initial stages of turbinate growth. Turbinates were not completely absent in Fgf20-null
mice, however, implying that there are additional signals that may collaborate with FGF20.
These signals could be other FGFs, many of which are expressed in and around the developing
OE (Bachler and Neubüser, 2001; Kawauchi et al., 2004; Zhu et al., 2016).
Interestingly, lineage tracing suggested that Fgf20-expressing cells are multipotent OE
progenitors that expand the OE, thereby tying OE expansion with turbinate growth (Yang et al.,
2018). These cells are referred to as FEP (Fgf20-expressing, epithelium-spanning progenitor)
cells. Furthermore, specific disruption of Wnt/βCat signaling in the OE showed that Wnt/βCat is
required to maintain FEP cells in an undifferentiated state, as well as to regulate Fgf20
expression. Deletion of βCat in the OE, therefore, also resulted in malformed turbinates, but
much more severely than deletion of Fgf20. This could be due to the loss of other Wnt/βCat
directly-regulated E→M signals or to the loss of additional signals secreted by FEP cells, since
these progenitors were not maintained in the absence of Wnt/βCat signaling (Yang et al., 2018).

Mesenchymal-to-epithelial signaling in the developing main olfactory system
Interestingly, the total OE surface area in Fgf20-null mice was decreased by roughly
~17% (Yang et al., 2018). This suggests that an M→E feedback signal regulates OE surface area,
coordinating it with changes to turbinate size and shape. The identity this signal is currently not
known, although candidates exist, such as Wnt ligands. Mesenchymal sources of Noggin, a
BMP/TGF-β inhibitor, has been implicated in defining the boundary of the olfactory pit (Forni
et al., 2013b), and is another candidate. The role of Noggin in later stages of OE development
(i.e. OE expansion) is not known. Other candidates include Follistatin and Activin, two epithelial
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signals that regulate OE differentiation but that are also expressed in the underlying mesenchyme
(Gokoffski et al., 2011b; Kawauchi et al., 2009b). Mechanical forces from the mesenchyme and
developing turbinates could also play a role in regulating OE surface area. Consistent with this,
after E14.5, FEP cells reside in negatively-curved regions of the OE, which are formed by the
developing turbinates (see Figs. 2D, 4D). This suggests that the growth of turbinates may play a
role in maintaining the FEP cell niche.
To explore the potential for Noggin signaling and turbinate growth to affect OE
development, we examined Fgf20GFP-Cre expression as a marker of FEP cells in Noggin-null mice
(NogginLacZ; McMahon et al., 1998). Using an antibody to β-galactosidase (LacZ), we detected
Noggin expression exclusively in chondrocytes of the nasal capsule, septum, and turbinates at
E17.5 (Figs. 3A, 3B). Compared to control mice (NogginLacZ/+; Fgf20GFP-Cre/+), Noggin-null mice
(NogginLacZ/LacZ; Fgf20GFP-Cre/+) had slightly malformed turbinates with dramatic chondrocyte
hyperplasia in the nasal capsule, but relatively normal appearing OE. Turbinate protrusion was
not severely affected at E17.5, and therefore most of the negatively-curved OE regions were
maintained, along with the corresponding FEP cell niche (Figs. 3A, 3B, arrowheads). This
suggests that Noggin signaling is not directly required for OE development or the maintenance of
the FEP cell niche, but rather acts tissue-intrinsically to regulate turbinate chondrogenesis.
Interestingly, turbinate n2, which in control mice forms two branches with negatively-curved OE
at the branch point, was not branched in Noggin-null mice. As a result, the branch-point negative
curvature of the OE was absent, along with FEP cells (Figs. 3A, 3C, arrows). This result suggests
that negative curvatures in the OE, and therefore compressive forces from turbinate
development, are required to maintain the FEP cell niche. A more specific experiment altering
turbinate shape and OE negative curvature formation will be required to support this conclusion.
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Nevertheless, this idea gives rise to an interesting model in which progenitor cells in the
developing OE regulate turbinate development, the growth of which then exert mechanical
forces to shape the OE and regulate OE progenitor cells (see Figure 2.4B).

2.5 Conclusions and Future Directions
The hypothesis that neurosensory epithelia and the surrounding skull communicate during
development is widely held. The close juxtaposition of sensory epithelia and parts of the skull
strongly hints at this. Moreover, evolutionary factors acting on such crosstalk could provide an
elegant mechanism accounting for the diversity of neurosensory organ and skull morphologies
across vertebrates. While many studies over the past few decades have proposed the existence of
intricate developmental epithelial-mesenchymal interactions in both the inner ear and the
olfactory system, the identities of these signals have just recently begun to be uncovered.
Furthermore, the idea of mechanical forces contributing to epithelial-mesenchymal interactions
has been suggested, but not addressed experimentally. Additionally, all studies discussed in this
review have focused on stages of chondrogenesis in otic and nasal capsule development. It is not
known whether the inner ear and the OE regulate osteogenesis.
In the inner ear, only FGF signaling has been identified as an E→M signal (see Figure
2.4A), but it is unclear whether the otic capsule defect in Fgf9-null mice is due directly to the
loss of FGF9 signaling. Wnt/βCat signaling has also been heavily implicated, but the otic
epithelium has not been definitively shown to be a source of Wnt ligands that signal to the
mesenchyme. No M→E signals have been identified in vivo. However, the importance of
mechanical forces resulting from mesenchymal proliferation was demonstrated in semicircular
canal development (Pirvola et al., 2004; Salminen et al., 2000). The POM, in addition, is critical
for sensory hair cell differentiation in the cochlear epithelium (Braunstein et al., 2009; Xu et al.,
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2007b). Identifying M→E signals, therefore, may potentially be important for therapeutic
regeneration of lost or injured sensory hair cells.
In the OE, FGF20 is the first identified E→M signal that regulates turbinate development
(see Figure 2.4B). However, other unidentified signals likely exist that function similarly or
redundantly with FGF20. Additional Wnt/βCat-dependent or FEP-expressed signals have yet to
be found, and may be a good starting point in the search for other E→M signals. The
identification of such signals has partly been hindered by the lack of a specific genetic tool to
target the OE. The identification of Fgf20GFP-Cre expression in FEP cells should allow gene
deletion widely and specifically in the OE (see Yang et al., 2018). Additionally, we present here,
for the first time, in vivo evidence suggesting that turbinate growth affects OE development,
potentially by regulating an OE progenitor niche. In future studies, this idea of mechanical forces
from turbinate growth deserves more attention as a mechanism for regulating OE development.
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Figure 2.1 Schematic of inner ear and periotic mesenchyme development
(A-D) Whole mount (top) and cross-sectional (bottom) view of the inner ear at E10.5 (A), E12.5
(B), E14.5 (C), and E17.5 (D). The dorsal (vestibular; blue) and ventral (cochlear; purple)
parts of the inner ear develop from the otocyst (ot), surrounded by periotic mesenchyme.
The outer layer of the periotic mesenchyme develops into the otic capsule (red), which
91

becomes cartilaginous at around E14, while the inner part differentiates into otic
fibrocytes (pink). Condensing mesenchyme is represented by reddish-pink. D, dorsal; M,
medial; amp, cristae ampullaris of the semicircular canal; co, cochlea; ed, endolymphatic
duct and sac; fp, fusion plate; hb, hindbrain; sa, saccule; sc, semicircular canals; ut,
utricle.
(E)

Cross-sectional view of the developed cochlear duct, showing the organ of Corti (purple)
containing sensory hair and supporting cells in the scala media (scm), as well as the fluidfilled scala vestibuli (scv) and scala tympani (sct). The spiral ganglion (sg) contains
neurons that relay electrical signals from the sensory hair cells to the brain. bm, basilar
membrane; oc, otic capsule; slb, spiral limbus; slg, spiral ligament.
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Figure 2.2 Schematic of main olfactory epithelium, posterior nasal capsule, septum, and
turbinate development
(A-D) Frontal sections through the posterior nasal cavity at E10.5 (A), E12.5 (B), E14.5 (C),
and E17.5 (D). The olfactory epithelium (OE; purple) develops from the nasal pit (np).
The nasal pit rim (light blue), where Fgf8 is expressed, has been shown to give rise to
epidermal and respiratory epithelia, but not OE (Forni et al., 2013b). The OE is encased
within the posterior nasal capsule, which is separated into left and right halves by the
nasal septum (S), and have interior projections called ethmoturbinates. A layer of
mesenchyme (pink) separates the OE from the underlying nasal capsule, septum, and
turbinates (red), which become cartilaginous at around E14. Condensing mesenchyme is
represented by reddish-pink. There are six ethmoturbinates in mice, which are mainly
lined by OE, but also respiratory epithelium (RE; light blue). From most anterodorsal to
posteroventral, the turbinates are endoturbinate I (n1), ectoturbinate i (c1), endoturbinate
II (n2), ectoturbinate ii (c2), endoturbinate III (n3), and endoturbinate IV (n4). D, dorsal;
M, medial; fb, forebrain.
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Figure 2.3 Turbinate protrusion shapes the OE to maintain OE progenitor cells
(A,B) Serial anterior (A) and posterior (B) frontal sections through the posterior nasal cavity of
E17.5 control (NogginLacZ/+; Fgf20GFP-Cre/+) and Noggin-null (NogginLacZ/LacZ;
Fgf20GFP-Cre/+) mice. (A, B) NogginLacZ expression (in chondrocytes) is identified by
an antibody to β-galactosidase (LacZ; red); Fgf20GFP-Cre expression in the olfactory
epithelium (OE) is identified by an antibody to GFP (GFP-Cre; green); arrowheads
indicate regions of negatively-curved OE formed by the turbinates, which act as niches
for Fgf20-expressing OE progenitors (FEP cells).
(C)

Magnification of boxed region in (A), on an adjacent section; Sox2 expression in apical
and basal OE nuclei and FEP cells is identified by an antibody (red); arrows indicate loss
of negatively-curved OE and FEP cells (green) in Noggin-null mice. D, dorsal; M,
medial; n2, endoturbinate II; n3, endoturbinate III; RE, respiratory epithelium; S, septum;
Scale bars, 500 µm. Reference Figure 2.2D for olfactory system schematic at E17.5.
Method: serial, frontal, frozen sections of the E17.5 nasal cavity were immunostained
with rabbit anti-GFP and chick anti-β-galactosidase antibodies, followed by appropriate
secondary antibodies, and imaged with a Zeiss LSM 700 confocal microscope (see Yang
et al., 2018).
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Figure 2.4 Model of established epithelial-mesenchymal interactions during inner ear and
olfactory system development
(A)

In the inner ear at E12.5, FGF9 (and Netrin 1, not shown) from the dorsal otocyst
regulates the proliferation of adjacent mesenchymal cells, some of which differentiate
into chondrocytes. Mechanical force from mesenchymal proliferation, in turn, is required
to push together epithelial walls for fusion plate formation to initiate semicircular duct
development. FGF9 from the roof of the cochlear duct (cd) is required for remodeling of
the adjacent mesenchyme during scala vestibuli formation (Pirvola et al., 2004). FGF9
plus FGF20 from the floor of the cochlear duct signals to the adjacent mesenchyme,
which sends a yet unidentified signal back to the cochlear epithelium to regulate
progenitor proliferation (Huh et al., 2015b).

(B)

In the olfactory system at E17.5, FGF20 from progenitors located at negatively-curved
olfactory epithelium regulates the proliferation of adjacent mesenchymal cells, which
differentiate into chondrocytes that form the protruding turbinate (Yang et al., 2018).
Mechanical force from turbinate growth, in turn, generates negative curvature in the
epithelium, which may be required to maintain Fgf20-expressing olfactory progenitors
(FEP cells).
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Chapter 3
Fgf20 and Sox2 interact during cochlear
sensory epithelium specification and
differentiation
3.1 Summary
Elucidating the genetic and developmental pathways regulating cochlear sensory epithelium
specification and differentiation is important for the advancement of regenerative therapies to
treat sensorineural hearing loss. Previous studies have identified Fibroblast Growth Factor (FGF)
signaling as essential during inner ear development. Specifically, loss of FGF receptor 1 (Fgfr1)
leads to the loss of hair and supporting cells in the cochlear sensory epithelium, attributable to
defects in progenitor cell specification via the transcription factor Sox2. Contrarily, we have
previously shown that the loss of FGF20, the proposed ligand for FGFR1, leads to defects in hair
and supporting cell differentiation, independent of Sox2. Here, we confirm previous findings and
show that FGF20-FGFR1 signaling is required during the initiation of hair and supporting cell
differentiation. However, FGFR1 has an additional FGF20-independent role in regulating Sox2
during prosensory specification. We further show that Fgf20 and Sox2 epistatically interact
during these processes, preferentially affecting the development of the outer sensory
compartment and the basal end of the cochlea. These findings allude to an intricate
developmental program regulating the precise patterning of the cochlear sensory epithelium.

96

3.2 Introduction
The inner ear contains six sensory organs required for the senses of hearing and balance. The
cochlea is the auditory organ. It contains specialized sensory epithelia, called the organ of Corti,
made up of hair and supporting cells (HCs and SCs). In mammals, this sensory epithelia is
elegantly patterned, with one row of inner hair cells (IHCs) and three rows of outer hair cells
(OHCs), separated by two rows of pillar cells, which form the tunnel of Corti. Each row of
OHCs is associated with a row of supporting cells called Deiter’s cells. Here, we refer to pillar
cells and Deiter’s cells collectively as SCs.
Congenital and acquired sensorineural hearing loss are common disorders (Desai et al.,
2001; Vohr, 2003) and there are currently no biological therapeutics. In mammals, once hair
cells are lost, they cannot be regenerated. A goal of regenerative medicine is to induce the
replacement of lost HCs after injury with new HCs differentiated from remaining cells with
stem-cell like potential. Reactivation of developmental processes occurring during HC
differentiation is likely required to achieve this goal. Therefore, we must understand the intricate
genetic and developmental pathways regulating HC differentiation.
The organ of Corti develops from a strip of progenitor cells at the floor of the early
developing cochlear duct, called the prosensory domain (Groves and Fekete, 2012). Prosensory
cells, progenitors that make up the prosensory domain, are bipotent, differentiating into both hair
cells and supporting cells (Fekete et al., 1998). These progenitors are initially proliferative during
early stages of cochlea development. However, at around embryonic day 12.5 (E12.5), they
begin exiting the cell cycle and express the cyclin-dependent kinase inhibitor p27Kip1 (Cdkn1b)
in a wave (Chen and Segil, 1999; Lee et al., 2006). This wave of cell cycle exit starts at the apex
of the cochlea (the cochlear tip), and reaches the base of the cochlea by about E14.5. After cell
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cycle exit, the progenitors then begin differentiating into hair and supporting cells in a wave
traveling in the opposite direction along the cochlea. This differentiation wave starts at the
midbase at around E13.5, and spreads to the apex and the rest of the base within a couple of days
(Groves et al., 2013). Therefore, development of the cochlear sensory epithelia has been
described as occurring in two distinct steps: prosensory specification (formation of the
prosensory domain and cell cycle exit) and differentiation of prosensory cells into HCs and SCs.
Sox2 is one of the most well-studied transcription factors in cochlear sensory epithelium
development. It is also one of the earliest markers of prosensory cells (Gu et al., 2016; Mak et
al., 2009). Mice with specific Sox2 hypomorphic mutations in the inner ear have hearing
impairment with decreased numbers of HCs and SCs in the cochlear sensory epithelium, and
mice with specific Sox2 null mutations are completely deaf and have no HCs or SCs (Dong et al.,
2002; Kiernan et al., 2005). Sox2 has shown to be necessary and sufficient for prosensory
specification. Decreased Sox2 expression leads to the loss of p27Kip1 expression at E14, a marker
for the prosensory domain (Kiernan et al., 2005), while ectopic Sox2 expression in cochlear
nonsensory epithelium can induce sensory specification and generate ectopic HCs and SCs (Pan
et al., 2013; Puligilla and Kelley, 2016).
The Fibroblast Growth Factor (FGF) signaling pathway also plays vital roles in cochlea
development (Ebeid and Huh, 2017). Studies utilizing cochlear explants showed that inhibition
of FGF signaling prior to and during stages of prosensory differentiation resulted in decreased
HC and SC number (Hayashi et al., 2008). Signaling through FGF receptor 1 (FGFR1), in
particular, is essential during this process. Conditional deletion of Fgfr1 (Fgfr1-CKO) in the
developing cochlear epithelium resulted in a lack of most HCs and SCs (Ono et al., 2014; Pirvola
et al., 2002). This has been attributed to decreased Sox2 expression in the prosensory domain of
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Fgfr1-CKO mice, leading to a defect in prosensory specification (Ono et al., 2014; Pirvola et al.,
2002).
FGF20 has been implicated as the FGFR1 ligand during cochlea development. Both in
vitro inhibition of FGF20 with an anti-FGF20 antibody (Hayashi et al., 2008) and in vivo
knockout of Fgf20 (Fgf20-KO) (Huh et al., 2012b) led to decreased HCs and SCs, similarly to
the Fgfr1-CKO phenotype. However, although the Fgf20-KO phenotype is very similar to that of
Fgfr1-CKO, it is not as severe. While Fgfr1-CKO mice are missing almost all OHCs and some
IHCs, Fgf20-KO mice are only missing 2/3 of OHCs and have a full complement of IHCs (Huh
et al., 2012b). This suggest that another FGF ligand may be redundant with and compensating for
the loss of FGF20, the identity of which is currently unknown.
Another difference between Fgfr1-CKO and Fgf20-KO mice is the proposed mechanism
accounting for the decrease in HC and SC number. Interestingly, formation of the prosensory
domain is not disrupted in Fgf20-KO mice. Unlike in Fgfr1-CKO mice, Sox2 is not
downregulated in Fgf20-KO mice (Huh et al., 2012b). Rather, FGF20 seems to be involved
during prosensory cell differentiation. This difference between the Fgfr1-CKO and Fgf20-KO
phenotypes has led to questions and disagreements in the field over the exact role of
FGF20/FGFR1 signaling during cochlear sensory epithelium development, and its relationship
with Sox2.
Here, we hypothesize that FGFR1 signaling has functions in both steps of cochlear
sensory epithelium development: an earlier role in prosensory specification via Sox2, and a
slightly later role in initiation of differentiation. We show evidence that FGF20 likely acts
exclusively in the differentiation role. When we combined Sox2 hypomorphic (Sox2Ysb/Ysb) and
Fgf20-KO mutations in mice, thereby disrupting both prosensory specification and
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differentiation, we recaptured the Fgfr1-CKO and severe Sox2 hypomorphic phenotype. We
further show that Sox2, in addition to maintaining the prosensory domain, also regulates Fgf20
expression. These results help elucidate the functions of FGF20, FGFR1, and Sox2 during
cochlear sensory epithelium development.

3.3 Results
3.3.1 The Fgf20-null cochlear phenotype is less severe than the Fgfr1conditional null phenotype
Previous studies have shown that conditional deletion of Fgfr1 from the mouse cochlear
epithelium leads to a loss of almost all OHCs and some IHCs (Ono et al., 2014; Pirvola et al.,
2002), while deletion of Fgf20 leads to a loss of only 2/3 of OHCs (Huh et al., 2012b). To rule
out the effect of genetic background accounting for these differences, we generated Fgfr1
conditional knockout (Fgfr1-CKO: Foxg1Cre/+;Fgfr1flox/-) and Fgf20 knockout (Fgf20-KO: Fgf20/-

) mice along with litter mate controls (Fgfr1flox/+, Fgfr1flox/-, Foxg1Cre/+;Fgfr1flox/+, and Fgf20+/-,

respectively) on a mixed C57/B6 and 129 genetic background in separate mouse matings.
Foxg1Cre targets most of the otic vesicle as early as E9.5 (Hébert and McConnell, 2000b) and has
been used in other studies to conditionally delete Fgfr1 (Ono et al., 2014; Pirvola et al., 2002). In
the Fgf20- allele, exon 1 of Fgf20 is replaced by a sequence encoding a GFP-Cre fusion protein
(Huh et al., 2015b). We also refer to this null allele as Fgf20Cre.
We examined the cochleae at P0 (Figures 3.1A and 3.1B) and quantified the length of the
cochlear duct and the number of IHCs, OHCs, and SCs (Figures 3.1C-3.1F). In both Fgf20-KO
and Fgfr1-CKO cochleae, there were gaps in the sensory epithelium that lacked HCs and SCs
along the entire cochlear duct. In these gaps, there were Sox2-expressing cells which we interpret
to be undifferentiated progenitor cells (Figure 3.1B, arrows), showing that in both Fgf20-KO and
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Fgfr1-CKO cochleae, there were defects in differentiation. Quantitatively, Fgfr1-CKO cochleae
had a 28% reduction in cochlear length compared to control (Fgfr1Cre/+;Fgfr1flox/+) cochleae,
while Fgf20-KO cochleae had a 6% reduction compared to controls (Fgf20+/-). Fgfr1-CKO
cochleae had a 40% reduction in the number of IHCs, while Fgf20-KO did not have a significant
reduction. Fgfr1-CKO had almost a complete lack of OHCs, a 97% reduction, while Fgf20-KO
only had a 76% reduction. For SCs, Fgfr1-CKO had an 84% reduction, while Fgf20-KO had a
59% reduction. These results were all expected based on previous studies and showed that the
Fgfr1-CKO phenotype is more severe than the Fgf20-KO phenotype in cochlear length and in the
number of HCs and SCs. This suggests that an additional FGF ligand is compensating for the
loss of FGF20 (Figure 3.1G).
Interestingly, while the total number of IHCs was decreased in Fgfr1-CKO cochleae, this
decrease was only observed in the basal and middle turns of the cochlea, not in the apical turn
(Figure 3.2A). In addition, the number of IHCs normalized to cochlear length was slightly
increased in Fgf20-KO cochleae, and this increase was only observed in the middle and apical
turns of the cochlea, not in the basal turn (Figure 3.2A). This increase in IHCs could be
explained by the shortened cochlear duct length. No such basal/middle/apical turn discrepancies
existed in the number of OHCs or SCs in either genotype (Figures 3.2B and 3.2C). It seems that
due to a yet unidentified mechanism, there were fewer IHCs in the basal turn of the cochleae,
compared to the rest of the cochleae, in both Fgfr1-CKO and Fgf20-KO mice.

3.3.2 Genetic rescue of the Fgf20-null phenotype suggests that FGF20 is
required for hair cell and supporting cell differentiation.
We have previously shown that recombinant FGF9, which is biochemically similar to FGF20
(Ornitz and Itoh, 2015b), is able to rescue the loss of HCs and SCs in Fgf20-KO explant
cochleae (Huh et al., 2012b). Interestingly, while treatment with FGF9 at E13.5 and E14.5 was
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able to rescue the Fgf20-KO phenotype, treatment at E15.5 was not. This temporal rescue
specificity suggests that FGF20 signaling is required for HC and SC development at the initiation
of differentiation.
To determine the precise role of FGF20 in cochlea development (prosensory specification
vs. differentiation), we sought to more precisely determine the temporal requirement of FGF20
signaling. To achieve this, we developed an in vivo genetic rescue model of the Fgf20-null
phenotype by ectopically expressing FGF9. We combined Fgf20Cre with the ROSArtTA (Belteki et
al., 2005) and TRE-Fgf9-IRES-eGfp (White et al., 2006) alleles. We generated Fgf20-rescue
(Fgf20Cre/βgal; ROSArtTA/+; TRE-Fgf9-IRES-eGfp) mice along with littermate controls: Fgf20-het
(Fgf20Cre/+; ROSArtTA), Fgf9-OA (Fgf20Cre/+; ROSArtTA/+; TRE-Fgf9-IRES-eGfp), and Fgf20-null
(Fgf20Cre/βgal; ROSArtTA). These mice express the reverse tetracycline transactivator (rtTA) in the
Fgf20Cre lineage, which contains the prosensory domain and proximal (neural, towards the spiral
ganglion) floor of the cochlear duct at E13.5 to E15.5 (Huh et al., 2015b). In mice expressing
TRE-Fgf9-IRES-eGfp, rtTA drives the expression of FGF9 upon doxycycline (Dox) induction.
Initially, pregnant dams were fed a Dox diet from E13.5 to E15.5 and pups were
harvested at P0 to examine HC and SC development. As expected, Dox treatment did not appear
to affect HC or SC development in Fgf20-het and Fgf20-null cochleae, both of which showed the
expected phenotypes (Figures 3.3A and 3.3B). Notably, ectopic expression of FGF9 during these
stages did not affect HC or SC development in Fgf9-OA cochleae, showing that FGF20/FGF9 is
not sufficient to produce ectopic HCs and SCs. However, ectopic expression of FGF9 resulted in
a full rescue of the number and patterning of HCs and SCs in Fgf20-rescue pups. The results
from all of the rescue experiments are summarized in Figure 3.3C, where the number of OHCs
and SCs are represented as a percentage of that of Fgf20-het mice treated with the same Dox
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regimen. The organ of Corti in these rescue pups had one row of IHCs, three rows of OHCs, and
5 rows of SCs throughout the entire length of the cochlear duct, without any gaps (Figures 3.3A
and 2B). This shows that FGF20/FGF9 signaling at E13.5-E15.5 is sufficient for HC and SC
differentiation.
To more precisely determine the timing of rescue sufficiency, we fed pregnant dams Dox
for a period of 24 hours starting at E13.5, E14.5, or E15.5. With E13.5 Dox, patterning and OHC
number in the basal turn of the cochlea were completely rescued (Figures 3.3A). However, OHC
number in the middle and particularly apical turns was partially, but not completely rescued,
resulting in regions with two rows of OHCs instead of three. For instance, in the apical turn,
OHC number was restored to 81% of Fgf20-het mice, which is statistically significantly
increased compared to Fgf20-null, but also statistically significantly decreased compared to
Fgf20-het. With E14.5 Dox, patterning and OHC number in the middle and apical turns were
completely rescued. However, OHC number in the basal turn was not completely rescued, with
regions of one or two rows of OHCs. With E15.5 Dox, patterning and OHC number was not
rescued in the basal and middle turns, as gaps still formed between islands of HCs. However,
OHC number in the apical turn was partially rescued, with two or three rows of OHCs not
separated by gaps. In all of these experiments, the rescue of SCs followed the same pattern as
that of OHCs (Figure 3.3B).
These rescue results show that FGF20/FGF9 is sufficient for OHC and SC differentiation
in the basal turn of the cochlea at E13.5, and in the middle and apical turns at E14.5-E15.5. Since
the initiation of HC and SC differentiation occurs in the base (specifically midbase) of the
cochlea at E13.5 and progresses apically over the next two days, these results strongly imply that
FGF20 functions during the initiation of differentiation, rather than prosensory specification.
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3.3.3 FGFR1 has a role in prosensory specification in addition to
differentiation
Because the Fgfr1-CKO phenotype is more severe than that of Fgf20-KO, we hypothesized that
another FGF ligand partially compensates for the loss of FGF20 during the initiation of
differentiation. To test this hypothesis, we examined the expression of Etv4 (also known as
Pea3) and Etv5 (also known as Erm), two well-established downstream effectors of FGF
signaling (Ornitz and Itoh, 2015b), by RNA in situ hybridization in the middle turn of the E14.5
cochlea. The expression of these two genes have been shown to be downregulated with FGF
signaling inhibition in E14 cochlear explants (Hayashi et al., 2008). At E14.5, there were two
domains of Etv4 and Etv5 expression in control cochleae: one in the prosensory domain, and one
in the outer sulcus (Figure 3.4B, brackets, refer to Figure 3.4A). However, in Fgf20-KO
cochleae, expression of both genes was completely absent from the prosensory domain. In Fgfr1CKO cochleae, expression of both genes was similarly absent from the prosensory domain.
Unexpectedly, the decrease in Etv4/5 expression in Fgfr1-CKO cochleae was not more severe
than the decrease in Fgf20-KO cochleae. This suggests that FGF20 is the only important ligand
for FGFR1 during the initiation of differentiation.
To explain this finding, we hypothesized that FGFR1 signaling, via another ligand, may
have a role in cochlea development prior to differentiation, perhaps during prosensory
specification. We therefore examined Sox2 expression as a marker of the prosensory domain. As
expected, and confirming previous findings (Huh et al., 2012b; Ono et al., 2014; Pirvola et al.,
2002), the expression of Sox2 (by RNA in situ hybridization and immunofluorescence) was not
decreased in Fgf20-KO cochleae compared to control (Figure 3.4C). However, it was noticeably
decreased in Fgfr1-CKO cochleae. This indicates that FGFR1 has an additional role, independent
of FGF20, in regulating Sox2 and prosensory specification.
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Previous studies have also reported a decrease in proliferation in the Kölliker’s organ
(refer to Figure 3.4A) in Fgfr1-CKO cochleae (Pirvola et al., 2002). We replicated this result by
examining EdU (5-ethynyl-2’-deoxyuridine) incorporation rates in the cochlea at E14.5. Fgfr1CKO mice had almost a complete lack of EdU-incorporating Kölliker’s organ cells, while Fgf20KO mice did not show a decrease in EdU incorporation (Figure 3.4D). This finding is consistent
with an additional FGF ligand signaling via FGFR1, likely at an earlier stage. We do not know if
and how the proliferation defect in the Kölliker’s organ contributes to the reduction in HC and
SC number in Fgfr1-CKO mice.

3.3.4 Decrease in Sox2 expression results in similar phenotypes to
Fgf20/Fgfr1 deletion
As stated in the introduction, FGFR1 has been hypothesized to regulate prosensory specification
via Sox2 (Munnamalai et al., 2012; Ono et al., 2014; Pirvola et al., 2002). Mice with an inner
ear-specific Sox2 hypomorphic mutation (Sox2Ysb/Ysb, see below) have defects in prosensory
specification, accounting for a small loss of HCs and SCs, whereas mice with inner-ear specific
Sox2 null mutations have a complete lack of prosensory specification and a complete absence
sensory epithelium (Kiernan et al., 2005). We wanted to examine how much the reduction in
Sox2 expression in Fgfr1-CKO cochlea contributes to the phenotype. To do so, we combined the
Sox2- (Sox2 constitutive null) and Sox2Ysb alleles to severely reduce, but not completely abolish
Sox2 expression during cochlea development, on a similar genetic background as our Fgf20-KO
and Fgfr1-CKO mice. The Sox2Ysb allele has an insertion in chromosome 3, resulting in
hypomorphic Sox2 expression in the inner ear (Dong et al., 2002; Kiernan et al., 2005).
We generated Sox2+/+ (wildtype), Sox2Ysb/+, Sox2Ysb/Ysb, and Sox2Ysb/- mice to study the
effects of varying levels of hypomorphic Sox2 expression on sensory epithelium development.
We hypothesized that if Fgfr1 acts upstream of Sox2, then by reducing Sox2 expression, we can
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at least partially recapture the Fgfr1-CKO cochlea phenotype. At P0, Sox2Ysb/+ cochleae
developed relatively normally, with three rows of OHCs and one row of IHCs (Figure 3.5A).
Interestingly, there were occasional ectopic IHCs medial to the normal row of IHCs, especially
in the middle and apical turns of the Sox2Ysb/+ cochlea (Figure 3.5A, arrowheads); however, there
was no significant increase in IHC number (total or normalized to length) compared to wildtype
cochleae (Figure 3.5D). The Sox2Ysb/Ysb cochlea appeared much more abnormal, with gaps in the
sensory epithelium that lacked HCs and SCs in the basal turn (Figures 3.5A and 3.5B), similar to
what was previously observed (Kiernan et al., 2005). Interestingly, in Sox2Ysb/Ysb cochleae, the
gaps between sensory islands lacked Sox2-expressing cells (Figure 3.5B, arrows), unlike in
Fgf20-KO and Fgfr1-CKO cochleae, suggesting that the phenotype is due to severe disruptions
to prosensory specification, and not differentiation. Moreover, at the base, in the sensory islands
between the gaps, there were often four rows of OHCs and six rows of SCs. In the middle and
apical turns, there were the normal three rows of OHCs and five rows of SCs. Strikingly, there
were numerous ectopic IHCs throughout the middle and apical turns, sometimes forming an
entire second row of cells in the (Figure 3.5A), resulting in increased number of IHCs in the
middle turn (Figure 3.6A). However, the total and length-normalized number of IHCs in
Sox2Ysb/Ysb cochleae did not significantly differ from that of wildtype cochleae (Figure 3.5D). In
terms of OHCs, Sox2Ysb/Ysb cochleae exhibited a 40% decrease in total number compared to
wildtype cochleae (Figure 3.5E). This decrease was not quite as severe when normalized to
cochlear length (21% reduction). Notably, compared to wildtype, Sox2Ysb/Ysb cochleae had
significantly less OHCs in the basal and middle turns, but not the apical turn (Figure 3.6B).
Sox2Ysb/- cochleae lacked almost all HCs and SCs, except at the very apex (Figures 3.5A and
3.5B). The decrease in OHC number (93%) in Sox2Ysb/- cochleae compared to wildtype was
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more severe than the decrease in IHC number (75%). Notably, IHC number was significantly
decreased in the basal and middle turns, but not the apical turn (Figure 3.6A). OHC number was
significantly decreased throughout all three turns, but appeared least affected in the apical turn
(Figure 3.6B). In all of these genotypes, the number of SCs followed the pattern as the number of
OHCs (Figures 3.5F and 3.6C).
Overall, these results showed that while both are IHCs and OHCs were affected by the
loss of Sox2, OHCs were more sensitive to decrease in Sox2 expression than IHCs, and the base
of the cochlea was more sensitive than the apex. Notably, both of these features were found in
Fgfr1-CKO cochleae, where there were almost no OHCs along the entire cochlear duct, and the
decrease in IHCs was only found in the basal and middle turns. Therefore, we conclude that the
decrease in Sox2 expression in Fgfr1-CKO cochleae could account for the sensory epithelium
phenotype. Furthermore, the decrease in Sox2 expression could also account for the difference
between the Fgfr1-CKO and Fgf20-KO phenotypes, since Fgf20-KO cochleae, which had
normal Sox2 expression, did not have a decrease in the number of IHCs.

3.3.5 Sox2 is upstream of, but epistatic to, Fgf20
Similarities between the Fgf20/Fgfr1 deletion and Sox2 hypomorph phenotypes suggest that
these genes belong to the same genetic pathway. As expected, at E14.5, Sox2 expression was
decreased in Sox2Ysb/- cochleae, similarly to and more severely than Fgfr1-CKO cochleae (Figure
3.7A). However, there was no decrease in EdU-incorporation in the Kölliker’s organ of Sox2Ysb/cochleae, unlike in Fgfr1-CKO cochleae (Figure 3.7B). This suggests that the proliferation
phenotype in Fgfr1-CKO cochleae is Sox2 independent.
Previous studies and results reported here suggest that Fgfr1 is upstream of Sox2. To rule
out the possibility that Sox2 may be upstream of Fgf20/Fgfr1, we examined Etv4/5 expression in
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Sox2Ysb/- at E14.5. Surprisingly, both Etv4 and Etv5 were dramatically downregulated in the
prosensory domain of Sox2Ysb/- cochleae compared to control (Figure 3.7C). This shows that
FGF20/FGFR1 signaling was disrupted downstream of Sox2. Next, we examined Fgfr1 and
Fgf20 expression and found that while Fgfr1 expression was not changed in Sox2Ysb/- cochleae at
E14.5, Fgf20 expression was absent (Figure 3.7D). This suggests that while Fgfr1 is upstream of
Sox2, Fgf20 is downstream of Sox2. This model predicts that Fgf20 expression would be
downregulated in Fgfr1-CKO. This was confirmed by in situ at E14.5 (Figure 3.7F).
The loss of Fgf20 expression in Sox2Ysb/- cochleae suggests that the Sox2Ysb/- phenotype
could be partially due to the absence of FGF20-mediated differentiation. To test this, we
ectopically expressed TRE-Fgf9-IRES-eGfp in the Fgf20Cre-lineage to try to rescue the Sox2Ysb/phenotype. Importantly, using the Cre-reporter ROSAmTmG (Muzumdar et al., 2007b), we showed
that despite the absence of Fgf20 expression in Sox2Ysb/- cochleae at E14.5, the Fgf20Cre-lineage
was mostly unchanged in Sox2Ysb/-; Fgf20Cre/+; ROSAmTmG cochleae at E14.5, compared to control
(Sox2Ysb/+; Fgf20Cre/+; ROSAmTmG; Figure 3.7E). We generated Sox2Ysb/-; Fgf20Cre/+; ROSArtTA/+;
TRE-Fgf9-IRES-eGfp (Sox2Ysb/- Fgf9-OA) mice along with Sox2Ysb/-; Fgf20Cre/+ littermate
controls that were either missing the ROSArtTA or TRE-Fgf9-IRES-eGfp alleles (Sox2Ysb/- control)
. Pregnant dams were fed Dox chow at either E13.5 to E15.5 (n = 2), E11.5 to P0 (n = 1), or
E10.5 to E15.5 (n = 1) and pups were harvested at P0. In all four Sox2Ysb/- Fgf9-OA pups, there
was no rescue of the cochlear phenotype (Figure 3.7G). This strongly suggests that Sox2 and
Fgf20 act during different steps in a developmental pathway, instead of a direct genetic pathway.
In a developmental pathway, unlike in a genetic pathway, the upstream gene is epistatic to the
downstream gene. Sox2 is required for prosensory specification, a process that must occur prior
to Fgf20-mediated differentiation. Therefore, when prosensory specification is severely disrupted
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in Sox2Ysb/- mutants, ectopic FGF signaling cannot induce differentiation. These results are,
therefore, consistent with our hypothesis that Fgf20 is required during differentiation, and not
prosensory specification (Figure 3.7H).

3.3.6 Sox2 and Fgf20 interact epistatically during cochlea development
To explore the Sox2-FGF20 interaction in more detail, we combined Fgf20- with the Sox2- allele.
Our results from above suggest that Sox2 and Fgf20 act during distinct steps in a developmental
pathway. To determine whether the two genes may also interact in the same genetic pathway, we
analyzed Fgf20+/+;Sox2+/+ (wildtype), Fgf20+/-;Sox2+/+ (Fgf20-het), Fgf20+/+;Sox2+/- (Sox2-het),
and Fgf20+/-;Sox2+/- (double-het) mice for epistatic interaction (Figure 3.8A). At P0, cochlear
length did not significantly differ among the four genotypes (Figure 3.8B). HC quantification
showed that neither Fgf20 nor Sox2 exhibited heterozygous insufficiency for total or lengthnormalized number of IHCs/OHCs (Figures 3.8C and 3.8E). However, in Fgf20-het and much
more so in Sox2-het cochleae, occasional ectopic IHCs can be found in the middle and apical
turns of the cochlear duct (Figure 3.8A, arrowheads). However, in double-het cochleae, many
more ectopic IHCs were found, even in the basal turn. These ectopic IHCs led to an increase in
the total and length-normalized number of IHCs in double-het cochleae, compared to wildtype
(Figure 3.8C). Notably, a significant increase in IHCs was only found in the basal turn, not the
middle or apical turns (Figure 3.8D). In the basal turn, IHC number was significantly increased
in double-het cochleae compared to wildtype, Fgf20-het, and Sox2-het. This result reveals an
epistatic interaction between Fgf20 and Sox2. Double-het cochleae also had a significant
decrease in total and length-normalized number of OHCs compared to wildtype (Figure 3.8E).
Again, a significant decrease in OHCs was only found in the basal turn, not the middle or apical
turns (Figure 3.8F).
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To more closely evaluate the Fgf20-Sox2 epistatic interaction, we combined the Fgf20
and Sox2Ysb alleles to allow us to further reduce Sox2 levels. We also hypothesized that reduction
of Sox2 levels Fgf20-/- mice would recapture the Fgfr1-CKO phenotype, in which FGF20
signaling is lost in addition to a decrease in Sox2 expression. We interbred F1s from the same
parents to generate nine different F2 genotypes: Fgf20+/+;Sox2+/+, Fgf20+/+;Sox2Ysb/+, Fgf20+/;Sox2+/+, Fgf20+/-;Sox2Ysb/+, Fgf20+/+;Sox2Ysb/Ysb, Fgf20+/-;Sox2Ysb/Ysb, Fgf20-/-;Sox2+/+, Fgf20-/;Sox2Ysb/+, and Fgf20-/-;Sox2Ysb/Ysb. At P0, an overview of HCs and SCs showed that the Fgf20+/;Sox2Ysb/- phenotype mostly resembled that of Fgf20+/+;Sox2+/+, Fgf20+/+;Sox2Ysb/+, and Fgf20+/;Sox2+/+, except for the prevalence of ectopic IHCs (Figure 3.9A, arrowheads). The Fgf20+/;Sox2Ysb/Ysb phenotype mostly resembled that of Fgf20+/+;Sox2Ysb/Ysb, but with more gaps in the
basal cochlear turn and two rows of IHCs throughout the length of the cochlear duct. The Fgf20-/;Sox2Ysb/+ phenotype mostly resembled that of Fgf20-/-;Sox2+/+, but with smaller sensory islands.
The Fgf20-/-;Sox2Ysb/Ysb phenotype appeared by far the most severe, with almost a complete
absence of IHCs, OHCs, and SCs from the basal turn, and tiny sensory islands in the middle turn;
the apical turn appeared similar to that of Fgf20-/-;Sox2Ysb/+ and Fgf20-/-;Sox2+/+, however (Figure
3.9A).
We analyzed the quantified P0 phenotype via two-way ANOVA with the factors being
the dosage of Fgf20 (levels: Fgf20+/+, Fgf20+/-, Fgf20-/-) and Sox2 (levels: Sox2+/+, Sox2+/-, Sox2). Results from the two-way ANOVA and post-hoc Tukey’s HSD are presented in Figures 3.9G,
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3.9H, 3.10D, and 3.10E. Cochlear length and the total number of IHCs, OHCs, and SCs were all
significantly affected by both Fgf20 dosage and Sox2 dosage, as well as an interaction between
the two factors (Figures 3.9B-3.9D, 3.9F, and 3.9G). The statistically significant interaction
between Fgf20 and Sox2 dosages confirms the hypothesis that Fgf20 and Sox2 epistatically
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interact. Notably, Fgf20+/-;Sox2Ysb/Ysb cochleae had significantly fewer OHCs and SCs than
Fgf20+/+;Sox2Ysb/Ysb cochleae, and Fgf20-/-;Sox2Ysb/+ cochleae had significantly fewer OHCs than
Fgf20-/-;Sox2+/+ cochleae (Figure 3.9H). Importantly, Fgf20-/-;Sox2Ysb/Ysb cochleae had decreased
total and length-normalized number of IHCs, which was not observed in any of the other
genotypes, strongly supporting an interaction between Fgf20 and Sox2 (Fgf20+/+;Sox2Ysb/Ysb
cochleae did have a slight decrease in the total number IHCs, but not in length-normalized
number of IHCs). The large sensory gaps in the basal and middle turns of Fgf20-/-;Sox2Ysb/Ysb
cochleae, but not the apical turn, lacked Sox2-expressing cells (Figure 3.9E), suggesting that the
phenotype is attributable to a defect in prosensory specification as well as differentiation.

3.3.7 Sox2 and Fgf20 double mutants recapture the Fgfr1 conditional null
and Sox2Ysb/- phenotypes
Differences in the number of IHCs, OHCs, and SCs in the basal, middle, and apical turns of the
cochlear duct among the nine genotypes mostly followed the same pattern as the total number
IHCs, OHCs, and SCs (Figure 3.10A-3.10C). One exception is that Fgf20+/-;Sox2Ysb/Ysb cochleae
had significantly more IHCs in the middle and apical turns compared to Fgf20+/+;Sox2+/+,
Fgf20+/+;Sox2Ysb/+, Fgf20+/-;Sox2+/+, and Fgf20+/-;Sox2Ysb/+ cochleae (Figure 3.10E). Another
notable exception is that Fgf20-/-;Sox2Ysb/Ysb cochleae had significantly fewer IHCs in the basal
and middle turns, but not the apical turn (Figure 3.10E). This feature resembles that of Fgfr1CKO and Sox2Ysb/- cochleae.
In the basal end of the cochlea, the Fgf20-/-;Sox2Ysb/Ysb phenotype strongly resembles that
of Sox2Ysb/-, where there were almost a complete absence of sensory epithelium. To determine
whether this phenotype could be explained by a further decrease in Sox2 levels in Sox2Ysb/Ysb
cochleae due to the additional loss of Fgf20, we examined Sox2 expression at E14.5. As
expected, Fgf20-/-;Sox2Ysb/+ cochleae did not have a decrease in Sox2 expression in the
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prosensory domain compared to Fgf20+/-;Sox2Ysb/+ (Figure 3.11A). Interestingly, Fgf20-/;Sox2Ysb/Ysb cochleae also did not have a further decrease in Sox2 expression compared to
Fgf20+/-;Sox2Ysb/Ysb cochleae. Despite the loss of sensory epithelium in most of the basal turn,
Sox2 expression was not further decreased in the basal turn at E14.5 relative to the rest of the
Fgf20-/-;Sox2Ysb/Ysb cochlea (Figure 3.11A). These results confirm that Fgf20 has no role in
regulation of Sox2 expression. They do suggest, however, that Fgf20 has a Sox2-independent
role in regulating prosensory specification, which is only unmasked in a Sox2-hypomorphic
background.
Next, we examined proliferation rates of the E14.5 cochlea. Surprisingly, we found a
dramatic decrease in the number of EdU-incorporating cells in the Kölliker’s organ in Fgf20-/;Sox2Ysb/Ysb cochleae. This phenotype is similar to that of Fgfr1-CKO cochleae, which had an
absence of proliferation in the Kölliker’s organ. It is not currently known how this proliferation
defect contributes, if at all, to the defect in HC and SC development.

3.4 Discussion
3.4.1 Fgfr1 is involved in prosensory specification and differentiation, while
Fgf20 is only involved in differentiation
Fgf20 has been shown in vitro and in vivo to be required for HC and SC development; however,
the exact role of Fgf20 in this process has been a topic of debate. We previously reported that
Fgf20-null mice do not have defects in prosensory specification, and have a normally formed
prosensory domain (Huh et al., 2012b). We further showed that FGF20 signaling is important
during stages of initiation of differentiation, and that mice lacking Fgf20 have gaps in the
differentiated sensory epithelium filled with undifferentiated prosensory progenitors. However,
other studies have shown in vitro that FGF20, downstream of Notch signaling, regulates
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prosensory specification via Sox2 (Munnamalai et al., 2012). In addition, in vivo studies showed
that Fgfr1 is required for normal prosensory specification, likely via Sox2 (Ono et al., 2014).
Here, using an in vivo rescue model, we show that ectopic FGF9 signaling is sufficient to rescue
the Fgf20-null phenotype from E13.5 to E15.5, around the time of initiation of differentiation.
FGF9 induction rescued the phenotype in a temporalspatial pattern that matched the timing of
differentiation along the length of the cochlear duct. At E13.5, the base/mid-base of the cochlear
duct begins to differentiate into HCs and SCs; induction of FGF9 at this stage was sufficient to
fully rescue differentiation in the basal turn of the cochlea, but not the middle and apical turns.
At E15.5, the apex of the cochlear duct begins to differentiate; induction of FGF9 at this stage
was sufficient to rescue differentiation in the apical turn of the cochlea, but not the basal and
middle turns. These results suggest that during normal development, prosensory progenitors
require a temporally-restricted FGF20 signal just at or prior to differentiation. Moreover,
overexpression of FGF9 in an Fgf20 heterozygous background did not lead to an increase in the
number of HCs or SCs. This result, along with the temporally-restricted requirement for FGF20,
suggests that Fgf20 plays a permissive role in differentiation, rather than instructive.
Another topic of discussion in the field of cochlea development is the identity of FGFR1
ligands. Based on in vitro and in vivo phenotype similarities, FGF20 has been proposed as the
ligand (Hayashi et al., 2008; Huh et al., 2012b). However, the Fgf20-null phenotype, in which
two-thirds of OHCs fail to develop, is not as severe as the Fgfr1 conditional null phenotype,
which lacks almost all OHCs as well as half of the IHCs. Potential explanations for this include
differences in mouse genetic background, and the existence of another redundant FGF ligand. To
rule out the former, we examined here Fgf20-null and Fgfr1-conditional null mice on a similar
genetic background, and replicated the difference in phenotype severity. We also replicated the
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decrease in Sox2 expression in the prosensory domain previously reported in Fgfr1 conditional
null mice (Ono et al., 2014). We also reaffirmed that Sox2 expression in the prosensory domain
is not affected by the loss of Fgf20. This suggests that another FGF ligand signaling through
FGFR1 is required to maintain Sox2 expression during prosensory specification. The identity of
this ligand is currently unknown. We hypothesize here that this decrease in Sox2 expression is
accountable for the difference in the Fgfr1 conditional null and Fgf20-null phenotypes.
Foxg1Cre has been used in several studies to target otic epithelium, including to
conditionally delete Fgfr1 (Ono et al., 2014; Pirvola et al., 2002). One concern with the use of
Foxg1Cre is that it is a null allele (Hébert and McConnell, 2000b). Foxg1-null mice have
shortened cochlear length, although HC and SC differentiation did not appear to be directly
affected (Pauley et al., 2006). Previous studies (Brown and Epstein, 2011) and our results here
showed that Foxg1 is not haploinsufficient during cochlea development, as Foxg1Cre/+;Fgfr1flox/+
cochleae had very similar phenotypes to Fgfr1+/- cochleae. Moreover, the use of the Six1enh21Cre transgene, which targets the otic epithelium in a similar spatiotemporal pattern as Foxg1Cre,
to conditionally delete Fgfr1 resulted in the same phenotype as Foxg1Cre;Fgfr1flox/- cochleae. This
included the loss of almost all OHCs, loss of IHCs, and decreased prosensory Sox2 expression
(Ono et al., 2014). Therefore, the increased severity of Foxg1Cre;Fgfr1flox/- cochleae relative to
Fgf20-/- cochleae is likely not attributable to the loss of a copy of Foxg1.

3.4.2 Fgf20 and Sox2 interact during cochlea development
We show here strong evidence that Fgf20 and Sox2 interact epistatically during cochlea
development. Fgf20-/-;Sox2Ysb/+ cochleae had significantly worse phenotypes than Fgf20-/;Sox2+/+ cochleae, and Fgf20+/-;Sox2Ysb/Ysb had significantly worse phenotypes than
Fgf20+/+;Sox2Ysb/Ysb. The Fgf20-/-;Sox2Ysb/Ysb cochlear phenotype was by far the worst of all,
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missing almost all OHCs and more than half of IHCs. According to the two-way ANOVA, there
was a statistically significant interaction between Fgf20 and Sox2 in determining cochlear length
and the number of IHCs, OHCs, and SCs. Furthermore, neither Fgf20+/- nor Sox2+/- cochleae had
fewer OHCs or SCs compared to wildtype cochleae, while Fgf20+/-;Sox2+/- cochleae did. The
double heterozygous cochleae also had a slight increase in total IHC number, which was
statistically significant in the base, compared to wildtype, Fgf20+/-, and Sox2+/- cochleae.
Interestingly, there was a concurrent slight decrease in OHC number, also particularly in the
basal turn. Resultingly, the total HC number in double heterozygous cochleae compared to
wildtype was unchanged. This suggests the possibility of prosensory progenitors being pushed
away from the OHC fate towards the IHC fate. However, we do not have evidence to support
this hypothesis. Fgf20-/- and Fgf20+/-;Sox2Ysb/Ysb cochleae also had increased number of IHCs
normalized to length, but only in the middle and apical turns.
The epistatic interaction between Sox2 and Fgf20 is consistent with the two genes acting
in the same genetic pathway. This means that our model of Sox2 and Fgf20 acting in distinct
developmental processes (prosensory specification and differentiation, respectively), is not
entirely accurate. The lack of Sox2-expressing progenitors in sensory gaps along the basal and
middle turns of Fgf20-/-;Sox2Ysb/Ysb strongly suggest that the genetic interaction occurs during
prosensory specification. Sox2 also has known roles during HC and SC differentiation (Ahmed et
al., 2012; Dabdoub et al., 2008; Kempfle et al., 2016; Puligilla and Kelley, 2016), and the genetic
interaction may occur there as well (Figure 3.11C). Ultimately, however, while the two-step
model of cochlea development is well established and useful for understanding the complex
genetic and developmental regulation of sensory epithelia formation, prosensory specification
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and differentiation are likely not distinct developmental processes. Rather, they are part of the
same process (or spectrum of processes) occurring at distinct stages.

3.4.3 The Fgf20-/-;Sox2Ysb/Ysb phenotype resembles that of both Fgfr1
conditional deletion and Sox2Ysb/We hypothesized that the severity of the Fgfr1 conditional null phenotype is due to the loss of
FGF20 signaling during differentiation and decreased Sox2 expression causing disrupted
prosensory specification. Consistent with this hypothesis, the combination of Fgf20-/- and
Sox2Ysb/Ysb mutations phenocopied Fgfr1 conditional null cochleae. The similarities in phenotype
include roughly a one-third reduction in cochlear length, an almost complete absence of OHCs
and SCs, a roughly 50% loss of IHCs, and a proliferation defect in the Kölliker’s organ at E14.5.
However, the complete absence of sensory epithelium and Sox2-expressing cells in most of the
basal and middle turns of Fgf20-/-;Sox2Ysb/Ysb cochleae is more similar to the Sox2Ysb/- phenotype.
We conclude that the Fgfr1 conditional null, Fgf20-/-;Sox2Ysb/Ysb, and Sox2Ysb/- phenotypes likely
lie along the same spectrum, as these three genotypes all exhibited a lack of Fgf20
expression/signaling and varying levels of Sox2 expression (Figure 3.11D). Fgf20-null, in which
Sox2 expression was not affected, lies at the front end of this spectrum. Interestingly, this
spectrum shows that in the absence of Fgf20 expression/signaling, reductions in the level of Sox2
mostly severely affected sensory epithelium development of the cochlear base. As we move
further towards the Sox2Ysb/- end of the spectrum, more and more OHCs and IHCs are
preferentially lost from the cochlear base. We do not currently know why the base is more
sensitive to perturbations to FGFR1 signaling and Sox2 levels. As discussed below, this spectrum
also shows that the outer compartment (OHCs and outer SCs) are also more sensitive to these
same genetic perturbations (Figure 3.11D).

116

3.4.4 Outer compartment of the cochlear sensory epithelium is more sensitive
to the loss of Fgfr1, Fgf20, and Sox2 than the inner compartment.
In all of the genotypes we observed in this study, the loss outer compartment HCs (i.e. OHCs)
was predominant. Only in the most severe cases in which almost all OHCs were missing, as seen
in Fgfr1-CKO, Fgf20-/-;Sox2Ysb/Ysb, and Sox2Ysb/- cochleae, were IHCs lost as well.
Similarly, reduction in SC number always affected the outermost cells preferentially. This
suggests that the outer compartment sensory epithelium is more sensitive to the loss of Fgfr1,
Fgf20 and Sox2. The combination of Fgf20- and Sox2Ysb alleles elegantly demonstrates this: as
the dosage of Fgf20- and Sox2Ysb alleles increased, the number of OHCs progressively decreased,
and in the double homozygous mutants, the number of IHCs decreased as well.
Previous studies have noted that the dosage of Fgfr1 affects the degree of OHC and IHC
loss. In Fgfr1 hypomorphs with 80% reduction in transcription, only the third row of OHCs were
missing, while 90% hypomorphs had a slightly more severe phenotype (Pirvola et al., 2002).
Other studies have suggested that the timing of Fgfr1 deletion, and therefore of Sox2 expression
decrease, may affect the degree of OHC and IHC loss. When an earlier-expressed Cre driver
(Six1enh21-Cre) was used to conditionally delete Fgfr1, almost all OHCs and some IHCs were
lost, with a 66% reduction in Sox2 expression at E14.5 (Ono et al., 2014). When a laterexpressed Cre driver (Emx2Cre) was used, much more OHCs and IHCs remained, with only at
12% reduction in Sox2 expression. Our results are consistent with both of these studies, as we
show that FGF20 signaling is only necessary at a later stage during OHC development, while
FGFR1 and Sox2 are important earlier, affecting IHC and OHC development.
The increased sensitivity of the outer sensory compartment suggests that something from
the outer sulcus, which is abneural to the prosensory domain, may be inhibiting sensory
development. Bmp4, which is expressed in the outer sulcus, has been shown to pattern the
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cochlear epithelium prior to differentiation (Ohyama et al., 2010). BMP4 diffusion from the
outer sulcus creates a gradient of BMP4 signaling that is highest in the outer sulcus, intermediate
in the prosensory domain, and lowest in the Kölliker’s organ. Alterations to this gradient
revealed that an intermediate level of BMP4 signaling is required for prosensory specification
(Ohyama et al., 2010). It is conceivable that loss of FGF20, FGFR1, and/or Sox2 may subtly
shift the BMP4 gradient so that the outer prosensory domain receives higher levels of BMP4,
leading to inhibition of outer compartment development. This possibility addressed in Chapter 4.

3.4.5 Conclusions
Overall, this study resolves perceived inconsistencies in the literature regarding the severity of
Fgf20 and Fgfr1 null cochlea phenotypes and the role of FGF20-FGFR1 signaling. We propose
that during early stages of cochlea development (E11.5 to E13.5), FGF20 and a yet unidentified
FGF ligand signal to FGFR1 to regulate prosensory specification via, and independent of, Sox2.
Sox2, in turn, regulates Fgf20 expression, which signals through FGFR1 to initiate HC and SC
differentiation at around E13.5 to E15.5 (Figure 3.11C). It is currently not known what
downstream effector(s) FGF20/FGFR1 signaling is regulating during differentiation. This topic
will be a focus of future studies.

3.5 Methods
3.5.1 Mice
Mice were group housed with littermates, in breeding pairs, or in a breeding harem (2 females to
1 male), with food and water provided ad libitum. For timed-pregnancy experiments, embryonic
day 0.5 (E0.5) was assigned as noon of the day the vaginal plug was found. For postnatal
experiments, postnatal day 0 (P0) was determined as the day of birth. All studies performed were
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in accordance with the Institutional Animal Care and Use Committee at Washington University
in St. Louis.
Mice were of mixed sexes and maintained on a mixed C57BL/6J x 129X1/SvJ genetic
background. The following mouse lines were used:
•

Fgf20Cre (Fgf20-): knockin allele containing a sequence encoding a GFP-Cre fusion
protein replacing exon 1 of Fgf20, resulting in a null mutation (Huh et al., 2015a).

•

Foxg1Cre: knockin allele containing a sequence encoding Cre fused in-frame downstream
of the first 13 codons, resulting in a null mutation (Hébert and McConnell, 2000b).

•

Fgfr1flox: allele containing loxP sequences flanking exons 8 through 15 of Fgfr1. Upon
Cre-mediated recombination, produces a null mutation (Trokovic et al., 2003)

•

Fgfr1-: null allele generated by combining Fgfr1flox with Sox2Cre (Hayashi et al., 2002) to
delete Fgfr1 from the epiblast.

•

ROSArtTA: knockin allele containing a loxP-Stop-loxP sequence followed by a sequence
encoding rtTA-IRES-eGFP, targeted to the ubiquitously expressed ROSA26 locus. Upon
Cre-mediated recombination, reverse tetracycline transactivator (rtTA) and eGFP are
expressed (Belteki et al., 2005).

•

TRE-Fgf9-IRES-eGfp: transgene containing seven tetracycline-inducible regulatory
elements driving the expression of FGF9-IRES-eGFP (White et al., 2006).

•

Sox2Ysb: Inner ear specific Sox2 hypomorph allele resulting from a random insertion of a
transgene in chromosome 3, likely interfering with tissue-specific Sox2 regulatory
elements (Dong et al., 2002).

•

Sox2-: null allele generated by combining Sox2flox (Shaham et al., 2009) with Sox2Cre
(Hayashi et al., 2002) to delete Sox2 from the epiblast.
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•

ROSAmTmG: knockin allele containing a sequence encoding a membrane-localized
tdTomato (mT) flanked by loxP sequences, followed by a sequence encoding a
membrane-localized eGFP (mG), targeted to the ubiquitously expressed ROSA26 locus.
In the absence of Cre-mediated recombination, mT is expressed; upon Cre-mediated
recombination, mG is alternatively expressed (Muzumdar et al., 2007a).

3.5.2 Doxycycline induction
Pregnant dams were starved overnight the night before initiation of Dox induction and fed Dox
Diet, Grain-Based Doxycycline, 200 mg/kg (Bio-Serv, S3888) ad libitum starting at noon on the
start date of Dox induction. On the stop date of Dox induction, Dox Diet was replaced with
regular mouse chow at noon.

3.5.3 Sample preparation
For whole mount cochleae, inner ears were dissected out of P0 pups and fixed in 4% PFA in PBS
overnight at 4°C with gentle agitation. Samples were then washed x3 in PBS. Cochleae were
dissected away from the vestibule, otic capsule, and periotic mesenchyme with Dumont #55
Forceps (Roboz, RS-5010). The roof of the cochlear duct was opened up by dissecting away the
stria vascularis and Reissner’s membrane; tectorial membrane was removed to expose hair and
supporting cells.
For sectioning, heads from E14.5 embryos were fixed in 4% PFA in PBS overnight at
4°C with gentle agitation. Samples were then washed x3 in PBS and cryoprotected in 15%
sucrose in PBS overnight and then in 30% sucrose in PBS overnight. Samples were embedded in
Tissue-Tek O.C.T. compound (VWR International, 4583) and frozen on dry ice. Serial horizontal
sections through base of the head were cut at 12 µm with a cryostat, dried at room temperature,
and stored at -80°C until use.
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3.5.4 RNA in situ hybridization
Probe preparation: mouse cDNA plasmids containing the following inserts were used to make
RNA in situ probes, and were cut and transcribed with the indicated restriction enzyme (New
England Biolabs) and RNA polymerase (New England Biolabs): Fgfr1 transmembrane domain
(325 bp, HincII, T7, gift of K Peters), Fgf20 (653 bp, NcoI, Sp6), Sox2 (750 bp, AccI, T3, gift of
R. Lovell-Badge), Etv4 (~2300 bp, ApaI, Sp6, gift of G Martin), and Etv5 (~4000 bp, HindIII,
T3, gift of G Martin). Restriction digest and in vitro transcription were done according to
manufacturer’s instructions, with DIG RNA Labeling Mix (Sigma-Aldrich, 11277073910). After
treatment with RNase-free DNase I (Sigma-Aldrich, 04716728001) for 15 min at 37°C, probes
were hydrolyzed in hydrolysis buffer (40 mM NaHCO3, 60 mM Na2CO3) at 60°C for up to 30
min, depending on probe size.
Frozen section in situ hybridization: frozen slides were warmed for 20 min at room
temperature and then 5 min at 50°C on a slide warmer. Sections were fixed in 4% PFA in PBS
for 20 min at room temperature, washed x2 in PBS and treated with pre-warmed 10 µg/ml
Proteinase K (Sigma-Aldrich, 03115828001) in PBS for 7 min at 37°C. Sections were then fixed
in 4% PFA in PBS for 15 min at room temperature, washed x2 in PBS, acetylated in 0.25%
acetic anhydrate in 0.1M Triethanolamine, pH 8.0, for 10 min, and washed again in PBS.
Sections were then placed in pre-warmed hybridization buffer (50% formamide, 5x SSC buffer,
5 mM EDTA, 50 µg/ml yeast tRNA) for 3 h at 60°C in humidified chamber for prehybridization.
Sections were then hybridized in 10 µg/ml probe/hybridization buffer overnight (12-16 h) at
60°C. The next day, sections were washed in 1x SSC for 10 min at 60°C, followed by 1.5x SSC
for 10 min at 60°C, 2x SSC for 20 min at 37°C x2, and 0.2x SSC for 30 min at 60°C x2. Sections
were then washed in KTBT (0.1 M Tris, pH 7.5, 0.15 M NaCl, 5 mM KCl, 0.1% Triton X-100)
at room temperature and blocked in KTBT + 20% sheep serum + 2% Blocking Reagent (Sigma121

Aldrich, 11096176001) for 4 h. Blocking Reagent was dissolved in 100 mM Maleic acid, 150
mM NaCl, pH 7.5. Sections were then incubated in sheep anti-Digoxigenin-AP, Fab fragments
(1:1000, Sigma-Aldrich, 11093274910) in KTBT + 20% sheep serum + 2% Blocking Reagent
overnight at 4°C. Sections were then washed x3 in KTBT for 30 min at room temperature, and
then washed x2 in NTMT (0.1 M Tris, pH 9.5, 0.1 M NaCl, 50 mM MgCl2, 0.1% Tween 20) for
15 min. Sections were next incubated in NTMT + 1:200 NBT/BCIP Stock Solution (SigmaAldrich, 11681451001) in the dark at room temperature until color appeared. Sections were then
washed in PBS, post-fixed in 4% PFA in PBS for 15 min and washed x2 in PBS. Finally,
sections were dehydrated in 30% and then 70% methanol, 5 min each, followed by 100%
methanol for 15 min. Sections were then rehydrated in 70% and 30% methanol and then PBS, 5
min each, and mounted in 95% glycerol.

3.5.5 Histology and immunofluorescence
Whole mount: cochleae were incubated in PBS + 0.5% Tween-20 (PBSTw) for 1 h to
permeabilize. Cochleae were then blocked using PBSTw + 5% donkey serum for 1 h and then
incubated in PBSTw + 1% donkey serum with the primary antibody overnight at 4°C. Cochleae
were then washed x3 in PBS and incubated in PBS + 1% Tween-20 with the secondary antibody.
After wash in PBS x3, cochleae were mounted in 95% glycerol with the sensory epithelium
facing up.
Frozen slides were warmed for 30 min at room temperature and washed in PBS before
incubating in PBS + 0.5% Triton X-100 (PBST) for 1 h to permeabilize the tissue. Sections were
then blocked using in PBST + 5% donkey serum for 1 h and then incubated in PBST + 1%
donkey serum with the primary antibody overnight at 4°C in a humidified chamber. Sections
were then washed x3 in PBS and incubated in PBS + 1% Triton X-100 with the secondary
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antibody. After wash in PBS x3, slides were mounted in VectaShield antifade mounting medium
with DAPI (Vector Labs, H-1200).

3.5.6 Antibodies
The following compounds and antibodies were used:
•

Alexa Fluor 488-conjugated Phallodin (1:50, Invitrogen, A12379)

•

Rabbit anti-p75NTR (1:300, Millipore, AB1554)

•

Rabbit anti-Prox1 (1:1000, Millipore, ABN278)

•

Goat anti-Sox2 (1:200; Santa Cruz, sc-17320)

•

Alexa Fluor conjugated secondary antibodies (1:500; Thermo Fisher)

•

Sheep anti-Digoxigenin-AP, Fab fragments (1:1000, Sigma-Aldrich, 11093274910)

3.5.7 Cell proliferation assay
EdU (Thermo Fisher, E10187) was injected i.p. into pregnant dams at 100 µg per gram body
weight. Embryos were harvested at 1 h after injection. EdU was detected using the Click-iT EdU
Alexa Fluor 488 kit (Thermo Fisher, C10337) according to manufacturer’s instructions.

3.5.8 Imaging
Brightfield microscopy was done using a Hamamatsu NanoZoomer slide scanning system with a
20x objective or on a Zeiss AxioPlan 2 with a 10x or 20x objective. Images were processed with
the NanoZoomer Digital Pathology (NDP.view2) software.
Fluorescent microscopy was done using a Zeiss LSM 700 confocal or Zeiss Axio Imager
Z1 with Apotome 2, with z-stack step-size determined based on objective lens type (10x or 20x),
as recommended by the ZEN software (around 1 µm). Fluorescent images shown are maximum
projections. Low magnification fluorescent images shown of the whole cochlear duct required
stitching together, by hand, several images. mGFP and mTomato from the ROSAmTmG allele were
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detected by native fluorescence. All other fluorescences were detected by immunofluorescence.
Images were processed with ImageJ (imagej.nih.gov).

3.5.9 Measurements and cell quantification
Measurements and cell quantification (using the Cell Counter plugin by Kurt De Vos) were done
using ImageJ. Total cochlear duct length was defined as the length from the very base of the
cochlea to the very tip of the apex, along the tunnel of Corti. Hair cells were identified via
Phalloidin, which binds to F-actin (Avinash et al., 1993). Inner pillar cells were labeled via
p75NTR (Mueller et al., 2002), and supporting cells (SCs, including pillar cells and Deiter’s
cells) were labeled with a combination of Prox1 (Bermingham-McDonogh et al., 2006) and Sox2
(Mak et al., 2009). Inner hair cells (IHCs) were differentiated from outer hair cells (OHCs) based
on their neural/abneural location, respectively, relative to p75NTR-expressing inner pillar cells.
In Sox2Ysb/- cochleae, p75NTR expression was mostly absent, resulting in sensory islands
without p75NTR-expressing inner pillar cells. HCs not associated with inner pillar cells were
presumed to be IHCs during quantification. When a curved line was drawn connecting the
p75NTR islands along the organ of Corti, these presumed IHCs were always proximal to that
line. For total cell counts, IHCs, OHCs, and SCs were counted along the entire length of the
cochlea. Total cell counts were also normalized to cochlear length and presented as cell count per
100 µm of cochlea (e.g. IHCs/100 µm). For cell quantification at the basal, middle, and apical
turns of the cochlea, the cochlear duct was evenly divided into thirds, and total IHCs, OHCs, and
SCs were quantified for each third and normalized to length. For the Fgf20-rescue experiments
in Figure 3.3, IHCs, OHCs, and SCs from at least 300 µm regions of the base (10%), middle
(40%), and apex (70%) of the cochleae were counted and normalized to 100 µm along the length
of the cochlear duct.
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3.5.10

Statistics and plotting

All figures were made in Canvas X. Data analysis was performed using the Python programming
language (python.org) in Jupyter Notebook (jupyter.org) with the following libraries: Pandas
(pandas.pydata.org), NumPy (numpy.org) and SciPy (scipy.org). Plotting was done using the
Matplotlib library (matplotlib.org). Statistics (t-test, one-way ANOVA, and two-way ANOVA)
were performed using the SciPy module Stats; Tukey’s HSD was performed using the
Statsmodels package (statsmodels.org). All comparisons of two means were performed using
two-tailed, unpaired Student’s t-test. For comparisons of more than two means, one-way
ANOVA was used, except in Figures 3.9 and 3.10, where two-way ANOVA was used, with the
factors being Fgf20 (levels: Fgf20+/+, Fgf20+/-, Fgf20-/-) and Sox2 (levels: Sox2+/+, Sox2Ysb/+,
Sox2Ysb/Ysb) dosage. For significant ANOVA results at α = 0.05, Tukey’s HSD was performed for
post-hoc pair-wise analysis. In all cases, p < 0.05 was considered statistically significant. All
statistical details can be found in the figures and figure legends. In all cases, each sample
represents one animal. Data are represented as mean ± standard deviation (SD).
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Figure 3.1 The Fgf20-null cochlear phenotype is less severe than the Fgfr1-conditional null
phenotype
(A, B) Whole mount cochlea from P0 Fgf20+/-, Fgf20-/-, Foxg1Cre/+;Fgfr1flox/+, and
Foxg1Cre/+;Fgfr1flox/- mice showing (A) inner and outer hair cells (phalloidin, green)
separated by inner pillar cells (p75NTR, red) and (B) supporting cells (Prox1 and Sox2,
yellow). Zooms show the basal (base), middle (mid), and apical (apex) turns of the
126

cochlea. Scale bar, 100 µm (apex), 1 mm (whole). Arrows, gaps in the sensory epithelium
filled with Sox2-expressing cells.
(C-F) Quantification of cochlear duct length (C), total inner hair cells (IHCs) and IHCs per 100
µm of the cochlear duct (D), total outer hair cells (OHCs) and OHCs per 100 µm (E), and
total supporting cells (SCs) and SCs per 100 µm (F) at P0. Fgf20+/- and Fgf20-/- cochleae
were analyzed by unpaired Student’s t test; Fgfr1flox/+, Fgfr1flox/-, Foxg1Cre/+;Fgfr1flox/+,
and Foxg1Cre/+;Fgfr1flox/- cochleae were analyzed by one-way ANOVA. P values shown
are from the t test and ANOVA. * indicates p < 0.05 from Student’s t test or Tukey’s
HSD (ANOVA post-hoc). Error bars, mean ± SD.
(G)

A model of the existing understanding of the roles of FGF20 and FGFR1 signaling during
cochlear sensory epithelium development.
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Figure 3.2 Related to Figure 3.1
(A-C) Quantification of length-normalized number of (A) inner hair cells (IHCs/100 µm), (B)
outer hair cells (OHCs/100 µm), and (C) supporting cells (SCs/100 µm) in the basal
(base), middle (mid), and apical (apex) turns of P0 cochleae from Fgf20+/-, Fgf20-/Fgfr1flox/+, Fgfr1flox/-, Foxg1Cre/+;Fgfr1flox/+, and Foxg1Cre/+;Fgfr1flox/- mice. Fgf20+/- and
Fgf20-/- cochleae were analyzed by unpaired Student’s t test; Fgfr1flox/+, Fgfr1flox/-,
Foxg1Cre/+;Fgfr1flox/+, and Foxg1Cre/+;Fgfr1flox/- cochleae were analyzed by one-way
ANOVA. P values shown are from the t test and ANOVA. * indicates p < 0.05 from
Student’s t test or Tukey’s HSD (ANOVA post-hoc). Error bars, mean ± SD.
128

129

Figure 3.3 Genetic rescue of the Fgf20-null phenotype suggests that FGF20 is required for hair
cell and supporting cell differentiation
(A, B) Whole mount cochlea from P0 Fgf20+/-;ROSArtTA (Fgf20-het), Fgf20+/-;ROSArtTA;TreFgf9 (Fgf9-OA), Fgf20-/-;ROSArtTA (Fgf20-null), and Fgf20-/-;ROSArtTA;Tre-Fgf9 (Fgf20rescue) mice showing (A) inner and outer hair cells (phalloidin, green) separated by inner
pillar cells (p75NTR, red) and (B) supporting cells (Prox1 and Sox2, yellow). Basal
(base), middle (mid), and apical (apex) turns of the cochlea are shown. Fgf20-rescue
cochleae from four different Doxycycline chow (Dox) regimens are shown (E13.5-E15.5,
E13.5, E14.5, and E15.5). Fgf20-het, Fgf9-OA, and Fgf20-null cochleae shown are from
the E13.5-E15.5 Dox regimen. Scale bar, 100 µm.
(C)

Quantification of outer hair cells (OHC) and supporting cells (SC) from P0 Fgf9-OA
(Dox regimen: E13.5-E15.5), Fgf20-null (Dox regimen: E13.5-E15.5), and Fgf20-rescue
(all four Dox regimens) cochleae, presented as a percentage of the number of OHCs/SCs
of Fgf20-het cochleae from the same Dox regimen. * indicates p < 0.05 compared to
Fgf20-null cochleae from the same Dox regimen; ^ indicates p < 0.05 compared to
Fgf20-het cochleae from the same Dox regimen; Tukey’s HSD (one-way ANOVA posthoc).
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Figure 3.4 FGFR1 has a role in prosensory specification in addition to differentiation
(A)

Schematic of a cross section through the middle turn of the E14.5 cochlear duct. The
floor of the cochlear duct is categorized into three zones: outer sulcus (OS), prosensory
domain (PD), and Kölliker’s organ (KO). Neural indicates the side of the duct towards
the spiral ganglion cells; abneural indicates away.

(B-D) Sections through the middle turn of E14.5 cochlear ducts from Fgf20+/-, Fgf20-/-,
Foxg1Cre/+;Fgfr1flox/+, and Foxg1Cre/+;Fgfr1flox/- mice. DAPI, nuclei (blue). Scale bar, 100
µm.
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(B)

RNA in situ hybridization for Etv4 and Etv5. The two brackets indicate Etv4/5 expression
in the outer sulcus (left) and prosensory domain (right; lost in Fgf20-/- and
Foxg1Cre/+;Fgfr1flox/- cochleae).

(C)

RNA in situ hybridization and immunofluorescence for Sox2 (red).

(D)

EdU-incorporation (green). Dashed region indicates Kölliker’s organ.
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Figure 3.5 Decrease in Sox2 expression results in similar phenotypes to Fgf20/Fgfr1 deletion
(A, B) Whole mount cochlea from P0 Sox2+/+, Sox2Ysb/+, Sox2Ysb/Ysb, and Sox2Ysb/- mice showing
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(A) inner and outer hair cells (phalloidin, green) separated by inner pillar cells (p75NTR,
red) and (B) supporting cells (Prox1 and Sox2, yellow). Zooms show the basal (base),
middle (mid), and apical (apex) turns of the cochlea. Scale bar, 100 µm (apex), 1 mm
(whole); arrowheads, ectopic inner hair cells; arrows, gaps in the sensory epithelium
without Sox2-expressing cells.
(C-F) Quantification of cochlear duct length (C), total inner hair cells (IHCs) and IHCs per 100
µm of the cochlear duct (D), total outer hair cells (OHCs) and OHCs per 100 µm (E), and
total supporting cells (SCs) and SCs per 100 µm (F) at P0. P values shown are from oneway ANOVA. * indicates p < 0.05 from Tukey’s HSD (ANOVA post-hoc). Error bars,
mean ± SD.
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Figure 3.6 Related to Figure 3.5
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(A-C) Quantification of length-normalized number of (A) inner hair cells (IHCs/100 µm), (B)
outer hair cells (OHCs/100 µm), and (C) supporting cells (SCs/100 µm) in the basal
(base), middle (mid), and apical (apex) turns of P0 cochleae from Sox2+/+, Sox2Ysb/+,
Sox2Ysb/Ysb, and Sox2Ysb/- mice. P values shown are from one-way ANOVA. * indicates p
< 0.05 from Tukey’s HSD (ANOVA post-hoc). Error bars, mean ± SD.
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Figure 3.7 Sox2 is upstream of, but epistatic to, Fgf20
(A-E) Sections through the middle turn of E14.5 Sox2Ysb/+ and Sox2Ysb/- cochleae. DAPI, nuclei
(blue). Scale bar, 100 µm.
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(A)

Immunofluorescence for Sox2 (red).

(B)

EdU-incorporation (green) in sections through the middle turn of E14.5 cochleae. Dashed
region indicates Kölliker’s organ.

(C)

RNA in situ hybridization for Etv4 and Etv5. The two brackets indicate Etv4/5 expression
in the outer sulcus (left) and prosensory domain (right).

(D)

RNA in situ hybridization for Fgfr1 and Fgf20. Bracket indicates Fgfr1/Fgf20 expression
in the prosensory domain.

(E)

Fgf20Cre lineage (green) reported by the Cre-reporter ROSAmTmG in sections through the
middle turn of E14.5 Sox2Ysb/+;Fgf20Cre/+;ROSAmTmG and Sox2Ysb/-;Fgf20Cre/+;ROSAmTmG
cochleae. Non-Fgf20Cre-lineage in red.

(F)

RNA in situ hybridization for Fgf20 in sections through the middle turn of E14.5
Foxg1Cre/+;Fgfr1flox/+ and Foxg1Cre/+;Fgfr1flox/- cochleae. Bracket indicates Fgf20
expression in the prosensory domain. Scale bar, 100 µm.

(G)

Whole mount cochlea from P0 Sox2Ysb/-;Fgf20Cre/+;ROSArtTA (Sox2Ysb/- control) and
Sox2Ysb/-;Fgf20Cre/+;ROSArtTA;Tre-Fgf9 (Sox2Ysb/- rescue) mice showing hair cells
(phalloidin, green, arrowheads). Zooms show the basal (base) and apical (apex) turns of
the cochlea. Scale bar, 100 µm (apex), 1 mm (whole).

(H)

An updated model on the roles of FGF20 and FGFR1 signaling during cochlear sensory
epithelium development.
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Figure 3.8 Sox2 and Fgf20 interact epistatically during cochlea development
(A)

Whole mount cochlea from P0 Fgf20+/+;Sox2+/+, Fgf20+/-;Sox2+/+, Fgf20+/+;Sox2Ysb/+,
and Fgf20+/-;Sox2Ysb/+ mice showing inner and outer hair cells (phalloidin, green)
separated by inner pillar cells (p75NTR, red). Zooms show the basal (base), middle
(mid), and apical (apex) turns of the cochlea. Scale bar, 100 µm (apex), 1 mm (whole);
arrowheads, ectopic inner hair cells.

(B-F) Quantification of cochlear duct length (B), total inner hair cells (IHCs) and IHCs per 100
µm of the cochlear duct (C), IHCs/100 µm in the base, mid, and apex (D), total outer hair
cells (OHCs) and OHCs per 100 µm (E), and OHCs/100 µm in the base, mid, and apex
(F) at P0. P values shown are from one-way ANOVA. * indicates p < 0.05 from Tukey’s
HSD (ANOVA post-hoc). Error bars, mean ± SD.
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Figure 3.9 Sox2 and Fgf20 interact epistatically during cochlea development
(A, B) Whole mount cochlea from P0 Fgf20+/-;Sox2Ysb/+, Fgf20+/-;Sox2Ysb/Ysb, Fgf20-/-;Sox2Ysb/+,
Fgf20-/-;Sox2Ysb/Ysb mice showing (A) inner and outer hair cells (phalloidin, green)
separated by inner pillar cells (p75NTR, red) and (B) supporting cells (Prox1 and Sox2,
yellow). Zooms show the basal (base), middle (mid), and apical (apex) turns of the
cochlea. Scale bar, 100 µm (apex), 1 mm (whole); arrowheads, ectopic inner hair cells;
arrows, gaps in the sensory epithelium without Sox2-expressing cells.
(C-F) Quantification of cochlear duct length (C), total inner hair cells (IHCs) and IHCs per 100
µm of the cochlear duct (D), total outer hair cells (OHCs) and OHCs per 100 µm (E), and
total supporting cells (SCs) and SCs per 100 µm (F) at P0 in Fgf20+/+;Sox2+/+,
Fgf20+/+;Sox2Ysb/+, Fgf20+/-;Sox2+/+, Fgf20+/-;Sox2Ysb/+, Fgf20+/+;Sox2Ysb/Ysb, Fgf20+/;Sox2Ysb/Ysb, Fgf20-/-;Sox2+/+, Fgf20-/-;Sox2Ysb/+, and Fgf20-/-;Sox2Ysb/Ysb mice. Error bars,
mean ± SD.
(G)

P-values from two-way ANOVA analyzing the quantification from (C-F). The two
factors analyzed are Fgf20 (Fgf20+/+, Fgf20+/-, Fgf20-/-) and Sox2 (Sox2+/+, Sox2Ysb/+,
Sox2Ysb/Ysb) dosage.

(H)

Results from post-hoc Tukey’s HSD analyzing the two-way ANOVA from (G). Letters
(L, I, J, O, P, S, T; representing each measurement in panels C-F) indicate a statistically
significant decrease (p < 0.05) when comparing the row genotype against the column
genotype. L, cochlear length; I, total IHCs; J, IHCs/100 µm; O, total OHCs; P, OHCs/100
µm; S, total SCs; T, SCs/100 µm.
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Figure 3.10 Related to Figure 3.9
(A-C) Quantification of length-normalized number of (A) inner hair cells (IHCs/100 µm), (B)
outer hair cells (OHCs/100 µm), and (C) supporting cells (SCs/100 µm) in the basal
(base), middle (mid), and apical (apex) turns of P0 cochleae from Fgf20+/+;Sox2+/+,
Fgf20+/+;Sox2Ysb/+, Fgf20+/-;Sox2+/+, Fgf20+/-;Sox2Ysb/+, Fgf20+/+;Sox2Ysb/Ysb, Fgf20+/;Sox2Ysb/Ysb, Fgf20-/-;Sox2+/+, Fgf20-/-;Sox2Ysb/+, and Fgf20-/-;Sox2Ysb/Ysb mice. Error bars,
mean ± SD.
(D)

P-values from two-way ANOVA analyzing the quantification from (A-C). The two
factors analyzed are Fgf20 (Fgf20+/+, Fgf20+/-, Fgf20-/-) and Sox2 (Sox2+/+, Sox2Ysb/+,
Sox2Ysb/Ysb) dosage.

(E)

Results from post-hoc Tukey’s HSD analyzing the two-way ANOVA from (E). Letters
(L, I, J, O, P, S, T; representing each measurement in panels A-C) indicate a statistically
significant decrease (p < 0.05) when comparing the row genotype against the column
genotype. L, cochlear length; I, IHCs/100 µm; O, OHCs/100 µm; S, SCs/100 µm.
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Figure 3.11 Sox2 and Fgf20 double mutants recapture the Fgfr1 conditional null and Sox2Ysb/phenotypes
(A, B) Sections through the E14.5 Fgf20+/-;Sox2Ysb/+, Fgf20-/-;Sox2Ysb/+, Fgf20+/-;Sox2Ysb/Ysb,
Fgf20-/-;Sox2Ysb/Ysb cochleae. DAPI, nuclei (blue). Scale bar, 100 µm. Note: unlike in
Figure 3.9, we have switched the placement of images from Fgf20-/-;Sox2Ysb/+ and
Fgf20+/-;Sox2Ysb/Ysb cochleae to facilitate comparison.
(A)

Immunofluorescence for Sox2 (red) in the basal (base), middle (mid), and apical (apex)
turns of the cochlea.

(B)

EdU-incorporation (green) in sections through the middle turn of E14.5 cochleae. Dashed
region indicates Kölliker’s organ.

(C)

The latest model on the roles of FGF20 and FGFR1 signaling during cochlear sensory
epithelium development.

(D)

The Fgf20-/-, Foxg1Cre/+;Fgfr1flox/-, Fgf20-/-;Sox2Ysb/Ysb, Sox2Ysb/- cochleae can be
characterized as a spectrum of phenotypes preferentially affecting outer and basal
cochlear sensory epithelium, likely attributable to varying Sox2 levels on an Fgf20-null
background.
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Chapter 4
Analysis of transcriptomic changes in cochlear
prosensory progenitors in the absence of
FGF20 signaling
4.1 Introduction
Congenital and acquired sensorineural hearing loss are common problems, yet there are no
biologically-based therapies to treat these disorders. Sensorineural hearing loss is commonly
caused by damage to the organ of Corti, a part of the cochlea that houses hair cells (HCs), which
transduce sound into electrical signals, and supporting cells (SCs). Such damage leading to HC
loss is permanent in humans, as the mammalian organ of Corti is unable to regenerate HCs. One
potential approach to treating hearing loss due to loss of HCs is to reactivate developmental
pathways to promote differentiation of HCs from latent progenitors. Therefore, investigation of
developmental pathways regulating HC differentiation will benefit our understanding and
treatment of both congenital and acquired hearing loss.
In mouse cochlea development, FGF20-FGFR1 signaling in prosensory progenitors is
required for their differentiation into hair cells (HCs), specifically outer hair cells (OHCs), and
supporting cells (SCs; Hayashi et al., 2008; Huh et al., 2012; Ono et al., 2014; Pirvola et al.,
2002). Fgf20-null mice are deaf, with gaps of undifferentiated cells along the organ of Corti
separating islands of HCs and SCs and interrupting the normal patterning of the sensory
epithelium (Huh et al., 2012b). We showed in Chapter 3 that FGF20 is required during the
initiation of HC and SC differentiation. However, we do not know what target genes are being
146

regulated by FGF20 signaling during this process. Identifying such targets will be helpful for
identifying key players in HC and SC differentiation, which will be important for advancing
therapeutics in regenerating lost or damaged hair cells.
We used Next Generation RNA Sequencing (RNAseq) to study changes in gene
expression patterns in prosensory progenitors in the absence of FGF20 signaling. In our initial
attempt with RNAseq to study Fgf20-null prosensory cells, we dissected cochleae from E14.5
Fgf20+/- and Fgf20-/- embryos. However, we were unable to detect significant changes in gene
expression (data not shown). We attribute this failure to the lack of enrichment for our target cell
population, as the prosensory cells make up a small percentage of the total cochlear duct, and to
the long time it took to dissect the cochlear duct, which may have led to RNA degradation.
To solve both of these problems, we adapted the Translating Ribosome Affinity
Purification (TRAP) technology (Heiman et al., 2008). TRAP allows the isolation of translating
mRNA from specific cell populations without cell sorting or fine dissection. Our approach to
TRAP is via the ROSAfsTRAP allele (Zhou et al., 2013), which when activated by Cre recombinase,
leads to the expression of a GFP-tagged ribosomal protein (L10a-eGFP). Immunoprecipitation
(IP) for GFP then isolates polysomes and associated translating mRNA. We hypothesize that
combining TRAP with RNAseq (TRAPseq) is an efficient way to examine mRNA expression
patterns in our target cell population.

4.2 Results
4.2.1 Fgf20Cre targets TRAP L10a-eGFP expression to the prosensory domain
To evaluate the TRAP technique for our use, we combined the ROSAfsTRAP and Fgf20Cre alleles.
The Fgf20Cre allele was made by targeted insertion of a sequence coding a GFP-Cre fusion
protein replacing exon 1 of Fgf20 (Huh et al., 2015b). Fgf20 is expressed in prosensory cells at
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E14.5 (Huh et al., 2012b), and Fgf20Cre lineage includes the prosensory domain and the
Kölliker’s organ (Huh et al., 2015b). As expected, at E14.5, Fgf20Cre activated ROSAfsTRAP in the
prosensory domain, Kölliker’s organ, and some Sox2-negative spiral ganglion cells, based on
detection of L10a-eGFP fluorescence (Figure 4.1A, refer to Figure 4.1E). At P0, Fgf20Cre lineage
includes HCs, SCs, and the greater epithelial ridge, which develops from the Kölliker’s organ
(Huh et al., 2015b).
Another Fgf20 null allege, Fgf20βgal, was made by targeted insertion of a sequence
coding β-Galactosidase replacing exon 1 of Fgf20 (Huh et al., 2012b). The combination of the
Fgf20Cre and Fgf20βgal alleles to generate Fgf20-KO mice maintained the same dosage of Cre as
control mice (Fgf20Cre/+). Importantly, based on double fluorescence from the ROSAmTmG Crereporter allele, the Fgf20Cre lineage did not change in Fgf20Cre/βgal (Fgf20-KO) mice (Figure
4.1B). Based on these results, we hypothesized that the Fgf20Cre/+;ROSAfsTRAP/+ and
Fgf20Cre/βgal;ROSAfsTRAP/+ mice allowed us to enrich for prosensory progenitor mRNA to examine
changes in mRNA expression in these cells in the absence of FGF20 signaling.

4.2.2 Fgf20Cre TRAPseq enriched for prosensory domain mRNA
Based on results presented in Chapter 3, Figure 3.2, we chose E14.5 for the TRAPseq
experiment. In the initial experiment, we collected preTRAP (pre-immunoprecipitation) and
TRAP (post-immunoprecipitation) RNA from Fgf20Cre/+;ROSAfsTRAP/+ cochleae at E14.5 (Figure
4.1C; see section 4.5). Quantitative reverse transcription PCR (qRT-PCR) showed enrichment
for the prosensory cell marker Id2 (Jones et al., 2006) by TRAP, and depletion for the
mesenchyme marker Dermo1 (Huh et al., 2015b), also called Twist2 (Figure 4.1D).
Next, we performed TRAPseq on Fgf20-KO (Fgf20Cre/βgal; ROSAfsTRAP/+) and control
(Fgf20Cre/+; ROSAfsTRAP/+) E14.5 cochleae. Control and Fgf20-null embryos were generated at a
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1:1 ratio. For each litter, cochleae from all control embryos were pooled together for RNA
collection, and likewise for Fgf20-null embryos. Each sample represents RNA from pooled
tissue from a minimum of three embryos. In total 24 libraries were sequenced: 16 TRAP samples
(8 control and 8 Fgf20-null) and 8 pre-TRAP samples (4 control and 4 Fgf20-null). Sequenced
reads were mapped to the mouse genome and counted (see section 4.5).
Principal component analysis (PCA) of the 24 samples showed separation between
preTRAP and TRAP RNA samples along PC1 (Figure 4.2A). However, there was no separation
between control and Fgf20-null samples along PC1 or PC2. PC analysis of only the 16 TRAP
samples also did not show separation between control and Fgf20-null samples along the first two
PCs (Figure 4.2A). To assess the efficiency of the TRAP technique, differentially expressed gene
(DEG) analysis using DESeq2 (Love et al., 2014) was performed comparing preTRAP control
samples with TRAP control samples. 3850 DEGs were identified with adjusted p-value (padj) <
0.01 and Log2 Fold Change (LFC) < -1 or > 1 (Figure 4.2B). Of these, 2017 genes were
decreased in TRAP samples, compared to preTRAP (depleted by TRAP) and 1833 genes were
increased in TRAP samples, compared to preTRAP (enriched by TRAP). Among the genes
depleted by TRAP were mesenchymal markers Cd44 and Dermo1 (Huh et al., 2015b; Zhu et al.,
2006), vasculature markers Eln and Fbln1 (Cooley et al., 2008; Karnik et al., 2003), and
chondrocyte markers Runx2 and Matn1 (Fujita et al., 2004; Pei et al., 2008). This was expected,
since otic mesenchyme and capsule were included in the input tissue but did not express L10aeGFP. Bmp4, Lmx1a, and Gata2, markers for the outer sulcus (reference Figure 4.1D; Lilleväli et
al., 2004; Ohyama et al., 2010), which was also not captured by TRAP, were depleted as well.
Among the genes enriched by TRAP were prosensory domain markers Fgf20, Atoh1, Hey2,
Sox2, Gata3, and Id2 (Basch et al., 2011; Huh et al., 2012b; Jones et al., 2006; Kiernan et al.,
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2005; Luo et al., 2013; Woods et al., 2004), Kölliker’s organ markers Lfng, Fgf10, and Jag1
(Ohyama et al., 2010), and spiral ganglion markers Neurod1 and Tubb3 (Locher et al., 2014;
Puligilla et al., 2010), as expected. Gene set overlap analysis with gene ontology (GO) on genes
depleted by TRAP showed biological processes terms “angiogenesis” and “endochondral
ossification” among the most enriched (Table 4.1). GO analysis on genes enriched by TRAP
showed biological processes terms “sensory perception of sound”, “axon guidance”, and
“auditory receptor cell stereocilium organization” among the most enriched (Table 4.2). These
results strongly suggest that TRAP enriched for our target tissue mRNA.

4.2.3 TRAPseq revealed known and novel FGF target genes during cochlear
sensory epithelium differentiation
DEG analysis on control versus Fgf20-KO preTRAP samples resulted in, as expected, very few
DEGs. In fact, only three genes were found to be significantly changed (padj < 0.1): Tectb,
Calb1, and Fgf20. DEG analysis on control versus Fgf20-KO TRAP samples resulted in 54
DEGs with padj < 0.01 and 129 DEGs with padj < 0.1 (Figure 4.3A). The latter group of DEGs
includes Fgf20 as well as known downstream targets of FGF20-FGFR1 signaling in the
developing cochlea: Hey1, Hey2, Etv4, and Etv5 (Benito-Gonzalez and Doetzlhofer, 2014;
Hayashi et al., 2008; Ono et al., 2014), all of which had decreased expression in FGF20-KO
samples. Two other genes reported to be FGFR1 targets in the ear are Sox2 and Cdkn1b (Ono et
al., 2014), neither of which were significantly downregulated in Fgf20-KO samples, but were
among the top 500 DEGs ranked by padj. Interestingly, Lockd, a non-coding RNA near the
Cdkn1b locus and is co-expressed with Cdkn1b (Paralkar et al., 2016), is downregulated in
Fgf20-null and rank among the top 60 DEGs by padj. These and other DEGs that have been
associated with FGF signaling are listed in Table 4.3. Novel and potentially interesting targets of
FGF20 in the developing cochlea are listed in Table 4.4. GO analysis with the top 385 DEGs
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(cut-off of padj < 0.5) found enrichment of many neuronal and cell cycle biological processes
terms (Table 4.5), such as “regulation of neuron differentiation,” “forebrain neuron
differentiation,” “cell division,” and “cell cycle arrest” (rank 39). Notably, “sensory perception
of sound” was ranked 3rd and “sensory organ morphogenesis” and “ear development” ranked
among the top 30 most enriched terms.
To confirm the TRAPseq results, we used RNA in situ hybridization to examine the
expression patterns of DEGs in control (Fgf20Cre/+) and Fgf20-KO (Fgf20Cre/βgal) E14.5 cochleae.
We began with DEGs that have been well-linked to FGF signaling (see Table 4.3). As shown in
Chapter 3, Figure 3.4, in Fgf20-KO cochleae at E14.5, Etv4 and Etv5 expression in the
prosensory domain were lost, while Sox2 expression was not, consistent with the TRAPseq data
(Table 4.3). We also examined Dusp6, Etv1, Spry1, and Spry4, all of which have been associated
with FGF signaling in other contexts (Minowada et al., 1999; Willardsen et al., 2014; Yang et al.,
2018). While Dusp6 and Etv1 appeared downregulated in Fgf20-KO cochleae, consistent with
TRAPseq results, Spry1 and Spry4 expression were not detectable even in control cochleae via in
situ hybridization (Figure 4.4A). Two targets previously shown to be FGF20-regulated in the
cochleae (Benito-Gonzalez and Doetzlhofer, 2014), Hey1 and Hey2, both appeared
downregulated in Fgf20-KO cochleae, although Hey1 was only slightly downregulated. Overall,
validation of these known FGF targets showed that the TRAPseq experiment is sensitive to gene
expression changes in the absence of FGF20 signaling.
Next, we tried to validate some of the highest ranked DEGs by padj from TRAPseq.
These include Tectb (decreased in Fgf20-KO), Epyc (increased in Fgf20-KO), and Smpx
(increased in Fgf20-KO; Table 4.4). In control cochleae at E14.5, Tectb was expressed in the
prosensory domain and in the Kölliker’s organ; in Fgf20-KO cochleae, expression was lost from
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the prosensory domain but not the Kölliker’s organ (Figure 4.4B). In control cochleae, Epyc was
faintly expressed in the Kölliker’s organ; in Fgf20-KO cochleae, expression was dramatically
upregulated in the Kölliker’s organ, but not the prosensory domain. In control cochleae, Smpx
was faintly expressed in the prosensory domain; in Fgf20-KO cochleae, expression was slightly
upregulated. While these DEGs were validated, we do not currently know if any of them might
directly contribute to the Fgf20-KO phenotype.
To identify functionally significant FGF20 target genes, we focused our search on
transcription factors that have been associated with inner ear development. We identified three
DEGs that were downregulated in Fgf20-KO cochleae: Emx2, Sall1, and Sall3 (Table 4.4). Emx2
has been shown to be important in patterning the cochlear sensory epithelium; the loss of Emx2
leads to the loss of OHCs (Holley et al., 2010). However, Emx2 expression appeared restricted to
the outer sulcus and was not downregulated in Fgf20-KO cochleae by in situ hybridization at
E14.5. Sall1 and Sall3 are part of the same family of transcription factors with various roles in
development. SALL1, interestingly, has been linked to Townes-Brocks syndrome in humans,
which causes sensorineural hearing loss, among other developmental defects (Kohlhase et al.,
1998). Sall1 mutant mice expressing a truncated SALL1 protein have a phenotype similar to
Townes-Brocks syndrome, including hearing loss (Kiefer et al., 2003). However, the cochlear
phenotype of these Sall1 mutant or Sall1 null mice has not been reported. Interestingly, by in situ
hybridization, both Sall1 and Sall3 were expressed in the prosensory domain at E14.5, and both
were slightly downregulated in Fgf20-KO cochleae (Figure 4.4B).
We also noted three differentially-expressed transcription factors that were upregulated in
Fgf20-KO samples in the TRAPseq results: Gata2, Meis2, and Lmx1a (Table 4.4), all of which
have been studied within the context of inner ear development (Haugas et al., 2010; Koo et al.,
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2009; Lilleväli et al., 2004; Mann et al., 2017; Nichols et al., 2008; Sánchez-Guardado et al.,
2011; Steffes et al., 2012). Interestingly, these genes were also depleted by TRAP (Table 4.4),
suggesting that they are normally not prosensory-domain specific genes. In situ hybridization
results showed that these genes are all expressed in the outer sulcus, cochlear duct roof, or both,
but not the prosensory domain (Figure 4.4C). However, their expression did not appear to be
significantly changed in Fgf20-KO cochleae. A fourth gene that was depleted by TRAP and
upregulated in Fgf20-KO samples, albeit not significantly, is Bmp4. Bmp4 is interesting because,
as mentioned in Chapter 3, section 3.4, this signaling molecule is important in patterning the
outer sulcus, prosensory domain, and Kölliker’s organ (Ohyama et al., 2010). However, its
expression did not appear to be changed in Fgf20-KO by in situ hybridization (Figure 4.4C).
GO analysis on TRAPseq DEGs showed that the cell cycle may be affected by the loss of
FGF20 (Table 4.5). At E14.5, the cochlear prosensory domain have already exited the cell cycle
and turned on Cdkn1b (also p27kip1), a cyclin-dependent kinase inhibitor (Chen and Segil, 1999;
Lee et al., 2006). Interestingly, as mentioned above, Cdkn1b and a co-expressed noncoding
RNA, Lockd, were both found to be downregulated in Fgf20-KO samples by TRAPseq (Table
4.3), although Cdkn1b was not significantly downregulated. By immunofluorescence, Cdkn1b
expression did appear to be slightly decreased in Fgf20-KO cochleae, albeit not readily
noticeably (Figure 4.4D). To check if this potential decrease in Cdkn1b led to a defect in
prosensory progenitor cell cycle exit, we examined Ki67 expression by immunofluorescence.
Consistent with normal progression of cell cycle exit, the prosensory domain of both control and
Fgf20-KO cochleae did not express Ki67 at E14.5.
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4.3 Future Directions
Studies to test the functional importance of DEGs identified by TRAPseq are currently ongoing.
One of our main focuses is on Sall1 (and Sall3), which as mentioned above, has been linked to
sensorineural hearing loss but no cochlear phenotype has been reported. We have acquired the
Sall1-null mouse (Takasato et al., 2004) and the Sall1-truncated mutant mouse (Kiefer et al.,
2003). We will examine the cochlear development phenotype of heterozygous and homozygous
mice carrying these alleles. To test for genetic interactions between Fgf20 and Sall1, we will also
generate mice with null alleles of both genes to evaluate for an epistatic interaction. We
anticipate that the loss of Sall1 may be compensated for by Sall3 and Sall2 (which is also
expressed in the prosensory domain at E14.5, but was not downregulated in Fgf20-KO cochleae;
data not shown). Cochlear explant studies with morpholino or RNAi to knockdown all three
genes or using CRISPR-Cas9 to generate mice with null mutations in all three genes are potential
approaches to examine redundancy.
Other genes of interest are Hey1 and Hey2, two members of the Hes-related family of
Notch target genes (Fischer et al., 2004). As mentioned above, Hey1 and Hey2 have been
implicated as FGF20 effectors during cochlear sensory epithelium development involved in
prevention of premature HC and SC differentiation (Benito-Gonzalez and Doetzlhofer, 2014).
The cochlear phenotype of mice lacking both Hey1 and Hey2, in which there are some ectopic
HCs, is not nearly as severe as that of Fgf20-KO mice. This suggests that another gene may be
compensating for the loss of Hey1 and Hey2. Interestingly, we identified via TRAPseq that a
third member of the Hes-related gene family, Heyl, is significantly upregulated in Fgf20-KO
cochleae at E14.5. We hypothesize that this increase in Heyl may be responsible for inhibiting
HC and SC differentiation. One potential quick way to test this hypothesis is to overexpress Heyl
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in cochlear explants or examine Heyl null mice, which has been generated by the Knockout
Mouse Project (KOMP).
Tectb and Smpx are also potentially interesting to follow up on. TECTB is a major
glycoprotein in the tectorial membrane, an extracellular membrane required for sound
mechanotransduction (Rau et al., 1999). However, Tectb-null mice only have low-frequency
hearing loss, due to disruptions to the tectorial membrane structure, without loss of hair cells
(Russell et al., 2007). Smpx (also called Chisel) is a muscle protein associated with cytoskeleton
(Schindeler et al., 2005). Interestingly, this gene has been associated with X-linked hearing loss
in humans (Abdelfatah et al., 2013; Huebner et al., 2011). However, Smpx-null mice have not
been shown to have a hearing defect or much of an overt phenotype (Palmer et al., 2001). We
hypothesize that Tectb and Smpx are not functionally important downstream of FGF20, but rather
are rather markers of disrupted differentiation.
In conclusion, we have adapted the TRAP technique to study a relatively small
population of difficult-to-isolate cells: cochlear prosensory progenitors. By comparing TRAP to
pre-immunoprecipitation RNA samples, we showed that TRAP enriched for the target cell
population. TRAPseq comparing control and Fgf20-KO E14.5 cochlea samples showed
downregulation of known FGF signaling targets, which were validated by RNA in situ
hybridization. Overall, we conclude that TRAPseq is a useful technique for capturing and
characterizing transcriptomic changes in the developing cochlea.

4.4 Methods
Methods are as described in Chapter 3, section 3.5. Additional methods are below.
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4.4.1 Mice
ROSAfsTRAP: knockin allele containing a loxP-Stop-loxP sequence followed by a sequence
encoding L10a-eGFP, targeted to the ubiquitously expressed ROSA26 locus. Upon Cre-mediated
recombination, the polysomal protein L10a-eGFP is expressed (Zhou et al., 2013).

4.4.2 Translating ribosome affinity purification (TRAP)
Affinity matrix preparation: for each immunoprecipitation (IP): 30 µl of Streptavidin MyOne T1
Dynabeads (Invitrogen, 65602) were washed in 1x PBS using an end-over-end tube rotator and a
magnet, and resuspended in 88 µl of 1x PBS and conjugated to 12 µl of 1 µg/µl biotinylated
protein L (Pierce 29997) in PBS for 35 min at room temperature (RT) with gentle end-over-end
mixing on a tube rotator. Conjugated beads were then washed with 1x PBS + 3% IgG and
protease-free BSA (Jackson ImmunoResearch, 001-000-162) x5, followed by three washes in
low-salt buffer (20 mM HEPES KOH, pH 7.4, 10 mM MgCl2, 150 mM KCl, 1% NP-40 [Sigma
I8896-50ML], 0.5 mM DTT [Sigma, 646563], 100 µg/ml cycloheximide [Sigma C4859-1ML]).
Conjugated beads were then resuspended in low-salt buffer and mixed with 50 µg each of antiGFP antibodies Htz-GFP-19C8 and Htz-GFP-19F7 (Memorial Sloan-Kettering Monoclonal
Antibody Facility) overnight at 4°C with gentle end-over-end mixing to make the affinity matrix.
Immediately before IP, the affinity matrix was washed in low-salt buffer x3.
Sample collection: E14.5 embryos were harvested, on ice, from a mating producing 1:1
ratio of Fgf20Cre/+;ROSAfsTRAP/+ and Fgf20Cre/βgal;ROSAfsTRAP/+ progeny. Embryos were genotyped
by LacZ staining to look for Fgf20βgal expression in back skin hair follicles (back skin from
embryos were incubated in 2 mM MgCl2, 5 mM K3, 5 mM K4, 0.02% NP-40, and 1 mg/ml Xgal in N,N-dimethylformamide in 1x PBS for 30 min at 37°C, protected from light). Ventral
otocysts from the embryos were dissected out in dissection buffer (1x HBSS, 2.5 mM HEPESKOH, pH 7.4, 35 mM glucose, 4 mM NaHCO3, 100 µg/ml cycloheximide), separated from the
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dorsal otocyst (vesitule) without removal of the otic capsule, and pooled together by genotype.
Pooled ventral otocysts were homogenized in lysis buffer (20 mM HEPES KOH, pH 7.4, 150
mM KCl, 10 mM MgCl2, EDTA-free protease inhibitors [Roche, 04693159001], 0.5 mM DTT,
100 µg/ml cycloheximide, 10 µl/ml rRNasin [Promega N2515], 10 µl/ml Superasin [Applied
Biosystems, AM2696]) using a pre-chilled Kontes homogenizer (Kontes, 885512-0020). To
remove the nuclear fraction, homogenized samples were centrifuged for 10 min at 2000 g, 4°C.
The supernatant (S2) was mixed with 1/8 volume of 10% NP-40 and 300 mM DHPC
(reconstituted in lysis buffer; Avanti Polar Lipids 850306P) and incubated for 10 min on ice. To
remove the mitochondrial fraction, samples were then centrifuged for 15 min at 20,000 g, 4°C.
60 µl of the supernatant (S20) was saved as the pre-IP (preTRAP) control. The preTRAP S20
samples were incubated at 4°C until the RNA purification step, which was done in conjunction
with TRAP samples. The rest of the S20 was used for IP.
Immunoprecipitation: S20 was mixed with the affinity matrix for 24 hours at 4°C with
end-over-end mixing. The mixture (TRAP sample) was washed in high-salt buffer (20 mM
HEPES KOH, pH 7.4, 10 mM MgCl2, 350 mM KCl, 1% NP-40, 0.5 mM DTT, 100 µg/ml
cycloheximide, 1 µl/ml rRNasin, 1 µl/ml Superasin) for 2 min at RT, x4.
RNA purification: the Arcturus Picopure RNA Isolation Kit (Thermo Fisher, 12204-01)
was used to isolate RNA from preTRAP and TRAP samples according to manufacturer’s
instructions. RNA was eluted in 13 µl of elution buffer. Ventral otocysts from 3-7 embryos
ranged between 4-20 ng of TRAP RNA. RNA samples were stored at -80°C until use.

4.4.3 qRT-PCR
cDNA was synthesized from preTRAP and TRAP RNA using the iScript Select cDNA Synthesis
Kit (Bio-Rad, #170-8841). mRNA expression was measured using TaqMan Fast Advanced
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Master Mix (Life Technologies, 4444557) and TaqMan assay probes for Twist2 (Dermo1) and
Id2. Gapdh was used as normalization control. Results were analyzed by the ΔΔCT method
(normalized to Gapdh, then normalized to preTRAP). Each sample represents TRAP RNA from
one litter.

4.4.4 cDNA library preparation and sequencing
cDNA library preparation and sequencing were done at the Genome Technology Access Center
at Washington University (gtac.wustl.edu). RNA samples were analyzed on an Agilent 2100
Bioanalyzer; all RNA samples had an RNA Integrity Number (RIN) of > 9. cDNA was amplified
using Clontech’s SMARTer kit. The TRAPseq results presented are from two sequencing
experiments. In our first experiment, 8 TRAP samples (4 control and 4 Fgf20-null) and 4 preTRAP samples (2 control and 2 Fgf20-null) were sequenced on one Illumina HiSeq 3000 lane,
with single reads, 1 x 50 bps. In our second experiment, 12 additional samples were sequenced,
similarly to the first experiment. cDNA library preparation for the two experiments was done
independently.

4.4.5 Bioinformatic analysis
Alignment: Reads were mapped to GRCm38.p5 (Ensemble, GCA_000001635.7) using STAR
(Dobin et al., 2013), with the GRCm38.91 annotation file (Ensembl). Default parameters were
used, except for the following: multi-sample 2-pass, with default settings on first pass and
sjdbFileChrStartEnd (for novel splice junctions), ScoreMinOverLread=0.4,
MatchNminOverLread=0.4, MismatchNmax=5 on second pass (these parameters gave the most
consistent unmapped reads % across all 24 TRAPseq samples).
Counting and DEG analysis: BAM files were indexed and sorted using Rsamtools
(Morgan et al., 2018). Reads were counted using the SummarizedOverlaps method (mode =
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Union) from the R package GenomicAlignments (Lawrence et al., 2013). Genes were filtered out
from downstream analysis if less than 8 of 24 samples had 25 or more reads. PC analysis showed
separation between the 8 preTRAP samples and 16 TRAP samples along PC1, and also
separation between sequencing experiment 1 and experiment 2 along PC2. Removal of
Unwanted Variation (RUVs; Risso et al., 2014) was used to correct for this batch effect (k = 1).
DESeq2 (Love et al., 2014) with RUVs correction factors was used for DEG analysis, with alpha
= 0.1, BH multiple-comparisons correction.
Pathway analysis: gene ontology (GO) analysis was done using the R package topGO
(Alexa and Rahnenfuhrer, 2016) with the following parameters: nodeSize = 10; ontology =
biological processes (BP); algorithm = elim; statistic = fisher’s exact test.

4.4.6 RNA in situ hybridization
Probe preparation: mouse cDNA plasmids containing the following inserts were used to make
RNA in situ probes, and were cut and transcribed with the indicated restriction enzyme (New
England Biolabs) and RNA polymerase (New England Biolabs): Dusp6 (412 bp, Acc65I, T7, gift
of Suzanne Mansour), Etv1 (2500 bp, SpeI, T7, gift of Sung-Ho Huh), Spry1 (1500 bp, EcoRI,
T7, gift of George Minowada), Spry4 (900 bp, EcoRI, T7, gift of George Minowada), Hey1 (343
bp, EcoRI, T3, gift of Stacey Rentschler), Hey2 (819 bp, EcoRI, T7, gift of Stacey Rentschler),
Tectb (2746 bp, EcoRI, T7, gift of Doris Wu), Epyc (1522 bp, EcoRI, T7, Image clone 4037028),
Emx2 (~2500 bp, EcoRI, Sp6, gift of Doris Wu), Sall1 (450 bp, HindIII, T7, gift of Michael
Rauchman), Sall3 (551 bp, XbaI, T3, gift of Michael Rauchman), Gata2 (700 bp, BamHI, T3,
gift of Doris Wu), Meis2 (~5000 bp, EcoRI, T3, gift of Yingzi Yang), Lmx1a (600 bp, SphI, Sp6,
gift of Doris Wu), Bmp4 (1560 bp, AccI, T7). The Smpx probe was made from a PCR product
(gift of Jinwoong Bok) and transcribed with T7.
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4.4.7 Immunofluorescence
The following antibodies were used:
•

Rabbit anti-p27kip1 (Cdkn1b, 1:50, Neomarkers, RB-9019-P)

•

Rabbit anti-Ki67 (1:200, Abcam, ab15580)
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Figure 4.1 Fgf20Cre targets TRAP L10a-eGFP expression to the prosensory domain
(A)

Section through the middle turn of E14.5 cochlear ducts from Fgf20Cre/+;ROSAfsTRAP/+
embryos showing L10a-eGFP (TRAP; green) and Sox2 expression in the prosensory
domain (bracket), Kölliker’s organ, and spiral ganglion (SG).

(B)

Section through the middle turn of E14.5 cochlear ducts from Fgf20Cre/+;ROSAmTmG/+ and
Fgf20Cre/βgal;ROSAmTmG/+ embryos. Fgf20Cre-lineage expresses mGFP (mG, green); nonlineage expresses mTomato (mT, red).

(C)

qRT-PCR showing fold change in Dermo1 and Id2 expression (normalized to Gadph) in
TRAP RNA samples compared to preTRAP samples on Fgf20Cre/+;ROSAmTmG/+ E14.5
cochleae pooled from at least three embryos. Each dot represents a pooled sample.

(D)

Schematic of a cross section through the middle turn of the E14.5 cochlear duct. The
floor of the cochlear duct is categorized into three zones: outer sulcus (OS), prosensory
domain (PD), and Kölliker’s organ (KO).

(E)

Schematic showing an overview of the TRAPseq protocol (see section 4.5 Methods).
Briefly, ventral otocysts containing the cochlea were pooled from at least three E14.5
embryos per litter, according to genotype. Otocysts were homogenized and centrifuged to
make polysomes before immunoprecipitation to anti-GFP antibodies to collect TRAP
RNA for downstream applications.

DAPI, nuclei (blue); scale bar, 100 µm.
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Figure 4.2 Fgf20Cre TRAPseq enriched for prosensory domain mRNA
(A)

Principal Component Analysis (PCA) on 24 TRAPseq samples (8 preTRAP samples – 4
control, 4 Fgf20-KO; 16 TRAP samples – 8 control, 8 Fgf20-KO) showing separation of
preTRAP and TRAP samples, but not control and Fgf20-KO samples.

(B)

Volcano plot showing TRAP versus preTRAP differentially expressed genes. Positive
Log2 Fold Change suggests enrichment by TRAP; negative suggests depletion by TRAP.
padj, adjusted p-value (Benjamini-Hochberg method).
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Figure 4.3 Volcano plot showing Fgf20-KO versus control differentially expressed genes
identified by TRAPseq
padj, adjusted p-value (Benjamini-Hochberg method)

164

Figure 4.4 TRAPseq revealed known and novel FGF target genes during cochlear sensory
epithelium differentiation
(A-C) RNA in situ hybridization to validate TRAPseq results on section through the middle turn
of E14.5 cochlear ducts from Fgf20Cre/+ and Fgf20Cre/βgal embryos. Bracket, prosensory
domain.
(D-E) Section through the middle turn of E14.5 cochlear ducts. Immunofluorescence for
Cdkn1b (p27Kip1; D, green) and Ki67 (E, red). DAPI, nuclei (blue); Dashed outline,
prosensory domain.
Scale bar, 100 µm.
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Table 4.1 Top 12 enriched gene ontology (GO) terms from a list of 2017 differentially expressed
genes depleted by TRAP, compared to preTRAP samples.
Rank
1
2
3
4
5
6
7
8
9
10
11
12

GO ID
GO:0006954
GO:0001525
GO:0030198
GO:0045766
GO:0070374
GO:0001974
GO:0007155
GO:0030593
GO:0002548
GO:0007186
GO:0090090
GO:0001958

GO biological processes term
inflammatory response
angiogenesis
extracellular matrix organization
positive regulation of angiogenesis
positive regulation of ERK1 and ERK2 cascade…
blood vessel remodeling
cell adhesion
neutrophil chemotaxis
monocyte chemotaxis
G-protein coupled receptor signaling pathway
negative regulation of canonical Wnt signaling…
endochondral ossification
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p-value
3.30E-15
1.60E-12
2.20E-11
2.20E-10
2.70E-10
3.20E-10
8.80E-10
2.00E-09
8.70E-09
5.10E-08
2.20E-07
2.80E-07

Table 4.2 Top 12 enriched gene ontology (GO) terms from a list of 1833 differentially expressed
genes enriched by TRAP, compared to preTRAP samples.
Rank
1
2
3
4
5
6
7
8
9
10
11
12

GO ID
GO:0007605
GO:0007411
GO:0048791
GO:0048172
GO:0042391
GO:0007626
GO:0050885
GO:0019228
GO:0014059
GO:0017158
GO:0060088
GO:0045665

GO biological processes term
sensory perception of sound
axon guidance
calcium ion-regulated exocytosis of neurotransmitter
regulation of short-term neuronal synaptic plasticity
regulation of membrane potential
locomotory behavior
neuromuscular process controlling balance
neuronal action potential
regulation of dopamine secretion
regulation of calcium ion-dependent exocytosis
auditory receptor cell stereocilium organization
negative regulation of neuron differentiation
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p-value
6.30E-09
3.30E-08
7.00E-08
1.20E-06
2.00E-06
3.00E-06
3.60E-06
7.20E-06
9.90E-06
1.10E-05
1.70E-05
2.30E-05

Table 4.3 Control versus Fgf20-KO TRAP differentially expressed genes associated with FGF
signaling.
Rank
5
9
21
23
36
49
50
74
87
106
225
331

Gene
Hey2
Dusp6
Etv1
Etv5
Etv4
Lockd
Hey1
Fgf20
Spry4
Spry1
Sox2
Cdkn1b

Log2FC*
-1.12
-0.79
-0.72
-0.55
-0.60
-0.65
-0.55
-0.93
-0.45
-0.45
-0.45
-0.43

Enrichment**
1.54
0.44
-0.89
-0.02
1.11
-0.03
1.67
2.26
-0.73
1.06
2.50
0.39

p-adj
7.3E-11
2.4E-07
3.8E-05
1.2E-04
3.0E-03
1.0E-02
1.0E-02
3.3E-02
5.7E-02
1.0E-01
3.7E-01
4.7E-01

* Log2 Fold Change
** The Log2 Fold Change value for the gene in TRAP versus preTRAP comparison. Positive
value indicates enrichment by TRAP; negative value indicates depletion by TRAP.
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Table 4.4 Novel or interesting control versus Fgf20-KO TRAP differentially expressed genes.
Rank
1
71
89
182
3
46
4
28
47
61
96
236

Gene
Tectb
Sall1
Sall3
Emx2
Smpx
Nr2e1
Epyc
Heyl
Gata2
Meis2
Lmx1a
Bmp4

Log2FC*
-1.91
-0.49
-0.59
-0.61
1.09
1.04
1.21
0.65
0.55
0.48
0.55
0.41

Enrichment**
2.93
0.54
1.38
0.47
3.14
3.07
-0.92
-1.00
-1.58
-1.22
-0.90
-1.72

p-adj
1.1E-37
3.2E-02
6.1E-02
2.7E-01
3.6E-11
9.6E-03
6.0E-11
1.1E-03
9.6E-03
2.1E-02
7.6E-02
3.8E-01

* Log2 Fold Change
** The Log2 Fold Change value for the gene in TRAP versus preTRAP comparison. Positive
value indicates enrichment by TRAP; negative value indicates depletion by TRAP.
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Table 4.5 Top enriched gene ontology (GO) terms from a list of 385 differentially expressed
genes in Fgf20-KO compared to control.

Rank
1
2
3
5
6
7
9
12
13
14
21
28
30
33
35
38
39

GO ID
GO:0003184
GO:0045664
GO:0007605
GO:0007601
GO:0001709
GO:0046426
GO:0021879
GO:0051301
GO:0021795
GO:0009948
GO:0090596
GO:0043583
GO:2000177
GO:0045596
GO:0031175
GO:0060113
GO:0007050

GO biological processes term
pulmonary valve morphogenesis
regulation of neuron differentiation
sensory perception of sound
visual perception
cell fate determination
negative regulation of JAK-STAT cascade
forebrain neuron differentiation
cell division
cerebral cortex cell migration
anterior/posterior axis specification
sensory organ morphogenesis
ear development
regulation of neural precursor cell proliferation
negative regulation of cell differentiation
neuron projection development
inner ear receptor cell differentiation
cell cycle arrest

170

p-value
5.40E-06
6.80E-05
1.50E-04
3.60E-04
4.10E-04
4.10E-04
6.10E-04
1.12E-03
1.21E-03
1.23E-03
1.77E-03
2.50E-03
2.70E-03
3.29E-03
3.46E-03
4.33E-03
4.76E-03
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